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progenitor cells 
Sonia Shaw 
 
Maintenance of the blood system requires balanced cell-fate decisions of haematopoietic stem and 
progenitor cells (HSPCs). Individual haematopoietic stem cells (HSCs) decide between self-
renewal and differentiation and can generate all mature cell types. Cell-fate decisions are made at 
the single-cell level and are governed by regulatory networks. Dysregulation in this balanced 
process could lead to serious blood disorders such as leukaemia; therefore, it is important to 
understand how individual cells make these cell-fate decisions.  
To investigate HSPC populations, 1,654 cells were profiled by single-cell RNA-sequencing. Index 
sorting made it possible to sort HSPCs using broad sorting gates and retrospectively assign them 
to common HSPC populations, retaining all information about specific functionally pure 
populations while also capturing any intermediate cells normally excluded by conventional gating. 
Reconstruction of differentiation trajectories revealed dynamic expression changes associated with 
early lineage differentiation from HSCs. This transcriptional atlas of HSPC differentiation was 
further used to identify candidate genes for a CRISPR screen investigating genes implicated in 
HSC biology. These candidate gene perturbations were interrogated for changes in the expression 
of the HSC marker EPCR, as well as changes in apoptosis and lineage output. 
Transcription factors play a key role in regulating cell-fate decisions and operate within organized 
regulatory programs. To study relationships between transcription factors in HSPC populations, 
qRT-PCR was used to profile the expression of 41 genes, including 31 transcription factors, in 
HSPCs at the single-cell level. This approach confirmed known aspects of haematopoiesis and 
made deeper investigation of HSPC heterogeneity possible. Regulatory networks were 
reconstructed using Boolean network inference models and recapitulated differentiation of HSCs 
towards megakaryocyte–erythrocyte progenitors and lymphoid-primed multipotent progenitors. 
By comparing these two models, a rule specific to the megakaryocyte-erythrocyte progenitor 
network was identified, in which GATA2 positively regulated Nfe2 and Cbfa2t3h. This was 
subsequently validated using transcription factor binding profiles and in vitro luciferase assays 
using a model cell line.  
iii 
 
Overall, the work presented in this thesis confirmed known aspects of HSPC biology using single-
cell gene expression analysis and demonstrated how in silico approaches can be used to guide in 
vitro and in vivo investigations. In addition, the single-cell RNA-sequencing data was developed 
into an intuitive web interface that can be used to visualise the gene expression for any gene of 
choice at single-cell resolution across the HSPC atlas, providing a powerful resource for the 
haematopoietic community. 
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Chapter 1: Introduction 
 
Parts of this chapter have been adapted from the review article co-authored by Fiona Hamey and 
Sonia Shaw (Hamey et al. 2016). 
 
1.1. The adult haematopoietic system 
The haematopoietic system consists of cells of the blood and immune systems, and is created by 
haematopoiesis, the process of mature blood cell formation (Orkin and Zon 2008; Laurenti and 
Göttgens 2018). The adult human has an estimated turnover of around 1012 blood cells per day, 
sustained by the constant production of new cells (Ogawa 1993). All cells of the haematopoietic 
system arise from haematopoietic stem cells (HSCs), and the mature blood and immune cells are 
involved in performing critical functions such as oxygen and nutrient transport, immune protection, 
and wound repair.  
The haematopoietic system has been extensively studied due to the accessibility of material and 
the ability to isolate and study cells at multiple stages of differentiation (N. K. Wilson et al. 2015). 
It serves as a model system of adult stem cell biology, as well as the cell fate decisions that occur 
during HSC differentiation (Section 1.2) (Orkin and Zon 2008; Laurenti and Göttgens 2018). The 
haematopoietic system is an important system to study, as dysregulation during haematopoiesis 
can lead to serious blood disorders, such as leukaemia (Section 1.3). 
1.1.1. The haematopoietic hierarchy 
The adult haematopoietic system is classically described as a hierarchy, in which long-term HSCs 
(LT-HSCs) lie at the apex of the tree and differentiate through progressively more committed 
progenitors that give rise to all the mature blood cell types (Fig. 1.1). The mature cells produced 
can be divided into myeloid, erythroid, and lymphoid cells, with specific functions ranging from 
oxygen transport by erythrocytes and phagocytosis of pathogens by macrophages, to functions in 
innate and adaptive immunity by lymphocytes such as natural killer cells or B- and T-cells (Bryder, 
Rossi, and Weissman 2006). 
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Figure 1.1. The haematopoietic differentiation hierarchy. The classic view of the haematopoietic tree, based on 
publications by Moignard et al. and Wilson et al. (Moignard et al. 2013; N. K. Wilson et al. 2015). Long-term HSCs 
(LT-HSCs) sit at the top of the hierarchy and differentiation through progressively more committed progenitor cells 
into mature blood cell types. FSR-HSC: finite self-renewal HSC; MPP: multipotent myeloid progenitor; PreMegE: 
pre-megakaryocyte-erythrocyte progenitor; MEP: megakaryocyte-erythrocyte progenitor; CMP: common myeloid 
progenitor; GMP: granulocyte-macrophage progenitor; LMPP: lymphoid multipotent progenitor; CLP: common 
lymphoid progenitor; NK cell: natural killer cell. 
 
Haematopoietic stem and progenitor cells (HSPCs) are found in the bone marrow, the home of 
haematopoiesis in adult mammals (Eaves 2015). At the top of the hierarchy, HSCs are responsible 
for maintaining the entire haematopoietic system. LT-HSCs are capable of both symmetric and 
asymmetric division, meaning they can produce two HSCs or two progenitor cells, or one of each, 
respectively. They generally exist in a quiescent, non-replicative state, and are defined by their 
ability to reconstitute the haematopoietic system in irradiated mice over several months (Morrison 
and Weissman 1994). They were first phenotypically defined as Lineage- Thy1.1low Sca1+, where 
Lineage (Lin) describes a cocktail of mature blood cell markers (Spangrude, Heimfeld, and 
Weissman 1988). Since then, HSC isolation protocols have advanced and can isolate enriched HSC 
populations with increasing functional purity. These strategies are largely based on the LSK (Lin- 
Sca1+ c-Kit+) phenotype and isolate HSCs with up to 50% functional purity; however, higher 
enrichment can be achieved by using the signalling lymphocyte activation molecule (SLAM) 
family of surface markers, including CD48 and CD150, as well as endothelial protein C receptor 
(EPCR) (Beerman et al. 2010; Dykstra et al. 2007; Goodell et al. 1996; Morita, Ema, and Nakauchi 
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2010; Kiel et al. 2005; Balazs et al. 2006; D. G. Kent et al. 2009). In fact, 67% functional purity 
was achieved by isolating SLAM (CD48- CD150+) Sca1hi cells (N. K. Wilson et al. 2015). 
The LSK compartment, which makes up 0.05-1% of the adult bone marrow, also contains short-
term or finite self-renewal HSCs (FSR-HSC), and multipotent progenitors (MPPs). FSR-HSCs 
and MPPs are multipotent progenitors that can transiently provide multilineage repopulation in 
lethally irradiated mice but have limited self-renewal capacity (Spangrude, Heimfeld, and 
Weissman 1988; Curtis et al. 2004; Morrison et al. 1997; Okada et al. 1992; Harrison and Zhong 
1992). MPPs can be subdivided into four subpopulations: MPP1-4 (Pietras et al. 2015). MPP1 cells, 
or FSR-HSCs, were identified as a metabolically active subset of HSCs (A. Wilson et al. 2008; 
Cabezas-Wallscheid et al. 2014). MPP2 and MPP3 cells are distinct myeloid-biased subsets, with 
MPP2 biased towards megakaryocyte production, and MPP3 displaying granulocyte-macrophage 
potential. Finally, MPP4 cells are a lymphoid-primed MPP subset (Pietras et al. 2015). All four 
MPP subtypes work together to control blood production. It was originally thought that MPPs give 
rise to mature blood cells by directly differentiating into common myeloid progenitors (CMPs) and 
common lymphoid progenitors (CLPs) (Akashi et al. 2000; Kondo, Weissman, and Akashi 1997). 
However, more recent work showed that MPPs high in Flk2 expression produce both lymphoid 
and granulocyte-monocyte lineages (Adolfsson et al. 2001, 2005). These cells were named 
lymphoid-primed multipotent progenitors (LMPPs).  
LMPP cells expressed granulocyte-macrophage and lymphoid genes, and can produce 
granulocytes, macrophages, T- and B-cells, and only very rarely megakaryocyte-erythroid cells 
(Luc et al. 2008; Adolfsson et al. 2001, 2005). A study by Pronk et al. compared transcriptional 
profiles of CLPs and a pre-granulocyte-macrophage cell type with predominant myeloid potential, 
and found they were more similar to each other than either cell type was to cells of the erythroid 
lineage (Pronk et al. 2007). These results suggest that the lymphoid and myeloid lineages branch 
off earlier than the erythroid lineage, and LMPPs mark a first step towards lymphoid and myeloid 
lineages. As cells become increasingly lymphoid-restricted, granulocyte-monocyte potential is lost, 
resulting in CLPs. These cells lack myeloid potential, but can rapidly produce natural killer (NK) 
cells, B- and T-cells (Kondo, Weissman, and Akashi 1997). 
CMPs were identified by Akashi et al. as a population that can give rise to all myeloid lineages, 
producing megakaryocyte-erythroid progenitors (MEPs) and granulocyte-monocyte progenitors 
(GMPs) (Akashi et al. 2000). The functional and cell-fate identity of this population has been 
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challenged by several studies (Section 1.1.2). As it is possible to isolate both CMPs and LMPPs, it 
is possible GMPs can arise independently from both populations. These cells produce 
macrophages, granulocytes and mast cells (Dahlin and Hallgren 2015; Akashi et al. 2000). MEPs, 
on the other hand, exclusively produce erythrocytes, megakaryocytes, or mixed colonies (Akashi 
et al. 2000). Evidence suggests that MEPs may be derived from CMPs or directly from HSCs (H. 
Iwasaki et al. 2005). More detailed erythroid and myeloid progenitors can be elucidated using 
CD105, CD150 and CD41, which identified the PreMegE (pre-megakaryocyte-erythrocyte) 
population (Pronk et al. 2007). These cells produced erythrocyte, megakaryocyte, and mixed 
colonies, indicating PreMegEs have no granulocyte-macrophage potential and include bipotential 
progenitors as well as cells in early commitment stages. They are likely to occur slightly earlier in 
development than MEPs as functional and gene expression analyses indicate they are upstream of 
early unipotent cell populations that specifically give rise to erythroid colonies or megakaryocytes 
(Pronk et al. 2007). 
1.1.2. Challenges to the classic view of the haematopoietic hierarchy 
In recent years, questions have been raised that are altering the classical view of the haematopoietic 
hierarchy, in which all mature blood cells are produced from a single LT-HSC population 
(Cavazzana-Calvo et al. 2011). In mice, four subtypes of adult bone marrow HSCs were identified 
(α, β, γ and δ) that vary in their lineage bias and self-renewal activity (Dykstra et al. 2007). 
Specifically, α and β cells have robust self-renewal activity, but α cells are lymphoid potential-
deficient; γ cells are multipotent but have limited self-renewal activity and are derived from β cells, 
suggesting they represent an intermediate stage of repopulating cells; δ are the most lymphoid-
primed, lacking durable myeloid potential, and also have limited self-renewal capacity. Only β 
cells demonstrate traits typically associated with LT-HSCs (Dykstra et al. 2007). Other studies 
have also suggested the existence of lineage-primed HSCs alongside balanced HSCs based on 
repopulation kinetics, differential cytokine responses, and transcription factor expression patterns 
(Muller-Sieburg et al. 2002, 2004; Sieburg et al. 2006; Adolfsson et al. 2005; Arinobu et al. 2007). 
Overall, recent evidence suggests that more heterogeneity and lineage-priming exist in HSCs than 
previously recognised. 
Furthermore, the functional and cell-fate identity of CMPs has been questioned by multiple groups 
(Adolfsson et al. 2005; Arinobu et al. 2007; Bendall et al. 2014; Görgens et al. 2013; J. H. Levine 
et al. 2015; Murre 2007; Pronk et al. 2007; Laurenti et al. 2008; Yamamoto et al. 2013). A recent 
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study questioned the existence of the CMP population by using massively parallel RNA-
sequencing (MARS-seq) to measure gene expression in 2,730 myeloid progenitors. Paired with 
transplantation assays, the authors found that CMPs are not heterogeneous cells with undetermined 
fates, but are instead primed towards erythroid or myeloid fates (Paul et al. 2015). Perié et al. 
reached a similar conclusion with a genetic barcoding experiment, which showed that CMPs 
produce highly biased myeloid or erythroid outputs after 14 days (Perié et al. 2015). These studies 
suggest that cells defined as CMPs may actually be at an early commitment stage, and therefore 
question the usefulness of this classically defined population (Hamey et al. 2016). 
While the haematopoietic hierarchy has been well-defined, evidence of heterogeneity in HSPCs, 
as well as questions raised about cell functions and identities, demonstrate gaps in our 
understanding of the differentiation pathways towards myeloid, erythroid, and lymphoid cell fates.  
1.2. Cell fate decision making 
Cell fate decisions are controlled by patterns of gene expression and are essential in maintaining 
the haematopoietic system and determining haematopoietic differentiation pathways. Gene 
expression occurs when a DNA sequence is transcribed into RNA, which, for protein-coding genes, 
is translated into a protein by a ribosome. The process is regulated at every step by extrinsic 
signalling and epigenetic factors; understanding how gene expression is regulated is critical for 
understanding how cell fate decisions occur in haematopoiesis.  
1.2.1. Chromatin structure and epigenetics 
The genomes of higher eukaryotes are primarily made up of non-coding regions, as well as protein-
coding and RNA-coding genes, which only make up around one percent of the 3.3Gbp of sequence 
(Lander et al. 2001). The non-coding regions have important functions such as encoding regulatory 
DNA elements (section 1.2.2) and structural DNA elements, such as centromeres and telomeres 
(Alexander et al. 2010). 
Due to its large size, DNA must be packaged efficiently within the nucleus of every cell, while still 
allowing access to DNA for gene expression and DNA replication. This is achieved by supercoiling 
the DNA around histones to form nucleosomes (Kornberg and Lorch 1992, 1999). Accessibility to 
DNA is modified by chromatin remodellers, which are ATP-dependent enzymes that move 
histones along the DNA helix. This produces two chromatin states: euchromatin, which is open 
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and transcriptionally active, and heterochromatin, which is dense and silent (Felsenfeld and 
Groudine 2003).  
Epigenetic modifications are also able to influence transcription factor binding to DNA and 
regulation of gene expression by acting on both DNA and histones. DNA methylation at cytosine 
residues is a stable and heritable repressive mark, causing epigenetic silencing. It is essential for 
normal development and is involved in processes such as genomic imprinting and X-chromosome 
inactivation. Epigenetic post-transcriptional modifications of histones include acetylation, 
methylation, phosphorylation, ubiquitination and sumoylation of the histone tails (Jin, Li, and 
Robertson 2011). Specific proteins regulate histone modifications. These proteins include histone 
acetyl and methyl transferases, as well as histone deacetylases (Kouzarides 2007). Histone 
modifications regulate processes such as gene transcription, DNA replication and DNA repair 
(Cedar and Bergman 2009).  
1.2.2. Gene regulatory elements 
Gene regulatory elements (GREs) are categorised by their function and include promoters, 
enhancers, silencing elements, insulators, and locus control regions. GREs are generally cis acting, 
meaning they act on the same DNA strand (Maston, Evans, and Green 2006). 
RNA polymerase binds the promoter region to initiate transcription. The promoter has well 
characterised features that facilitate pre-initiation complex assembly, including specific DNA 
sequences to which general transcription factors bind, leading to the recruitment of the RNA 
polymerase. The most common is the TATA box, which is approximately 30bp upstream of the 
transcriptional start site. Once bound by the TATA-binding protein, the DNA is partially unwound 
to facilitate transcription (Lee and Young 2000).  
Enhancers are important for activating transcription above basal levels, resulting in tissue-specific 
gene expression. They are able to do so independent of location and orientation (Maniatis, 
Goodbourn, and Fischer 1987). Transcription factors bind to distal enhancers and cause the 
enhancer to loop to the promoter, whereas co-localised enhancer and promoter elements form 
“chromatin hubs” and integrate transcriptional regulation with other cis-regulatory elements 
(Bulger and Groudine 2011). The Mediator protein complex is important for coordinating 
promoter-enhancer interactions with the basal transcriptional machinery (Malik and Roeder 2010; 
Maston, Evans, and Green 2006).  
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Insulators block the transcriptional effect of neighbouring genes and prevent crosstalk between 
genomic regions. They are important for preventing inappropriate regulation of adjacent genes, as 
well as separating the genome into functional and non-functional transcriptional units (Bushey, 
Dorman, and Corces 2008; Joughin et al. 2010). Silencers also have a negative effect on 
transcription, and are sequence-specific elements that may exert their effect by directly interfering 
with the general transcription factor assembly, or by passively inhibiting other elements upstream 
of the target gene (Ogbourne and Antalis 1998; Maston, Evans, and Green 2006). Locus control 
regions enhance the expression of linked genes at distal chromatin regions in a tissue-specific and 
copy number-dependent manner. They are involved in regulating gene expression through 
chromatin domain-opening activity, as well as increasing transcriptional activity to physiological 
levels (Q. Li et al. 2002). Overall, different functions are executed by cis-acting GREs to contribute 
to the regulation of cell lineage-specific gene expression. 
1.2.3. Transcription factors 
Transcription factors are a key class of trans-acting transcriptional regulators that exert their effects 
by binding to DNA elements. Transcription factors rarely act independently, but rather form 
complexes with other transcription factors, chromatin modifiers and co-factors (Ravasi et al. 2010; 
Vaquerizas et al. 2009). An enhancer is usually bound by multiple transcription factors, which may 
have mutually exclusive or stabilising functions (M. Levine and Davidson 2005). Transcription 
factors may bind directly to specific DNA binding sites or indirectly through other transcription 
factors (Slattery et al. 2014). They often have cell type-specific expression patterns and play a key 
role in determining gene expression profiles and cell fates (Vaquerizas et al. 2009).  
1.2.3.1. Transcription factors in haematopoiesis 
A number of transcription factors are known to play key roles in haematopoiesis and HSC 
regulation. Indeed, examples of key transcription factors can be identified along the erythroid, 
myeloid, and lymphoid lineages. Tal1 encodes the transcription factor SCL, which is key for the 
development of HSPCs (Bloor et al. 2002). Disruption of Tal1 also causes defects in the erythroid 
and megakaryocytic lineages (Hall et al. 2003). Neutrophil differentiation is regulated by the 
transcription factor encoding gene Gfi1, as mice lacking its expression have defects in neutrophil 
production (Hock et al. 2003; Karsunky et al. 2002). Ikzf1 encodes the transcription factor 
IKAROS, which is key in normal B-cell development; mouse models demonstrate that an Ikaros-
null mutation results in foetal and adult defects in lymphopoiesis (J. H. Wang et al. 1996; Marke, 
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van Leeuwen, and Scheijen 2018). Therefore, given the key role transcription factors play in 
determining cell-fates, it is important to investigate their regulation to improve our understanding 
of gene expression dynamics during HSPC differentiation.  
Specific transcription factors important for haematopoiesis will be discussed in more detail in 
Chapters 4-6. 
1.2.4. Gene regulatory networks 
Haematopoiesis is determined by the complex regulation of gene expression through gene 
regulatory networks, which are made up of transcription factors, epigenetic regulators, as well as 
GREs (Davidson 2009). Transcription factors can regulate their own expression as well as that of 
other transcription factors, generating feed-back and feed-forward loops and creating complex 
interconnected circuits (John E. Pimanda and Gottgens 2010; Davidson 2009; Miranda-Saavedra 
and Göttgens 2008; Davidson 2010). Gene regulatory networks describe highly interconnected 
relationships between transcription factors and the genes they regulate, in which the effect on gene 
expression caused by transcription factor binding determines the stability of gene expression (Alon 
2007). The network therefore determines which transcription factors are expressed at any moment, 
defining cell identities. As such, investigating gene regulatory networks can be useful to understand 
how transcription factors interact to cause cell fate changes. Network reconstruction will be further 
discussed in Section 1.5.4.3. 
 
1.3. Dysregulation of transcriptional control in haematopoiesis 
The haematopoietic system is tightly regulated as any dysregulation in the gene regulatory network, 
such as transcription factor overexpression, deletion, or abnormal gene fusions, can result in 
imbalance and malignancy (Sive and Göttgens 2014). The disruption of transcription factor 
function can, for example, lead to leukaemia. The transcription factor Runx1 is essential during 
definitive haematopoiesis in embryonic development, and its absence causes embryonic death in 
mouse models (Q. Wang et al. 1996; Okuda et al. 1996). In adult human haematopoiesis, however, 
disruption of RUNX1 results in predisposition to acute myeloid leukaemia (AML) (Sun and 
Downing 2004; Sakurai et al. 2014; M. Ichikawa et al. 2004). The transcription factor was in fact 
discovered by an observation that the gene was rearranged in leukaemic cells of t(8;21) AML 
patients to form the RUNX1-ETO fusion protein (Miyoshi et al. 1991). The transcription factor 
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SCL was also identified by its role in T-cell acute lymphoblastic leukaemia (ALL), in which it was 
ectopically expressed due to t(1;14) chromosomal translocations (Begley et al. 1989). Lmo2 
encodes a transcription factor that normally activates an erythroid-specific gene expression 
program (Warren et al. 1994). It was identified by a t(11;14) translocation in T-cell ALL (Boehm 
et al. 1991). Mouse models have shown that activation of LMO2 by the translocation causes self-
renewal of committed T-cells, which accumulate additional mutations and eventually cause 
leukaemia (Herblot et al. 2000; Curtis and McCormack 2010). 
Understanding the processes regulating HSPC differentiation during normal haematopoiesis is 
therefore key for uncovering how its dysregulation results in aberrant decision-making, which in 
turn lead to serious blood disorders (Tenen 2003).  
1.4. Mammalian genome editing 
Targeted genome editing was first achieved by homologous recombination, in which a DNA 
sequence is exchanged between two similar sequences; it is also a DNA repair mechanism which 
replaces damaged DNA (Scherer and Davis 1979; Smithies et al. 1985; X. Li and Heyer 2008). 
Traditional methods took advantage of endogenous homologous recombination to alter the 
genome, which was a precise but inefficient approach and was only possible in mice due to the 
absence of culturable embryonic stem cells in other mammals (D. Carroll 2017).  
Advances in genome editing technologies have made it possible to perform genetic manipulations 
at higher efficiencies in all types of cells and organisms. These high-efficiency methods are 
programmable to cause a double-stranded break at the desired target, stimulating repair by 
homologous recombination or non-homologous end-joining (K. Lim 2015). These genome-editing 
technologies use engineered nucleases composed of a sequence-specific DNA-binding domain, 
which searches for the target locus, and a non-specific DNA cleavage molecule, which generates 
the double-stranded break (Gaj et al. 2013; K. Lim 2015). These methods include zinc-finger 
nucleases (ZFN), transcription activator-like effector nucleases (TALENs) and clustered regularly 
interspaced short palindromic repeats (CRISPR)/Cas9. Briefly, ZFNs are a hybrid of a DNA 
cleavage domain derived from a bacterial protein and zinc fingers identified from sequence-specific 
eukaryotic transcription factors. TALENs use the same DNA cleavage domain, but its sequence-
specific DNA-binding domain is derived from DNA recognition modules from transcription factors 
of plant pathogenic bacteria (D. Carroll 2017). CRISPR/Cas9, on the other hand, is a prokaryotic 
acquired immunity system and uses RNA molecules to target a genomic locus (Barrangou et al. 
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2007; Makarova et al. 2006). It has become the system of choice for genome editing, as it is a more 
efficacious, less expensive, and less cumbersome technology than ZFNs or TALENs. The 
CRISPR/Cas9 system was used in this thesis to perturb target genes in HSCs (Chapter 4). 
1.4.1. The CRISPR/Cas9 system 
The CRISPR/Cas9 system for genome editing was adapted from the acquired immunity mechanism 
of bacteria and archaea. The microbes capture viral DNA segments and integrate them between 
CRISPR sequences, which are transcribed into CRISPR RNAs (crRNA). The crRNA then guides 
the silencing of invading DNA by Cas nucleases. Cas9 in particular participates in crRNA 
biogenesis and destruction of invading DNA (Jinek et al. 2012; Sorek, Lawrence, and Wiedenheft 
2013).  
This system has recently been adapted for mammalian genome editing (Cong et al. 2013; Mali et 
al. 2013). A short guide RNA (gRNA) sequence is designed to bind a target sequence in the 
genome. The gRNA also binds the Cas9 nuclease and guides it to cut at the target location. This 
technology allows virtually any genomic location to be effectively targeted (P. D. Hsu, Lander, and 
Zhang 2014). The CRISPR/Cas9 technology also makes it possible to more easily perform genome-
wide knockout screens. Individual cells can be perturbed by one or more gRNA from a pooled 
library targeting thousands of genes. Cells that have had essential genes knocked out will die, but 
the surviving cells can be sequenced to uncover the genes causing their perturbation phenotype 
(Shalem et al. 2014; T. Wang et al. 2014).  
1.4.1.1. CRISPR/Cas9 use in investigations of the haematopoietic system 
CRISPR/Cas9 has also been used to perform genome editing of HSPCs. For example, lentiviral 
transduction of gRNAs and Cas9 into a single HSC was used to modify five genes and produce 
myeloid malignancy, generating an AML mouse model (Heckl et al. 2014). In human HSPCs, 
transfection of Cas9 and gRNA encoding plasmids was used to target B2M and CCR5 to investigate 
the possible therapeutic implications of the technology (Mandal et al. 2014). A CRISPR-Cas9 
knockin mouse, which expresses Cas9 and can be transfected with target gRNAs, has also been 
effectively used for genomic research (Platt et al. 2014; Pettitt et al. 2009). Tzelepis et al. designed 
a genome-wide CRISPR screening platform to identify therapeutic targets in AML. Cas9-
expressing mice were used to validate their murine lentiviral gRNA library. By transducing Cas9-
expressing cancer cell lines with the gRNA library, they identified 492 AML-specific cell-essential 
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genes as well as many other clinically actionable candidates (Tzelepis et al. 2016). These studies 
demonstrate the value of using CRISPR/Cas9 genome editing to interrogate HSPC biology with 
potential therapeutic implications. 
1.5. Single cell biology 
Analysis of transcriptional regulation has traditionally used bulk cell populations, often due to the 
limitations of available technologies. However, these analyses can only provide information on cell 
population averages (Moignard and Göttgens 2014). While HSPCs regulate their functional output 
at the population level, differentiation is a stochastic process occurring in individual cells (A. M. 
Klein and Simons 2011; Simons and Clevers 2011). Bulk expression analysis assumes 
homogeneity within a population and may therefore fail to capture the heterogeneity of the fate 
decision-making processes of individual cells (Fig. 1.2A). Advances in single-cell profiling 
technology have now made it possible to profile large numbers of individual cells simultaneously, 
which has been widely explored in HSPCs to increasingly define the heterogeneity within different 
cell types (N. K. Wilson et al. 2015; Paul et al. 2015; Hamey et al. 2016). 
1.5.1. Heterogeneity in HSPC populations 
It is widely accepted that haematopoiesis occurs in a hierarchical fashion, in which HSCs 
differentiate into mature blood cells, passing through intermediate progenitor states with varying 
lineage potential (Bryder, Rossi, and Weissman 2006; Pronk et al. 2007; Laurenti and Göttgens 
2018). Technological advances have made it possible to study the haematopoietic hierarchy in 
further detail, revealing heterogeneity within HSPC populations, including the HSC pool. Single-
cell clonal output investigations have shown that heterogeneity exists within the HSC compartment 
in terms of their self-renewal and repopulation potential, as well as their differentiation output, 
highlighting the need to study individual cells rather than population averages (Dykstra et al. 2007). 
Furthermore, the MPP compartment has been subdivided into four functionally distinct subgroups 
(Pietras et al. 2015; Cabezas-Wallscheid et al. 2014).  
Indeed, single-cell studies have also challenged the structure of the haematopoietic hierarchy. A 
study that isolated human cells from myeloid, erythroid, and megakaryocytic fates found that most 
of the multipotent cells in the bone marrow were in the HSC compartment and there was an absence 
of intermediate progenitor populations (Notta et al. 2015). Single-cell barcoding can be used to 
study functional properties of cells by tagging individual cells with unique barcodes that are 
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noncoding stretches of DNA (Naik, Schumacher, and Perié 2014). Cells are commonly labelled 
with these barcodes by retroviral transduction, allowing the cells to be tracked in vivo. Perié et al. 
used this technique to track the contribution of individual cells to different lineages after 
transplantation into lethally irradiated mice, sequencing the cells to reveal the barcode identity 
(Perié et al. 2015). They investigated whether the CLP-CMP divide is the first step of lineage 
commitment. As previously discussed, they found that the CMP population is composed of 
heterogeneous cells primed towards myeloid or erythroid outputs, suggesting they are at an early 
commitment stage. Furthermore, after transplanting barcoded HSCs and MPPs, they found that cell 
fates toward myeloid and erythroid lineages were mainly determined by the HSCs while most 
MPPs were restricted to a single fate (Perié et al. 2015). These studies together demonstrate the 
heterogeneity that exists within HSPCs, as well as the value single-cell analysis offers for resolving 
the behaviour of individual cells.  
1.5.2. Fluorescence-Activated Cell Sorting 
An essential first step in many single-cell profiling techniques is the isolation of individual cells. 
To do so, many studies take advantage of fluorescence-activated cell sorting (FACS), which 
quantitatively assesses fluorophores at single-cell resolution. Cells are stained with fluorophore-
conjugated antibodies against cell surface markers and separated based on multiple parameters, 
including size, granularity and fluorescent properties correlated to surface marker expression 
(Lindström 2012). Flow cytometers can detect 30 or more different parameters per cell, limited by 
the number of distinguishable fluorophores and capabilities of the instrument and analysis software 
(Nettey, Giles, and Chattopadhyay 2018; Brummelman et al. 2017). The sorted cells can then be 
used in various applications, such as functional or gene expression analyses. However, the cells 
can usually only be used for one type of experiment and therefore represent a snapshot of the cell 
population at the point of collection. If collected at the single-cell level, the snapshots are likely to 
reveal heterogeneity among the isolated cells. 
Index sorting is an important advancement in FACS, as it collects data for all the parameters 
measured, including well position for each single-cell sorted into a 96- or 384-well plate. By pairing 
FACS with index sorting, it is possible to obtain the FACS phenotype of every cell, to be 
retrospectively reviewed (Osborne 2011; Schulte et al. 2015). The index sorting data can then be 
paired with gene expression analysis to compare populations based on both gene and surface 
marker expression (Fig. 1.2B). This technique is widely applicable and can be used to characterise 
13  Introduction 
 
 
many cellular systems (Schulte et al. 2015; Hayashi et al. 2010). In the haematopoiesis field, 
Wilson et al. paired single-cell gene expression profiling with functional analyses to interrogate 
heterogeneity within HSC isolation strategies (N. K. Wilson et al. 2015). They defined a refined 
sorting strategy that separated HSCs from non-HSCs by retrospectively linking gene expression 
profiles and functional outcome to the index sorting data. Single-cell transplantation and RNA-
sequencing of the enriched population identified genes associated with long-term self-renewal. The 
study highlighted a key difference in the enrichment for cell cycle genes between functional HSCs 
and non-HSCs, where HSCs expressed higher levels of genes associated with negative regulation 
of cell proliferation and non-HSCs were primed towards proliferation (N. K. Wilson et al. 2015).  
 
Figure 1.2. Single-cell analysis. (A) Schematic demonstrating the importance of single cell analysis. Profiling a 
population using bulk analysis will only reveal population averages and therefore will obscure the heterogeneity that 
exists in individual cells. Single-cell technology makes it possible to collect measurements for individual cells, 
revealing the variance that exists in heterogeneous populations. (B) Sorting cells using fluorescence-activated cell 
sorting (FACS) makes it possible to isolate individual cells to be analysed using single-cell molecular profiling 
techniques. The technique used will vary based on the experimenter's interests and include qRT-PCR or scRNA-seq. 
FACS paired with index sorting collects data for all parameters measured, including surface marker expression and 
well position for each cell. The gene expression profiles can therefore be compared to the surface marker expression 
data to characterise populations and inform future work. qRT-PCR: quantitative real-time polymerase chain reaction; 
RNA-seq: RNA-sequencing. Figure adapted from Hamey et al. (2016). 
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Another technique for studying single cells is mass cytometry (Cytometry by Time of 
Flight/CyTOF). While FACS uses fluorochromes to label antibodies, mass cytometry instead 
requires the antibodies to be labelled with transition element isotopes, which are then quantified 
by the concentrations of metal-tagged antibodies (Bendall et al. 2012; Behbehani et al. 2012). Mass 
cytometry can measure 40 or more parameters simultaneously, allowing for in-depth investigations 
of cell phenotypes, limited only by the choice of antibodies. It can be a useful method for studying 
signalling cells in a variety of experimental conditions (Behbehani et al. 2012). However, the cells 
are not available for further molecular and functional analyses after mass cytometry; instead, the 
results may provide insights for designing FACS strategies for further investigations (Behbehani 
et al. 2012).  
1.5.3. Single-cell gene expression profiling 
The heterogeneity of cell populations also affects the analysis of regulatory relationships. Using 
population expression data to extrapolate to the single-cell level forces assumptions about how 
individual cells behave. It is necessary to know whether genes are expressed in the same cell to 
determine whether they are co-regulated or regulate each other; these relationships will be masked 
at the population level, which suggests all cells express the same level of each gene. Therefore, 
single-cell gene expression analysis is a useful tool to reveal the complex relationships that exist 
within a gene regulatory network. 
Single-cell technologies are rapidly advancing and expanding, with new technologies frequently 
being introduced. To study gene expression at the single-cell level, techniques such as quantitative 
real-time polymerase chain reaction (qRT-PCR) and single-cell RNA-sequencing (scRNA-seq) can 
be applied. qRT-PCR amplifies specific messenger RNA (mRNA) transcripts to measure the 
expression of selected genes; when performed on single cells, expression of multiple genes can be 
measured at the single-cell level (Sanchez-Freire et al. 2012). Fluidigm BioMarkTM is a dynamic 
array integrated microfluidics circuit which allows gene expression studies of up to 96 selected 
genes in 96 cells. This can be further extended by using multiplexing approaches (G. Guo et al. 
2013). The genes of interest are selected by the investigator, meaning the technique is best used for 
looking at specific questions, targets or systems (Moignard et al. 2013). Single-cell qRT-PCR has 
been widely used to interrogate heterogeneity and transcriptional regulation in HSPCs (G. Guo et 
al. 2013; N. K. Wilson et al. 2015; Moignard et al. 2013, 2015; Pina et al. 2012, 2015).  
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In contrast to qRT-PCR, which is limited to a small, curated set of genes, scRNA-seq is a 
transcriptome-wide approach for measuring gene expression. The mRNA from single cells is 
reverse-transcribed and the resulting complementary DNA (cDNA) is amplified and sequenced as 
a pool, with unique combinations of indexes marking each cell (Picelli et al. 2014; Kolodziejczyk 
et al. 2015). This method can be used to profile gene expression in individual cells within a 
population of interest, providing insights into differentiation lineages and the regulatory 
programmes governing these populations (Nestorowa et al. 2016). Similarly, MARS-seq is an 
automated method of RNA sequencing, designed to process thousands of multiplexed cells that are 
barcoded at the molecular, cellular and plate level (Jaitin et al. 2014). This approach allows the 
processing of thousands of cells as well as the characterisation of multiple cell populations within 
a single dataset for an in-depth and broad picture of variability and heterogeneity; however, 
compared to scRNA-seq, it results in much shallower sequencing depth per cell. New technologies 
are constantly emerging in the single-cell field, aiming to increase throughput while keeping costs 
low; the technologies relevant to this thesis are scRNA-seq and qRT-PCR, which will be explored 
further in Chapters 3 and 5, respectively. 
1.5.4. Computational analysis of single-cell data 
Single-cell expression profiling can produce tens to thousands of gene expression measurements 
per cell, in which each cell represents part of a heterogeneous population. These datasets are 
complicated to interpret due to the high-dimensionality nature of the data. Single-cell expression 
profiling therefore needs to be paired with computational methods to resolve the complex datasets 
and enable investigations of the underlying biology. 
1.5.4.1. Dimensionality reduction 
Dimensionality reduction methods make it possible to visualise high-dimensional data in a low-
dimensional space, most frequently in two or three dimensions. Doing so enables comparisons of 
gene expression between groups of cells. Dimensionality reduction methods have been widely 
applied to population expression data to uncover differences between cells (Fig. 1.3A) (Hamey et 
al. 2016).  
Principal component analysis (PCA) is a widely used linear dimensionality reduction method 
(Hotelling 1933a, 1933b; Pearson 1901; Jolliffe 2011). PCA applies a linear transformation to the 
data so that each principal component (PC) explains the maximum variance within the data. They 
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are ordered so that PC1 has the largest variance, followed by PC2, and so on; as such, plotting the 
data in the first two or three PCs can reveal separation between different cell states. PCA has been 
applied to single-cell analysis of HSPCs, for example to investigate aging and differentiation in 
HSCs or to interrogate the regulation of erythroid and myeloid fates (Kowalczyk et al. 2015; Pina 
et al. 2015).  
However, linear techniques may struggle with capturing complex structures and may not always 
be the most suitable visualisation for single-cell expression profiles. Recently, non-linear methods 
such as t-distributed stochastic embedding (t-SNE) and diffusion maps have been applied to single-
cell data to uncover more complex relationships in the data (Maaten and Hinton 2008; Haghverdi, 
Buettner, and Theis 2015). t-SNE embeds the data in a low-dimensional space while conserving 
the distribution of distances in the high-dimensionality space, meaning that cells with similar 
expression profiles are nearby on the reduced dimensionality plot. This method has been used on 
single-cell datasets to interrogate diverse aims, such as visualising the overlap between 
haematopoietic populations or investigating the molecular mechanisms underlying development in 
the mouse embryo (N. K. Wilson et al. 2015; Scialdone et al. 2016). These studies demonstrate the 
usefulness of t-SNE for representing heterogeneous single-cell datasets. 
Single-cell expression profiling can be used to capture molecular changes throughout 
differentiation. These datasets need to be visualised with an appropriate dimensionality reduction 
method, which can capture the continuous nature of differentiation. Diffusion maps consider 
lengths of diffusion-like random walks through the data in the high-dimensional space to determine 
a projection of the cells. This method has been adapted for use with single-cell expression data 
(Haghverdi, Buettner, and Theis 2015). Moignard et al. used the diffusion map method on single-
cell qRT-PCR data to visualise cell progression during early blood development, in which diffusion 
maps successfully separated populations from different time points and illustrated a progression 
through differentiation (Moignard et al. 2015). 
In addition to these methods, researchers have developed web interfaces that are accessible to non-
bioinformaticians. The advantage of these methods is the same as their disadvantage—the 
interfaces are quick and easy to use, producing a plot of a complex dataset within minutes, but the 
investigator has little to no input on how these plots are constructed. Still, these methods can be 
highly informative and do not require any computational skill to analyse the dataset. Two such 
methods are STREAM (Single-cell Trajectories Reconstruction, Examination and Mapping) and 
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SPRING (H. Chen et al. 2018; Weinreb, Wolock, and Klein 2018). STREAM was developed to 
reconstruct differentiation trajectories and capture gene expression changes during differentiation 
using pseudotime ordering, which orders cells in a putative differentiation trajectory based on gene 
expression (Section 1.5.4.2). STREAM uses a non-linear dimensionality method called modified 
local linear embedding (MLLE), which uses multiple weight vectors for each point while 
embedding the low-dimensional data (Z. Zhang and Wang 2006). STREAM is unique in that the 
visualisation includes density information throughout pseudotime to show how many cells of each 
investigated population are in which stage of differentiation. The online web-interface can also be 
used to identify genes important in defining branching points, as well as genes that transition across 
a given lineage branch (H. Chen et al. 2018).  
SPRING, on the other hand, uses a force-directed layout of k-nearest neighbour graphs to capture 
long-distance relationships between cells (Weinreb, Wolock, and Klein 2018). Cells are connected 
based on similarities in their expression profiles, and the connections form the edges of the graph. 
Edges are weighted by the strength of similarities between cells, and the graph is then generated 
by bringing similar cells together: the edges cause an attracting force between similar cells or a 
repelling force between cells that differ. Force-directed graphs have previously been used to 
visualise haematopoietic data collected by mass cytometry. The Klein lab have recently created an 
interactive web-interface for researchers to explore their scRNA-seq expression data (Spitzer et al. 
2015; J. H. Levine et al. 2015; Weinreb, Wolock, and Klein 2018). 
Overall, a wide range of dimensionality-reduction and visualisation methods are available; the best 
choice for a specific project will ultimately depend on the dataset and question at hand. These 
methods are further explored in Chapter 3. 
Dimensionality reduction makes it possible to not only visualise heterogeneity within a dataset, but 
to also group cells and query differences between populations. Clustering methods separate cells 
into groups in an unsupervised and unbiased way, based on information such as gene expression 
profiles (Fig 1.3B). Gene expression specific to individual populations can then be used to identify 
cell types or novel marker genes (Hamey et al. 2016). Hierarchical clustering is a well-established 
method that has been used extensively to identify subgroups of cells within single-cell data, and 
therefore connects or separates cells in a heterogeneous dataset based on their gene expression (N. 
K. Wilson et al. 2015; Moignard et al. 2013; G. Guo et al. 2013). 
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Figure 1.3. Single-cell profiling enables the exploration of cell population heterogeneities. (A) Dimensionality 
reduction techniques allow visualisation of heterogeneities within a population of cells based on single-cell expression 
profiles. Plotting cells in this two-dimensional coordinate system can confirm that subpopulations separate based on 
their expression profiles (i) or can be used to visualise data with a continuous nature, for example describing 
differentiation processes (ii). (C) Unbiased clustering techniques can be used to explore similarities between cells in 
single-cell datasets. In hierarchical clustering, as shown here, the most similar groups of cells are closely connected in 
the dendrogram. This structure then allows exploration of different levels of clustering within the data: for example, 
the cells can be split into three groups corresponding to their cell type. Figure adapted from Hamey et al. (2016). 
 
1.5.4.2. Reconstructing lineage differentiation 
During haematopoiesis, a cell increasingly specialises as it commits to one of several cell fates. 
Isolating populations at different stages of differentiation and profiling them at the single-cell level 
describes cell differentiation but is limited by time resolution and therefore assumes the cells are 
synchronised. However, as discussed in section 1.5.1, single-cell analysis reveals the large 
variation that exists in populations previously thought to be homogeneous in bulk studies (N. K. 
Wilson et al. 2015; Moignard et al. 2013, 2015; Pina et al. 2015). To resolve the heterogeneity 
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within data, in silico lineage reconstruction uses computational methods to infer lineage 
differentiation based on single-cell data. 
Individual cells undergoing differentiation can be clustered into groups based on single-cell 
expression profiling data. The most similar groups can be connected into a structure representing 
a lineage hierarchy (Fig. 1.4A) (Hamey et al. 2016). The spanning-tree progression analysis of 
density-normalised events (SPADE) algorithm uses this approach to construct lineage hierarchies 
from flow and mass cytometry data (P. Qiu et al. 2011). SPADE calculates a density-dependent 
sample of the data to ensure that rare populations are not obscured, after which the cells are 
clustered based on their expression profiles. The clusters are then linked in a tree structure 
representing the lineage hierarchy. An advantage of SPADE is that it includes rare cell populations 
and does not require prior information to infer the lineage structure, but the different random 
density-dependent samples can lead to different clusters and therefore alternative tree structures, 
limiting the stability of this approach (Hamey et al. 2016). SPADE was used by Guo et al. to 
construct a lineage tree of the haematopoietic hierarchy (G. Guo et al. 2010). The authors 
questioned whether commitment occurs at the CMP stage using single-cell qRT-PCR data 
quantifying 280 commonly used surface markers. The lineage tree constructed by SPADE showed 
CMPs were found in both megakaryocyte-erythrocyte (MegE) and lympho-myeloid lineages, and 
that MegE cells were closely connected to LT-HSCs, indicating a very early lineage bias (G. Guo 
et al. 2013).  
Scaffold is another computational method used to reconstruct differentiation hierarchies. The 
approach involves an initial clustering step, from which a force-directed graph is constructed. 
Spitzer et al. used Scaffold to visualise the hierarchy of the murine immune system based on single-
cell mass cytometry data (Spitzer et al. 2015). The authors constructed Scaffold maps for cells from 
different samples to compare the immune system organisation in different tissues, species, and 
genetic backgrounds, and demonstrated that circadian rhythm influenced the distribution of 
immune cells. Scaffold also allows new data to be projected onto an existing structure, making it 
possible to integrate multiple datasets from various tissues and disease states (Spitzer et al. 2015). 
These studies demonstrate how constructing differentiation hierarchies in silico can provide 
insights into biological systems. 
Ordering individual cell profiles by progress through differentiation is an exciting extension of 
inferring differentiation hierarchies. Assuming that gene and protein expression continuously 
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change as cells differentiate, and that a sample contains cells spread at a sufficient density through 
differentiation, it was hypothesised that single‐cell expression profiles could be used to arrange 
cells in ‘pseudotime’, where the position of a cell in pseudotime corresponds to its progress through 
differentiation (Fig. 1.4B) (Hamey et al. 2016). Algorithms have been designed based on these 
assumptions to solve this computational ordering problem. Trapnell et al. describe Monocle, which 
performs a dimensionality reduction in the data before constructing a graph on this lower 
dimensional representation and finding the minimum spanning tree (Trapnell et al. 2014). Cells are 
then ordered in pseudotime based on their position in the minimum spanning tree, making it 
possible to investigate changes in gene expression patterns throughout pseudotime. The authors 
used this approach to reconstruct the differentiation of human primary myoblasts and identify 
branching towards an alternative cell fate present in their data (Trapnell et al. 2014). 
Another algorithm, Wanderlust, was applied to single‐cell mass cytometry data to capture B‐cell 
development in human bone marrow (Bendall et al. 2014). Wanderlust first considers a k‐nearest‐
neighbour graph on the single‐cell expression data. The ordering of cells is based on the path 
lengths originating from a user‐defined starting cell. Wanderlust can cope with very large numbers 
of cells, and subsamples cells to obtain stable orderings, avoiding the possibility of ‘short circuits’ 
through the data. Using Wanderlust, Bendall et al. ordered cells encompassing B-cell development 
with the aim of inferring a developmental trajectory, and confirmed that all the landmarks of B-
cell lymphopoiesis were correctly ordered (Bendall et al. 2014).  
Both Monocle and Wanderlust have limitations, however. Monocle is unstable and susceptible to 
short circuits, meaning that multiple applications of Monocle on the same dataset may result in 
multiple different trajectory inferences. Furthermore, Wanderlust cannot be used to identify 
branches when a differentiation trajectory separates towards multiple lineages. Updates to both 
these methods have been released. Monocle was upgraded to Monocle 2, which uses reverse graph 
embedding instead of minimum spanning tree to reconstruct lineage trajectories. This method 
doesn’t require the user to predetermine the number of branches, allowing for more unbiased 
investigation of lineage potential (Mao et al. 2017; X. Qiu et al. 2017). Wishbone improved upon 
Wanderlust to avoid problems that could arise due to outliers in the data, and made it possible to 
identify cells that are differentiating towards an alternative cell fate (Setty et al. 2016).  
Furthermore, alternative algorithms have been developed for constructing pseudotime orderings. 
Haghverdi et al. developed diffusion pseudotime (DPT) to provide a more robust method that can 
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identify branching towards multiple fates (Haghverdi et al. 2016). DPT measures the distance 
between cells based on lengths of random walks through single-cell expression data. It then 
considers the relationships between orderings from the starting point and end point of the main 
trajectory to identify branching points. The authors used DPT to reconstruct gene expression 
changes through differentiation in murine developmental haematopoiesis using previously 
published single-cell qRT-PCR data (Haghverdi et al. 2016; Moignard et al. 2015). These methods 
therefore make it possible to investigate continuous differentiation processes within single-cell 
snapshot data and identify lineage trajectories to improve our understanding of differentiation 
hierarchies within biological systems. 
 
Figure 1.4. Reconstructing lineage differentiation using single-cell expression profiles. Methods have been 
developed to reconstruct lineage differentiation from single-cell measurements under the assumption that the cells 
closest in the differentiation process will have the most similar gene or protein expression profiles. (A) A cell 
population can contain several subpopulations (represented by different colours) from different stages of lineage 
differentiation (i). Individual cells can be clustered into groups based on gene or protein expression profiles (ii). By 
assigning similarity scores between groups, a graph can be constructed where each node corresponds to a cell cluster 
and the edges between nodes are weighted by similarity scores between clusters (iii). This graph can then be used to 
find a reconstruction of the lineage tree. (B) A seemingly homogenous population can contain cells at multiple stages 
of differentiation, depicted on a red-to-blue spectrum (i). These cells can be computationally ordered in pseudotime 
based on similarities in their expression profiles, representing their progress through differentiation (ii). Gene or protein 
expression patterns can then be explored along pseudotime to identify key biological events or factors linked to the 
differentiation process (iii). Figure adapted from Hamey et al. (2016). 
 
1.5.4.3. Identifying and modelling regulatory relationships 
It is important to define the underlying regulatory programmes governing haematopoietic 
differentiation to better understand how multipotent cells choose between different fates (Gottgens 
2015; Peter and Davidson 2015). Transcriptional regulatory networks are composed of 
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transcription factors and the cis-regulatory elements to which they bind (Section 1.2). Network 
reconstruction directly from experimental evidence has been limited to the simplest organisms due 
to the number of possible regulations and complex network structures in more complex organisms. 
Many studies have instead focused on inferring regulatory networks using gene expression data 
collected from multiple experimental perturbations or conditions. Small sample sizes and masked 
heterogeneity within cell types constrain network inference from population expression data; 
single-cell approaches represent a powerful alternative for identifying new regulatory relationships, 
as each cell represents an observation with its own expression levels, vastly increasing sample sizes 
(Hamey et al. 2016). 
The large sample sizes obtained by measuring single-cell gene expression can be used to identify 
potential regulatory relationships by considering correlations between genes (Fig. 1.5A). Setting a 
threshold on correlation strength can identify putative networks consisting of genes linked with the 
highest positive or negative correlations. Several studies have used this approach to identify and 
experimentally validate regulatory relationships between highly correlated genes (Moignard et al. 
2013; Pina et al. 2015). 
Decision-making in cells is governed by complex networks of transcriptional factors with possible 
combinatorial interactions between network elements. A regulatory relationship between two genes 
cannot therefore be considered in isolation, as it may depend on the presence or absence of 
additional transcription factors. Logical relations can be abstracted as Boolean functions, where 
gene expression is either “on” or “off” (Fig. 1.5B). These abstractions form part of a Boolean 
network, which make it possible to model and simulate regulatory networks. Single-cell gene 
expression data can be converted to binary data for each cell, providing a large number of possible 
Boolean states (Fig. 1.5C). Boolean network modelling has been used to computationally infer 
networks from single-cell expression data describing embryonic blood development and 
embryonic stem cells (Moignard et al. 2015; Xu et al. 2014). A drawback of Boolean modelling, 
however, is that the abstraction of gene expression levels to binary on/off states may discount 
quantitative expression differences. A recent study addressed this problem, making it possible to 
consider more than two expression levels for genes using Boolean modelling (Collombet et al. 
2017). 
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Figure 1.5. Inferring regulatory relationships from single-cell expression data. (A) Correlation between gene pairs 
can be calculated from single-cell gene expression measurements. Some gene pairs will exhibit positive correlation 
(red), whereas others will be negatively correlated (blue) (left gene-gene correlation heatmap). The strongly correlated 
gene pairs can be selected by setting thresholds; here, correlations below the threshold are in white (middle gene-gene 
strongest correlation heatmap). Connections between the highly correlated pairs can be drawn in a network diagram 
representing positive or negative correlations with red or blue lines, respectively (right). (B) Transcription factors can 
be part of combinatorial regulatory relationships. Activation of factor C by both factor A and B could be described by 
two different scenarios, represented by Boolean logic functions: either A or B alone activate C (Boolean Or), or both 
A and B need to bind to activate C (Boolean And). The truth tables detail the output of the And/Or functions. (C) 
Boolean functions can be used to model regulatory networks. Single-cell gene expression measurements (left) are 
converted into binary (ON/OFF) expression (middle) by setting an expression threshold. Computational methods 
applied to the binary data allow inference of regulatory relationships, represented by Boolean And/Or functions (right). 
Image adapted from Hamey et al. (2016). 
 
1.5.4.4. HSPC regulatory networks 
Single-cell data have been very useful to identify previously unrecognised regulatory networks and 
important factors in lineage commitment. Pina et al. used single-cell qRT-PCR to investigate self-
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renewing cells and erythroid- or myeloid-committed progenitors in mice (Pina et al. 2015). Lineage 
commitment was associated with negative gene regulatory relationships and Ddit3 was identified 
as a previously unrecognised key player in lineage commitment. Ddit3 was positively associated 
with Gata2 in self-renewing and committed cells, and negatively associated with Cebpa, important 
for neutrophil commitment. Knockdown of Ddit3 caused a loss of erythroid function and a switch 
to myelo-monocytic potential; conversely, enforcing its expression in GMPs increased self-renewal 
properties and reduced myeloid potential. Analysing wild-type and Ddit3-overexpressing GMPs 
by PCA confirmed that Ddit3 positively regulates erythroid fates while negatively regulating 
myeloid fates. The authors found that overexpressing Ddit3 altered the global transcription network 
of GMPs, increasing connectivity with Gata2 and preventing myeloid fate by stabilising primitive 
megakaryocyte-erythrocyte precursors. Regulatory network modelling therefore demonstrated that 
conflicting lineage-potential programmes exist at the point of cell commitment and identified a 
regulatory relationship between Gata2 and Ddit3 (Hamey et al. 2016; Pina et al. 2015).  
To analyse regulatory relationships between transcription factors during haematopoiesis, Moignard 
et al. used single-cell qRT-PCR to profile the expression of 18 key transcription factors in LT-
HSCs, PreMegEs, GMPs and CMPs (Moignard et al. 2013). Correlation analysis showed a 
reduction in negative correlations between transcription factors for individual populations 
compared to all cell populations as a whole, suggesting a lack of repression may be important in 
cell fate transitions. Two new regulatory links were identified: Gata2-Gfi1b and Gata2-Gfi1, 
highlighting a previously unrecognised regulatory triad where mutual inhibition between Gfi1b and 
Gfi1 is regulated by Gata2 (Hamey et al. 2016; Moignard et al. 2013).  
These studies highlight the utility of single-cell network interrogation in finding regulatory 
networks obscured in bulk population studies and increasing our understanding of cell-fate decision 
making during haematopoiesis. 
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1.6. Aims 
This thesis explores the transcriptional landscape of haematopoietic stem and progenitor cell 
differentiation. The “transcriptional landscape” describes gene expression during haematopoiesis, 
in which cells differentiate from an HSC to mature cells, moving through intermediate progenitor 
states (John E. Pimanda and Gottgens 2010; Waddington 1957). To understand how cell fate 
decisions are regulated and lead towards the different blood cell types, it is important to study gene 
expression regulation in the context of HSPC heterogeneity. Advances in single-cell technology 
make it possible to isolate and profile thousands of cells to study relationships between genes 
through differentiation. Furthermore, advances in genome editing and CRISPR/Cas9 technology 
make it possible to easily perturb target genes and study the implications on HSPC biology. In the 
work presented in this thesis, experimental and computational approaches are used to investigate 
haematopoiesis and address the following aims: 
• Profile the transcriptional landscape of haematopoietic stem and progenitor cells at the 
single-cell level 
• Investigate genes implicated in HSC biology using the CRISPR/Cas9 system  
• Identify and validate regulatory networks controlling differentiation in haematopoietic stem 
and progenitor cells 
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Chapter 2: Materials & Methods 
 
2.1. Cell culture 
2.1.1. Mammalian cell lines 
2.1.1.1. 416B 
CD34+ mouse haematopoietic suspension cell line. This cell line was used for luciferase assays 
(Section 2.2.3). 416B cells were grown in Roswell Park Memorial Institute Medium (RPMI 1640, 
Sigma R8758) with 10% foetal calf serum (FCS, Sigma), 1% penicillin-streptomycin (P/S, Sigma, 
P0781-100ml) and 1% L-Glutamine (Sigma) at 37°C and 5% CO2. Cells were passaged every 2-3 
days to maintain cells between 2x105 cells/ml and 1x106 cells/ml. The cell count should never 
exceed 1x106 cells/ml. 
2.1.1.2. 293T 
Human cell line derived from the HEK 293 cell line containing the SV40 T antigen. This cell line 
was used to produce recombinant retroviruses. 293T cells were grown in Dulbecco’s Modified 
Eagle’s Medium (DMEM D6429, Sigma) with 10% FCS, 1% P/S, and 1% L-Glutamine at 37°C 
and 5% CO2. Cells were passaged every 2-3 days to maintain 30-80% confluency. 
2.1.1.3. HoxB8-Cas9 
Mouse cell line generated from the HoxB8-FL cell line (Redecke et al. 2013) and contains the Cas9 
protein. This cell line was used for validating guide RNAs for CRISPR screening (Section 2.2.2). 
HoxB8-Cas9 cells were grown in RPMI 1640, 10% Hyclone foetal bovine serum (FBS, Gibco), 
5% Flt3 conditioned media (produced in house; Section 2.1.1.3.1), 1% P/S, 1% L-Glutamine, 50 
µM 2-mercaptoethanol (Invitrogen) and 1 µM oestradiol (Sigma). The cells were maintained at 
37°C and 5% CO2. Cells were passaged every 3-4 days to maintain cells between 1x10
5 cells/ml 
and 1.5x106 cells/ml.  
2.1.1.3.1. Flt3 conditioned media 
This medium was used to supplement the HoxB8 complete medium. FLT3 medium was made from 
B16-FL cells. B16-FL cells were cultured in RPMI 1640, 10% Hyclone FBS, 50 µM 2-
mercaptoethanol, 1% P/S and 1% L-Glutamine. Once the cells were confluent, the medium was 
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harvested and replaced daily for 3 days. After 3 days, the supernatant was pooled, centrifuged, 
filtered through a 0.2 µM filter and stored at -20°C. 
2.1.2. HSC maintenance 
Primary HSCs were isolated from wild-type (C57BL/6) and Cas9 transgenic mice. The cells were 
grown in StemSpan SFEM (StemCellTechnologies), 1% P/S, 1% L-Glutamine, 100 µM 2-
mercaptoethanol, 20 ng/ml IL-11 (R&D Systems), 300 ng/ml SCF (R&D Systems) and 10% FBS. 
FBS was batch-tested by the Kent lab. Cells were maintained in flat- or U-bottom 96-well plates at 
37°C and 5% CO2. Cell medium was changed every 4 days and cells were only passaged if they 
were kept in culture for more than 7 days. 
2.1.2.1. Cas9 transgenic mice 
Dr George Vassiliou generously gifted our lab with the Cas9 transgenic mouse line used in this 
thesis (Tzelepis et al. 2016). The mouse line was kept in a C57BL/6 background and was created 
by inserting a human EF1a promoter-driven Cas9 expression cassette into the Rosa26 locus in the 
JM8 mouse embryonic stem cell line (Pettitt et al. 2009). CBS maintained the mouse stock.  
 
2.2. Cell Biology 
2.2.1. Flow cytometry 
BD Falcon 5 ml polypropylene tubes were used for all sorting procedures on the BD Influx4, 
Influx5 and BD FACSMelody (BD Biosciences). BD Falcon 5ml polystyrene tubes were used for 
all flow cytometry analysis on the BD LSRFortessa™ (BD Biosciences) unless otherwise stated. 
2.2.1.1. Fluorescence Activated Cell Sorting (FACS): bone marrow HSPCs 
The vertebrae, sternum, femurs, tibiae, and iliac crests were collected into 15 ml FACS buffer (2% 
heat-inactivated FBS in phosphate-buffered saline (PBS) without calcium and magnesium) from 
mice (Table 2.1). All procedures were performed in compliance with the United Kingdom Home 
Office regulations for animal work. 
All centrifugation steps were performed at 300 g for 5 minutes. 
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The bones were crushed with a pestle and mortar and bone marrow tissue was harvested and filtered 
through a 70 µm cell strainer (BD Falcon). Cells were centrifuged and resuspended in 3 ml FACS 
buffer. 5 ml of ammonium chloride (StemCellTechnologies) was added for red cell lysis. The cells 
were incubated on ice for 10 minutes after which 7 ml of FACS buffer was added to neutralize the 
ammonium chloride, and the cells were centrifuged again. The cells were resuspended in 500 µl 
FACS buffer in a 5 ml polystyrene tube and lineage depleted using the EasySepTM Mouse 
Haematopoietic Progenitor Cell Enrichment Kit (StemCellTechnologies, used 2015-2017) or the 
EasySepTM Mouse Haematopoietic Progenitor Cell Isolation Kit (StemCellTechnologies, used 
2017 onwards). The protocol for both kits was altered from the manufacturer’s protocol.  
EasySepTM Mouse Haematopoietic Progenitor Cell Enrichment Kit modified protocol: 5 µl/ml of 
EasySepTM Mouse Haematopoeitic Progenitor Cell Isolation Cocktail was added to the 
resuspended cells and the cells were incubated on ice for 15 minutes. 80 µl/ml of EasySepTM Biotin 
Selection Cocktail was then added, and the cells were incubated on ice for another 15 minutes. The 
EasySepTM Mouse Progenitor Magnetic Microparticles were vortexed for 30 seconds and 50 µl/ml 
were added to the cells. The cells were incubated on ice for a further 10 minutes, after which the 
tube was topped up with FACS buffer up to 2.5 ml. 
EasySepTM Mouse Haematopoietic Progenitor Cell Isolation Kit modified protocol: 1:100 of 
EasySep™ Mouse Hematopoietic Progenitor Isolation Cocktail was added to the resuspended cells 
and the cells were incubated on ice for 15 minutes. The EasySep™ Streptavidin RapidSpheres™ 
were vortexed for 30 seconds and added to the cells in a 1:25 ratio. The cells were incubated on ice 
for a further 10 minutes, after which the tube was topped up with FACS buffer up to 2.5 ml. 
The cells were run through the EasySep™ Magnet (StemCellTechnologies) twice, each time for 3 
minutes. After lineage depletion, cells were stained for 30 minutes with the appropriate panel of 
antibodies (Section 2.2.1.4). Cells were then centrifuged and resuspended in 500 µl FACS buffer 
or stained with a secondary antibody when necessary. Prior to FACS, 7-amino-actinomycin (7-
AAD, ThermoFisher) or 4’,6-Diamidino-2-Phenylindole (DAPI, Invitrogen) was added to each 
sample as a viability dye. The BD Influx4 and Influx5 were used for all cell sorting. Cell sorting 
was performed by the CIMR Flow Cytometry Core. 
Single-stain controls and an all-stain control were made using non-lineage depleted cells and were 
used as gate-setting controls. The all-stain control was made by staining mouse bone marrow cells 
before lineage depletion and was made for every mouse used. 
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Table 2.1. Mouse strain, age, sex, and number used for FACS. 
Chapter Experiment Strain  Age (weeks) Sex (F/M) Number 
5 single-cell qRT-PCR C57BL/6 8-12 F 3 
3 single-cell RNA-seq C57BL/6 8-12 F 5 
4 CRISPR screen Cas9 19-22 F/M 3-8 
For single-cell gene expression analysis, single cells were sorted into 96-well plates into either the mixture required 
for Fluidigm BioMarkTM HD (Section 2.4.1) or for Smart-Seq2 (Section 2.4.2) (Picelli et al. 2014). For CRISPR 
screening, bulk HSCs (250 cells) were sorted into 96-well U-bottom plates into HSC base medium (without cytokines). 
 
2.2.1.2. HoxB8-Cas9 retroviral transduction analysis 
HoxB8-Cas9 cells were transduced with guide RNA (gRNA) retroviruses (Section 2.2.3.4) and 
analysed on day 3 post-transduction. The cells were analysed by flow cytometry using the BD 
LSRFortessaTM. Cells were washed with 1 ml FACS buffer and centrifuged at 300 g for 5 minutes. 
Once spun down, the cells were resuspended in 500 µl FACS buffer + 7-AAD, except for unstained 
and green fluorescent protein (GFP) controls, which were resuspended in 500 µl FACS buffer only. 
The cells were then analysed for GFP expression. 
2.2.1.3. HSC retroviral transduction analysis: flow cytometry 
2.2.1.3.1. Day 7 analysis by flow cytometry 
E-SLAM HSCs (Lin- CD48+ CD150- CD45+ EPCR+) from Cas9 transgenic mice were transduced 
with gRNA retroviruses (Section 2.2.3.5). On day 7 post-transduction, the cells were analysed by 
flow cytometry using the BD LSRFortessaTM. Cells were pipetted up and down and 100 µl was 
transferred to a new U-bottom 96-well plate (BD Falcon). The cells were stained in the wells using 
the E-SLAM2 panel (Table 2.3), which did not require any secondary staining. After 30 minutes 
on ice, cells from each well were transferred into individual 1.4 ml polypropylene tubes 
(ThermoFisher). The empty wells were washed with 200µl FACS buffer + 7-AAD, which was then 
added to the corresponding polypropylene tube (final volume: 300 µl). Single-stain and all-stain 
controls were prepared in FACS buffer without the addition of 7-AAD. A small fraction of cells 
taken from an empty vector sample were used as a GFP single-stain control. 
Results were analysed using FlowJo_V10 and statistical analysis was performed in GraphPad 
Prism 8. Both the percentage of GFP+ Lin- EPCR+ cells and the median EPCR expression in GFP+ 
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Lin- cells was recorded. Each set of gRNAs was compared to the empty vector using a one-way 
analysis of variance (ANOVA) and Dunnett’s multiple comparisons test. In the analysis of median 
EPCR expression, the results for the three gRNAs for each gene were pooled and reanalysed 
together using the same statistical significance tests. 
2.2.1.3.2. Annexin V apoptosis analysis by flow cytometry 
Annexin V BUV395 (BD Biosciences) was added to the E-SLAM2 panel towards the end of this 
investigation to see whether the CRISPR perturbation phenotypes affected apoptosis. A 10X 
Annexin V Binding Buffer (BD Biosciences) was required to see the Annexin V staining. It was 
freshly diluted in distilled water for each use.  
Cells were stained in 100 µl HSC medium as described above using the E-SLAM2 panel with the 
addition of Annexin V BUV395. After 30 minutes on ice, cells from each well were transferred 
into individual 1.4 ml polypropylene tubes. The empty wells were washed with 200 µl Binding 
Buffer + 7-AAD, which was then added to the corresponding polypropylene tube (total volume: 
300 µl). The 1.4 ml polypropylene tubes were placed inside 5 ml polystyrene tubes for flow 
cytometry analysis. Single-stain and all-stain controls were prepared in Binding Buffer only. A 
small fraction of cells taken from an empty vector sample were used as a GFP single-stain control. 
Cells that were positive in both Annexin V and 7-AAD were already dead, whereas cells that were 
Annexin V positive and 7-AAD negative were in early apoptosis. Viable cells were negative for 
both viability markers. 
Results were analysed using FlowJo_V10 and statistical analysis was performed in GraphPad 
Prism 8. Each set of gRNAs was compared to the empty vector using a one-way analysis of 
variance (ANOVA) and Dunnett’s multiple comparisons test.  
2.2.1.3.3. FACS: GFP+ cells for genotyping and differentiation assays 
On day 7 post-transduction, the HSCs that were analysed by flow cytometry were pooled and spun 
down at 300 g for 5 minutes. Once centrifuged, 200 µl of medium was removed and replaced with 
100 µl of fresh complete medium. 
On day 10 post-transduction, the HSCs were sorted for genotyping and differentiation assays. Only 
the EPCR+ samples were used for these investigations. Although the cells were sorted on 7-AAD 
and GFP only, they were additionally stained with the GFP sorting panel (Table 2.3). 100 µl of 
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medium was removed for staining (total staining volume: 100 µl). After 30 minutes on ice, cells 
from each well were transferred into individual 5 ml polypropylene tubes. The empty wells were 
washed with 200µl FACS buffer + 7-AAD, which was then added to the corresponding tube (total 
volume: 300µl). The cells were sorted on the BD FACSMelody for genotyping and differentiation 
assays as detailed below: 
• Differentiation assays: cells were sorted into 1.5 ml Eppendorf tubes filled with 300 µl HSC 
base medium. Each sample was sorted for GFP+ and GFP- cells and for three cell counts: 
100, 200 and 400 cells. When there were too few cells, only the 100 and 200 cell counts 
were sorted. 
• Genotyping: cells were sorted into 1.5 ml Eppendorf tubes filled with 100 µl FACS buffer. 
Each sample was sorted for GFP+ cells only. Cells were sorted for the maximum number 
of cells possible, i.e. until the sample was empty. 
2.2.1.4. Antibody Panels 
Table 2.2. List of antibodies used for FACS and flow cytometry. 
Antigen Fluorophore Manufacturer Clone 
Annexin V BUV395 BD Biosciences --- 
B220 Pe-Cy7 Biolegend RA3-6B2 
CD105 APC Biolegend MJ7/18 
CD150 Pe-Cy7 Biolegend TC15/12F12.2 
CD150 PB Biolegend TC15/12F12.2 
CD16/32 PE Biolegend 93 
CD16/32 Al647 Biolegend 93 
CD3 Pe-Cy7 Biolegend 17A2 
CD34 FITC BD Pharmingen RAM34 
CD41 FITC BD Pharmingen Mw/Reg30 
CD45 BV711 Biolegend 30-F11 
CD45 FITC Biolegend 30-F11 
CD48 APC Biolegend HM48-1 
CD48 PB Biolegend HM48-1 
c-Kit APC-Cy7 Biolegend 2B8 
EPCR PE Stem Cell Tech. RMEPCR1560 
Flk2 (CD135) Pe-Cy5 e-Bioscience A2F10 
Gr-1 Pe-Cy7 Biolegend RB6-8C5 
IL-7Ra Biotin Biolegend A7R34 
Lineage Cocktail (Lin)  Stem Cell Tech. * 
Mac1 Pe-Cy7 Biolegend M1/70 
Nk1.1 Pe-Cy7 Biolegend PK136 
Sca1 PB Biolegend E13-161.7 
Sca1 BV421 Biolegend 108133 
Sca1 BV605 Biolegend 108133 
Streptavidin BV510 Biolegend * 
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Antigen Fluorophore Manufacturer Clone 
Ter119 Pe-Cy7 Biolegend Ter-119 
*Lineage Cocktail (StemCellTechnologies) was a pre-mixed combination of biotinylated antibodies targeting non-
haematopoietic cells and non-progenitor cells (CD5, CD11b, CD19, CD45R/B220, Ly6G/C(Gr-1), TER119, 7-4). The 
lineage cocktail was used with Streptavidin BV510 for FACS and flow cytometry analysis. 
 
Table 2.3. Antibody panels used for FACS and flow cytometry. 
Staining Panel Antibodies Chapter 
PreMegE Lin BV510, Sca1 PB, CD105 APC, CD150 Pe-Cy7, CD16/32 PE, 
CD41 FITC, 7-AAD 
5 
MPP Lin BV510, IL-7Ra Biotin, c-Kit APC-Cy7, Sca1 PB, Flk2 Pe-Cy5, 
CD34 FITC, 7-AAD 
5 
ST-HSC Lin BV510, IL-7Ra Biotin, c-Kit APC-Cy7, Sca1 PB, CD48 APC, 
CD150 Pe-Cy7, CD34 FITC, CD16/32 PE, CD135 Pe-Cy5, 7-AAD 
5 
HSPC Lin BV510, EPCR PE, CD48 PB, Sca1 BV605, CD34 FITC, Flk2 Pe-
Cy5, CD150 Pe-Cy7, CD16/32 Al647, c-Kit APC-Cy7, DAPI 
3 
E-SLAM 1 Lin BV510, EPCR PE, CD48 APC, CD150 Pe-Cy7, c-Kit APC-Cy7, 
Sca1 BV421, CD45 FITC, 7AAD 
4 
E-SLAM 2 Gr1 Pe-Cy7*, Mac1 Pe-Cy7*, B220 Pe-Cy7*, CD3 Pe-Cy7*, Ter119 
Pe-Cy7*, Nk1.1 Pe-Cy7*, Sca1 BV605, CD45 BV711, CD150 PB, 
EPCR PE, CD48 APC, c-Kit APC-Cy7, 7AAD 
º Annexin V BUV395 
4 
GFP Sorting 
Panel 
Gr1 Pe-Cy7*, Mac1 Pe-Cy7*, B220 Pe-Cy7*, CD3 Pe-Cy7*, Ter119 
Pe-Cy7*, Nk1.1 Pe-Cy7*, EPCR PE, 7AAD 
4 
* Antibodies used to generate a lineage cocktail were conjugated to the same fluorophore. 
º Annexin V BUV395 was added to the E-SLAM2 panel for apoptosis analysis (Section 2.2.1.3.2) 
 
2.2.2. HSC retroviral transduction analysis: differentiation assays 
Differentiation assays were performed on day 10 post-transduction. After flow analysis, the 
remaining cells representing each perturbation phenotype were pooled. Initially, fractions of cells 
equalling to roughly 400, 200 and 100 cells were taken and placed into a methylcellulose-based 
medium (MethoCult™ GF M3434, StemCellTechnologies). However, it was not possible to 
differentiate GFP positive and negative cells microscopically. Therefore, an additional FACS step 
was included. Cells were sorted based on GFP expression on either the BD FACSMelody (BD 
Biosciences) or the BD Influx 4 sorter. Cells were sorted directly into 300 µl HSC medium without 
cytokines. Specific numbers of both GFP+ and GFP- cells were sorted separately (400, 200, and 
100 cells). If there were too few cells, only the 100 and 200 cell counts were sorted. The cells were 
then placed into 2.7 ml methylcellulose-based medium and vortexed. Once all air bubbles had 
dissipated from the medium (usually after 5-10 minutes), the mixture was split between 2 wells of 
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a 6-well SmartDish™ (StemCellTechnologies) using a 5 ml syringe and 16-gauge needle. The 
plates were incubated at 37°C and 5% CO2. After 10 days, the plates were imaged and analysed 
using STEMvision™ Acquisition and Analyzer software (StemCellTechnologies) on the “Human 
14-Day CFU” setting. Burst forming unit-erythroid (BFU-E), colony forming unit-granulocyte-
macrophage (CFU-GM), and colony forming unit-granulocyte-erythrocyte-macrophage-
megakaryocyte (CFU-GEMM) colonies were manually assigned in the STEMvision™ Marker 
software.  
2.2.3. Retrovirus Production and Transduction 
2.2.3.1. Gene selection 
Gene selection for the HSC CRISPR screen (Chapter 4) was performed based on the MolO and 
SuMO genes that were previously identified, which are listed in Table 2.4 (N. K. Wilson et al. 
2015). The expression of each gene was visualized on the mouse single-cell gene expression atlas 
(Nestorowa et al. 2016). Genes that did not have expression specific to the LT-HSC region were 
not considered for further analysis. Violin plots were produced for the remaining candidate genes 
to select for genes that have highest expression in the E-SLAM and LT-HSC populations. By doing 
so, the list of 44 genes was narrowed down to 16 candidate genes. 
Table 2.4. MolO and SuMO genes. 
MolO Genes SuMO Genes 
Cd82 Gimap6 Pdzk1ip1  Vwf Ablim1 Inhba Wfdc2 
Cdkn1c Gstm1 Ptpn14  Cd74 Ly6e Ifitm1* 
Cldn10 Limd2 Smtnl1  Cyp27a1 Mapk12 Ly6a* 
Ctsf Ltb Sox18  Gbp6 Ndnf Mllt3* 
Fads3 Mettl7a1 Sqrdl  Gbp8 Ralgapa1 Procr* 
Fgfr3 Neo1  Trim47  Gm4951 St8sia4 Ramp2* 
Gimap1 Pde1b  Ubl3  Ifitm3 Tftp2 Sult1a1* 
Genes were identified by Wilson et al. (2015). Genes in bold are genes that were chosen for the CRISPR screen.  
* represent genes that are both MolO and SuMO genes. 
 
2.2.3.2. Oligo Generation 
Once the candidate genes were selected, gRNA sequences were chosen. The Brie gRNA library 
(Doench et al. 2016) provided sequences for gRNAs for most of the candidate genes; however, 
where unavailable, gRNAs were designed using the “Broad Institute sgRNA Designer: 
CRISPRko” tool, selecting S. pyogenes (NGG) as the CRISPR enzyme and mouse as the target 
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taxon (Broad Institute 2018). The chosen gRNA sequences were checked using UCSC Genome 
Browser to make sure that each sequence was present only within the gene of interest. If there was 
overlap with other genes, a new sequence was generated and verified. Three gRNA sequences were 
chosen per gene of interest. 
The gRNAs were modified to meet the criteria of the published protocol for cloning into the 
pKLV2-U6gRNA5(BbsI)-PGKpuro2AmAG-W CRISPR gRNA expression vector (Tzelepis et al. 
2016). A G nucleotide was appended at the 5’ end of each sequence. The 5’ overhang of the top 
oligo was CACC and the 5’ overhang of the complement bottom oligo was CAAA. All oligos 
(Table 2.5) were ordered through Sigma at 100 mM in TE buffer, purified by desalt purification. 
2.2.3.3. Production of retroviruses in 293Ts 
293T cells at 70% confluency (10 cm plates) were used to produce retroviruses. On day 0, 293Ts 
were transfected using TransIT-LT1 Transfection Reagent (Mirus). A transfection reagent mix 
(500 µl DMEM + 45 µl TransIT-LT1) and DNA mix (5 µg construct + 5 µg pMD2.G + 5 µg ∆R8.9 
in 500 µl DMEM) were prepared for each construct of interest. The DNA mix was slowly and 
drop-wise added to the transfection reagent mix, mixed gently, and incubated at room temperature 
for 30 minutes. The mixture was then added slowly and drop-wise to 10 cm plates containing 293T 
cells in 10 ml 293T medium. The plates were incubated at 37°C. On day 1, the medium was 
changed from 293T medium to 6 ml base HSC medium (no cytokines and 2-mercaptoethanol). On 
day 2, the supernatant was recovered from each plate using a 5ml syringe, filtered through a 0.45µm 
filter and aliquoted into 2ml cryogenic tubes (ThermoFisher Nunc™ Cryovials). These tubes were 
then stored at -80°C. 
This protocol was also adapted to be performed in 6 well plates, using 100 µl DMEM + 9 µl 
TransIT-LT1 for the transfection reagent mix and 1 µg of the construct, pMD2.G and ∆R8.9 in 100 
µl DMEM for the DNA mix. On day 1, the medium was changed to 1.5 ml base HSC medium. All 
other steps are as previously described. 
2.2.3.4. Batch-testing of retroviruses in HoxB8-Cas9 cells 
Retroviruses made for the HSC CRISPR screen (Chapter 4) were tested for transduction efficiency 
in the HoxB8-Cas9 cell line before being used in primary cells. On the day of transduction (Day 
0), HoxB8-Cas9 cells were plated at 3.3 x 105 cells in 440 µl HoxB8 complete medium in a 24-
well plate. 5.33 µl polybrene (1 mg/ml, Sigma) was added to each well for a final concentration of 
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8 µg/ml. For batch testing, between 12 and 22 of the viruses made at one time (Section 2.2.3.3) 
were tested, along with an empty vector and untreated control. 100 µl of viral supernatant was 
added to the appropriate well and topped up with 120 µl of HoxB8 medium. The plate was then 
centrifuged for 90 min at 779 g at 32°C (maximum acceleration, no brake). After centrifugation, 
the plate was incubated for 90 min at 32°C. 330 µl of medium was then removed and replaced with 
560 µl of fresh complete medium. The plate was then incubated at 37°C and 5% CO2. The 
following day (Day 1), 440 µl of fresh medium was added to each well. On Day 2, the cells were 
split 1:2 to prepare for analysis the next day. On Day 3, the cells were analysed for GFP expression 
by flow cytometry (Section 2.2.1.2). 
2.2.3.5. Retroviral transduction of HSCs 
To prepare for retroviral transduction of HSCs, 96-well U-bottom plates were first coated with 
Retronectin (Clontech) to improve transduction efficiency. The stock Retronectin (1 µg/µl) was 
diluted 1:100 in PBS and 50 µl was added to the each well. The plates were incubated for 2 hours 
at room temperature before the Retronectin was discarded. 50 µl of 2% bovine serum albumin 
(BSA, Sigma)/PBS was then added to the wells and incubated for 30 minutes at room temperature. 
After 30 minutes, the 2% BSA/PBS was removed and replaced with 110 µl base HSC medium. 
The plate was then kept in the fridge until required later that day. 
HSCs were isolated from the bone marrow of Cas9 transgenic mice as previously described 
(Section 2.2.1.1) and were first sorted into two bulk populations using the E-SLAM1 panel: Lin- 
CD48+ CD150- EPCR+ (referred to as EPCR+ cells), and Lin- CD48+ CD150- EPCR- (referred to 
as EPCR- cells), where EPCR- cells were used as controls. All sorting was done on the BD Influx4 
and Influx5. The first sort was performed in 2.0 Drop Enrich mode. The EPCR- and EPCR+ cells 
were then sorted in bulk (250 cells) directly into 110 µl base HSC medium in a 96-well U-bottom 
plate, using the 1.0 Drop Pure mode. 
Once the cells were sorted, each well was topped up with 10 µl of a 12X Cytokine Cocktail (5 
µg/ml IL-11, 100µg/ml SCF), 0.2 µl 50mM 2-mercaptoethanol, and 1 µl of 1 mg/ml polybrene. 1 
µl of virus was added to the wells as appropriate. Empty vector and untreated controls were used 
for each FACS experiment and 3 replicates for each virus were collected when possible (depending 
on the number of cells sorted).  
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After the addition of virus, the cells were spun down at 600 g for 30 minutes at 32°C (maximum 
acceleration, no brake). The cells were then incubated for 30 minutes at 32°C, after which they 
were maintained in a 37°C and 5% CO2 incubator. The next day (Day 1), each well containing cells 
was topped up with 80 µl of complete HSC medium. The cell medium was changed on Day 4 by 
carefully removing 120 µl of medium from each well and replacing it with 120 µl of fresh complete 
medium. On Day 7, cells were analysed for changes in EPCR expression by flow cytometry 
(Section 2.2.1.3). On Day 10, cells were sorted for differentiation assays (Section 2.2.2) and 
genotyping (Section 2.4). 
2.2.3.6. Oligo sequence list 
Table 2.5. Sequences of gRNAs used for the HSC CRISPR screen. 
Oligo Name Sequence (5' - 3') 
Cdkn1c_sg1_pKLV2_L CACCGCGGGTCGGAGGTCGCGACCA 
Cdkn1c_sg2_pKLV2_L CACCGAGACGACCAGGGCCTCGAAG 
Cdkn1c_sg3_pKLV2_L CACCGCGTGGCGACTCGGGACGGCG 
Cdkn1c_sg1_pKLV2_R AAACTGGTCGCGACCTCCGACCCGC 
Cdkn1c_sg2_pKLV2_R AAACCTTCGAGGCCCTGGTCGTCTC 
Cdkn1c_sg3_pKLV2_R AAACCGCCGTCCCGAGTCGCCACGC 
Fgfr3_sg1_pKLV2_L CACCGGTATAGTTGCCACGATCGGA 
Fgfr3_sg2_pKLV2_L CACCGGAGGCTGGCAGCGTGTACGC 
Fgfr3_sg3_pKLV2_L CACCGTGACAAGGACCTGTCGGACC 
Fgfr3_sg1_pKLV2_R AAACTCCGATCGTGGCAACTATACC 
Fgfr3_sg2_pKLV2_R AAACGCGTACACGCTGCCAGCCTCC 
Fgfr3_sg3_pKLV2_R AAACGGTCCGACAGGTCCTTGTCAC 
Neo1_sg1_pKLV2_L CACCGCGTAACCGATGGCATAACCT 
Neo1_sg2_pKLV2_L CACCGGGTTCCAAGATTATCCACAG 
Neo1_sg3_pKLV2_L CACCGAACACCGTTATCTGGCAATG 
Neo1_sg1_pKLV2_R AAACAGGTTATGCCATCGGTTACGC 
Neo1_sg2_pKLV2_R AAACCTGTGGATAATCTTGGAACCC 
Neo1_sg3_pKLV2_R AAACCATTGCCAGATAACGGTGTTC 
Pde1b_sg1_pKLV2_L CACCGCAACACCATCTCGATAACCA 
Pde1b_sg2_pKLV2_L CACCGAAAACTCATCAGAAACACTG 
Pde1b_sg3_pKLV2_L CACCGGGACTGCAGTAGAGTATGTG 
Pde1b_sg1_pKLV2_R AAACTGGTTATCGAGATGGTGTTGC 
Pde1b_sg2_pKLV2_R AAACCAGTGTTTCTGATGAGTTTTC 
Pde1b_sg3_pKLV2_R AAACCACATACTCTACTGCAGTCCC 
Ramp2_sg1_pKLV2_L CACCGGAATCAATCTCATCCCACTG 
Ramp2_sg2_pKLV2_L CACCGACCAAGCCGAGATCCACCCG 
Ramp2_sg3_pKLV2_L CACCGCTCTTGTACTCATACCAGCA 
Ramp2_sg1_pKLV2_R AAACCAGTGGGATGAGATTGATTCC 
Ramp2_sg2_pKLV2_R AAACCGGGTGGATCTCGGCTTGGTC 
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Oligo Name Sequence (5' - 3') 
Ramp2_sg3_pKLV2_R AAACTGCTGGTATGAGTACAAGAGC 
Smtnl1_sg1_pKLV2_L CACCGCTAAGAGTGGCGAATCAGGG 
Smtnl1_sg2_pKLV2_L CACCGAGAGACCGGAAGTGACACAA 
Smtnl1_sg3_pKLV2_L CACCGAGCAGAGGTTACTGTCAACG 
Smtnl1_sg1_pKLV2_R AAACCCCTGATTCGCCACTCTTAGC 
Smtnl1_sg2_pKLV2_R AAACTTGTGTCACTTCCGGTCTCTC 
Smtnl1_sg3_pKLV2_R AAACCGTTGACAGTAACCTCTGCTC 
Sox18_sg1_pKLV2_L CACCGAGCAGCGGCCCCGATTCCAG 
Sox18_sg2_pKLV2_L CACCGCAGAGTGGGTAGCTCGCGGA 
Sox18_sg3_pKLV2_L CACCGCCGACGAGTTGCGCATTCGG 
Sox18_sg1_pKLV2_R AAACCTGGAATCGGGGCCGCTGCTC 
Sox18_sg2_pKLV2_R AAACTCCGCGAGCTACCCACTCTGC 
Sox18_sg3_pKLV2_R AAACCCGAATGCGCAACTCGTCGGC 
Inhba_sg1_pKLV2_L CACCGACAAGCAATCCGCACGTCCA 
Inhba_sg2_pKLV2_L CACCGCGAGGAAATGGGCTTAAAGG 
Inhba_sg3_pKLV2_L CACCGCTGCTGCTGAAATAGACGGA 
Inhba_sg1_pKLV2_R AAACTGGACGTGCGGATTGCTTGTC 
Inhba_sg2_pKLV2_R AAACCCTTTAAGCCCATTTCCTCGC 
Inhba_sg3_pKLV2_R AAACTCCGTCTATTTCAGCAGCAGC 
Ndnf_sg1_pKLV2_L CACCGGACTGTGGTACGTCCAAAGG 
Ndnf_sg2_pKLV2_L CACCGAAGGGGTTAAAGTCTAGACC 
Ndnf_sg3_pKLV2_L CACCGCAGTGGAACTCAAAGACGGG 
Ndnf_sg1_pKLV2_R AAACCCTTTGGACGTACCACAGTCC 
Ndnf_sg2_pKLV2_R AAACGGTCTAGACTTTAACCCCTTC 
Ndnf_sg3_pKLV2_R AAACCCCGTCTTTGAGTTCCACTGC 
Wfdc2_sg1_pKLV2_L CACCGCACACTACTAAACCACCGGG 
Wfdc2_sg2_pKLV2_L CACCGACAGTAGCAACCCTAGTAGG 
Wfdc2_sg3_pKLV2_L CACCGTGGGACTACTACTCAATCAG 
Wfdc2_sg1_pKLV2_R AAACCCCGGTGGTTTAGTAGTGTGC 
Wfdc2_sg2_pKLV2_R AAACCCTACTAGGGTTGCTACTGTC 
Wfdc2_sg3_pKLV2_R AAACCTGATTGAGTAGTAGTCCCAC 
Pdzk1ip1_sg1_pKLV2_L CACCGCGGCGAAGACGATTGCAACA 
Pdzk1ip1_sg2_pKLV2_L CACCGAGAACACAGCGACAGCAATG 
Pdzk1ip1_sg3_pKLV2_L CACCGCAACCACTTCTGGTGCCAGG 
Pdzk1ip1_sg1_pKLV2_R AAACTGTTGCAATCGTCTTCGCCGC 
Pdzk1ip1_sg2_pKLV2_R AAACCATTGCTGTCGCTGTGTTCTC 
Pdzk1ip1_sg3_pKLV2_R AAACCCTGGCACCAGAAGTGGTTGC 
Procr_sg1_pKLV2_L CACCGTCCAAGACAACCATCATGTG 
Procr_sg2_pKLV2_L CACCGTGCGCCCTTTGTAACTCCGA 
Procr_sg3_pKLV2_L CACCGGCCACATCGAAGAAGACATG 
Procr_sg1_pKLV2_R AAACCACATGATGGTTGTCTTGGAC 
Procr_sg2_pKLV2_R AAACTCGGAGTTACAAAGGGCGCAC 
Procr_sg3_pKLV2_R AAACCATGTCTTCTTCGATGTGGCC 
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Oligo Name Sequence (5' - 3') 
Sult1a1_sg1_pKLV2_L CACCGGGTGGCAAGCTAGATAAGTG 
Sult1a1_sg2_pKLV2_L CACCGATGTGTCTTAATGATCCGTG 
Sult1a1_sg3_pKLV2_L CACCGTCCGCAAAGTATTTGATGAG 
Sult1a1_sg1_pKLV2_R AAACCACTTATCTAGCTTGCCACCC 
Sult1a1_sg2_pKLV2_R AAACCACGGATCATTAAGACACATC 
Sult1a1_sg3_pKLV2_R AAACCTCATCAAATACTTTGCGGAC 
Trim47_sg1_pKLV2_L CACCGTGATGAGGGCCACAGTACGG 
Trim47_sg2_pKLV2_L CACCGACGCGACAGTAGCGCTCCAG 
Trim47_sg3_pKLV2_L CACCGCTGGGACCGGCCCAACATTG 
Trim47_sg1_pKLV2_R AAACCCGTACTGTGGCCCTCATCAC 
Trim47_sg2_pKLV2_R AAACCTGGAGCGCTACTGTCGCGTC 
Trim47_sg3_pKLV2_R AAACCAATGTTGGGCCGGTCCCAGC 
Gbp8_sg1_pKLV2_L CACCGCACTAAACCAGAGCACACCC 
Gbp8_sg2_pKLV2_L CACCGCGTCTGGCAGGACAGAATCA 
Gbp8_sg3_pKLV2_L CACCGGCTAGAGCTGAAGTTAAATG 
Gbp8_sg1_pKLV2_R AAACGGGTGTGCTCTGGTTTAGTGC 
Gbp8_sg2_pKLV2_R AAACTGATTCTGTCCTGCCAGACGC 
Gbp8_sg3_pKLV2_R AAACCATTTAACTTCAGCTCTAGCC 
Gm4951_sg1_pKLV2_L CACCGTGGGGTGACGGACAAAACCA 
Gm4951_sg2_pKLV2_L CACCGGGTGAGAGCAACATTGAGCG 
Gm4951_sg3_pKLV2_L CACCGATTCTACTTCGTGAGAACAC 
Gm4951_sg1_pKLV2_R AAACTGGTTTTGTCCGTCACCCCAC 
Gm4951_sg2_pKLV2_R AAACCGCTCAATGTTGCTCTCACCC 
Gm4951_sg3_pKLV2_R AAACGTGTTCTCACGAAGTAGAATC 
 
Table 2.6. Primer sequences used to sequence the pKLV2-U6gRNA5(BbsI)-PGKpuro2AmAG-W vector. 
Primer Name Primer Sequence (5' - 3') 
SN037_Seq_F1 AGATAATTAGAATTAATTTGACTG 
SN037_Seq_F2_LKO.15 GACTATCATATGCTTACCG 
SN037_Seq_R1 CATGCTCCAGACTGCCTTG 
 
2.2.4. Luciferase Assays 
Luciferase assays were used to validate regulatory relationships between genes, inferred from in 
silico regulatory network models (Chapters 5 and 6). The two relationships interrogated were 
between Gata2 and Nfe2, and Gata2 and Cbfa2t3h. The Cbfa2t3h minimal and full promoter 
sequences, as well as the Nfe2 enhancer sequence, were cloned into pGL2-Basic and pGL2-
Promoter vectors (Section 2.3.4.4). The mm10 mouse genome coordinates of chromosomal regions 
tested are as follows: chr8:122699004-122701098 for the Cbfa2t3h full promoter, 
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chr8:122699111-122699377 for the Cbfa2t3h minimal promoter, and chr15:103258245-
103258850 for the Nfe2 enhancer. Both wild-type and mutant GATA2 constructs were generated, 
in which all GATA2 binding sites were mutated to prevent binding activity.  
Luciferase assays were performed with the help of Sarah Kinston as previously described 
(Bockamp et al. 1995). 416B cells were transfected with the linearized Nfe2 and Cbfa2t3h 
constructs and pPGK-Neo by electroporation. The transfected cells were harvested, washed, and 
centrifuged. A luciferase buffer was made up with LB buffer (25 mmol/L Tris-phosphate buffer 
pH 7.8, 8 mmol/L MgCI2, 1 mmol/L 1,4-Dithio-DL-threitol [DTT], 1% Triton-X 100, 1% BSA 
and 15% glycerol), ATP and the luciferase substrate D-Luciferin (Promega). 100 µl of sample was 
mixed with the luciferase buffer and incubated for 5 minutes in the dark at room temperature. The 
samples were then assayed for light emission in a Berthold LB 953 luminometer (Berthold).  
In analysing the results from the luciferase assay, the luciferase activity was normalised against 
empty vector and the fold change was used to show differences in luciferase activity. 
 
2.3. Molecular Biology 
2.3.1. Agarose gel electrophoresis 
DNA fragments were separated by size using agarose gel electrophoresis. The amount of agarose 
(Biogene) used ranged between 0.8-3.0% depending on the application. Agarose was mixed with 
1xTBE (Tris/Borate/EDTA; produced on site) and dissolved in a microwave. Once the solution 
cooled, 0.5 µg/ml ethidium bromide solution (Sigma) was added to stain DNA.  
Samples were mixed with a 6x loading dye (NEB). DNA reference ladders (50 bp-1 kb, NEB) were 
used according to the expected size of the DNA. Gels were run on an electric field of 80-120 V and 
the DNA was then visualized using a UV transilluminator. 
2.3.2. DNA purification 
2.3.2.1. Gel extraction 
DNA was visualized using a UV transilluminator and the bands of interest were excised using a 
scalpel blade. DNA was then extracted using the QIAquick Gel Extraction Kit (Qiagen) as per 
manufacturer’s instructions and eluted in 30 µl elution buffer. 
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2.3.2.2. PCR purification 
PCR fragments were purified using the QIAquick PCR Purification Kit (Qiagen) as per 
manufacturer’s instructions and eluted in 30 µl elution buffer.  
2.3.3. Plasmid purification 
Plasmids were purified from starting cultures of various volumes. Starting cultures consisted of 
lysogeny broth (LB) + 100 µg/ml ampicillin (Sigma) inoculated with a single bacterial colony. 
Bacteria were cultured for 16 hours at 37°C, shaking at 220 rpm. Culture volumes used are detailed 
in the appropriate subsections. 
2.3.3.1. Mini Preps 
Mini preps were performed following the QIAprep Spin Miniprep Kit (Qiagen) as per 
manufacturer’s instructions, from a 2 ml starting culture. DNA was eluted in 30 µl ultra-pure water. 
The DNA was then sequenced (Source BioScience) and run on an agarose gel to confirm the 
presence of correctly sized DNA fragments.  
2.3.3.2. Maxi Preps 
Maxi preps were performed to purify large quantities of plasmid DNA. The volume of the starting 
culture was 100 ml. Maxi preps were performed following the Plasmid DNA Purification Kit 
(Macherey-Nagel) following the “Maxi” instructions (AX 500). DNA was resuspended in 200-300 
µl ultra-pure water.  
2.3.3.2. Xtra Maxi Prep 
Xtra maxi preps were performed when a very large quantity of plasmid DNA was required, for 
example to purify a vector used as a backbone or for retrovirus production. The volume of the 
starting culture was 300 ml. Xtra maxi preps were performed following the NucleoBond Xtra® 
Maxi Kit (Macherey-Nagel) as per manufacturer’s instructions. DNA was resuspended in 200-300 
µl ultra-pure water. 
2.3.4. Cloning strategies 
2.3.4.1. Restriction Digests 
Restriction enzymes and buffers were purchased from New England Biolabs. Digests were 
performed in 50-100 µl volumes depending on the application and quantity required. Restriction 
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enzymes made up no more than 10% of the reaction volume. Reactions consisted of the restriction 
enzyme, the appropriate 10X buffer, DNA, and ultra-pure H2O. The reactions were incubated at 
37°C for 1 hour to overnight, and then purified by gel extraction or PCR purification. 
2.3.4.2. Weissman protocol 
This protocol was used for cloning gRNA into the pKLV2-U6gRNA5(BbsI)-PGKpuro2AmAG-W 
plasmid (Addgene), which was digested with BbsI. The protocol was originally described by the 
Weissman lab (Adamson et al. 2016) and then adapted as described below. 
Annealing: Oligos were annealed by mixing 1µl of the forward and reverse oligos (10 µM) with 
23 µl dH2O and 25 µl 2X Annealing Buffer (200mM potassium acetate, 60 mM HEPES-KOH pH 
7.4, 4 mM Magnesium Acetate). The mixture was incubated at 95°C for 5 minutes, then left to 
anneal by gradually cooling to room temperature (on the benchtop, not in a PCR machine) for 10-
20 minutes. The annealed oligos were diluted 20-fold for ligation. 
Ligation: 500ng of the digested vector backbone was mixed with 10 µl of 1:20 diluted annealed 
oligos, 2 µl of fresh 10X T4 ligase buffer (NEB), 1 µl T4 ligase (NEB). The volume was made up 
to a 20 µl total reaction volume. A negative control was made by using dH2O instead of annealed 
oligos. The ligation mixture was incubated at room temperature for 1-4 hours, or overnight at 16°C.  
Transformations were done using MegaX DH10BTM T1® ElectrocompTM Cells (ThermoFisher) 
following the manufacturer’s protocol. All of the transformed bacteria were plated onto a LB+ 
Ampicillin plate (made on site) and incubated at 37°C overnight. 
2.3.4.2.1. Modified Weissman protocol 
The Weissman protocol was modified to incorporate a Rapid DNA Ligation Kit (Roche), which 
contained a 5X DNA dilution buffer, T4 DNA ligation buffer, and ligase. The oligos were annealed 
as previously described and diluted 1:20 in water. The 5X DNA dilution buffer was diluted in 
sterile H2O. 100 ng of the digested vector backbone was mixed with 2 µl of the diluted annealed 
oligos in up to 10 µl of 1X DNA dilution buffer. 10 µl of T4 DNA ligation buffer and 1 µl ligase 
were added to the mix and incubated at room temperature for 5 minutes. The ligation mixture was 
then used for transformations in DH5α cells (Invitrogen). 
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2.3.4.3. Yusa Lab protocol 
This protocol was used for cloning gRNA into the pKLV2-U6gRNA5(BbsI)-PGKpuro2AmAG-W 
and pKLV2-U6gRNA5(BbsI)-PGKpuro2AmAG-W-ccdB plasmids (provided by Oliver Dovey, 
Vassiliou lab), which were digested with BbsI. The protocol was described by the Yusa lab 
(Tzelepis et al. 2016). 
Oligo phosphorylation and annealing: 1 µl each of the forward and reverse strand oligos (10 mM) 
were mixed with 1 µl of 10X T4 ligase buffer (NEB), 0.5 µl of T4 PNK (NEB) and 6.5 µl dH2O. 
The mixture was placed in a PCR machine and the following program was run: 30 min at 37°C → 
5 min at 95°C → ramp down to 25°C at 0.1°C/sec → 4°C (hold). The annealed oligos (ds-oligo) 
were diluted to 7.1 pmol/µl in EB buffer (Qiagen) by diluting 2 µl ds-oligo in 139 µl EB, 3µl of 
which was then diluted in 57 µl EB. 
Ligation: 1 µl of 20ng/µl digested vector backbone was mixed with 2 µl diluted ds-oligo, 1 µl 10X 
ligase buffer, 1 µl T4 ligase and 5 µl dH2O. A negative control was made by using dH2O instead 
of ds-oligo. The mixture was incubated at 16°C for 2 hours to overnight. 
Transformations were done using Library EfficiencyTM DH5αTM Competent Cells (ThermoFisher). 
5 µl of the ligation mixture was mixed with 50 µl bacterial cells and incubated for 30 minutes on 
ice. The cells were heat-shocked at 42°C for 45 seconds, and then incubated on ice for 5 minutes. 
250 µl SOC medium was added to the cells and the transformed bacteria were incubated at 37°C 
for 30 min (shaking at 300 rpm). The transformed bacteria were plated onto a LB+ Ampicillin plate 
and incubated at 37°C overnight. 
2.3.4.4. Cloning for luciferase assays 
GeneArt Strings (ThermoFisher) were ordered for the Cbfa2t3h minimal promoter and full 
promoter, as well as the Nfe2 enhancer region. These GeneArt String products had both wildtype 
and mutated GATA2 sites. 20 bp of the pBluescript KS vector were inserted at either end of the 
sequence to enable Gibson Assembly (Section 2.3.4.4.1). The mutated sequences were cloned into 
the pGL2-Basic Vector or pGL2-Promoter Vector by Gibson Assembly. 
For Gibson Assembly, the digested backbone and GeneArt String fragments were used in a 1:1 
ratio. They were mixed with deionized H2O and 2X Gibson Assembly Master Mix (NEB) in a 20 
µl reaction volume. The mixture was incubated at 50℃ for 15 minutes, after which it could be used 
for transformations. 
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2.3.4.4.1. GeneArt String Sequences 
Restriction enzyme site GATA2 binding site Mutated base pair 
Cbfa2t3h minimal promoter (restriction enzymes XhoI/HindIII): chr8:122699111-122699377 
GTACCGAGCTCTTACGCGTGCTAGCTCGAGGTGGGAGGTCTCAGGGCTACAGGCGGGATAGGAGGAAGTTG
TTGGGAAGTCAGACCGGAATGGCATGGTGGAGGGAGAACCGGCAACCAGGCAGATGGTTCCTGACGAGGAA
GCTCTGGGCACAGCTGCAGGCCCCCGACCCCCACCGCATTATCACTGTGACACAGCTGGCTGCCTCACCCC
TGAAGGCTGCAGGAGGACCTCCCCCATGCTGTCCCCAAGCCCGCCCCGTGTCACATGAGGCCCTGCAGACT
CCCACCCTCCGTCAAGCTTGGCATTCCGGTACTGTTGGTAAAA 
Cbfa2t3h minimal promoter - mutated (restriction enzymes XhoI/HindIII)  
GTACCGAGCTCTTACGCGTGCTAGCTCGAGGTGGGAGGTCTCAGGGCTACAGGCGGGCGAGGAGGAAGTTG
TTGGGAAGTCAGACCGGAATGGCATGGTGGAGGGAGAACCGGCAACCAGGCAGATGGTTCCTGACGAGGAA
GCTCTGGGCACAGCTGCAGGCCCCCGACCCCCACCGCATTGGCACTGTGACACAGCTGGCTGCCTCACCCC
TGAAGGCTGCAGGAGGACCTCCCCCATGCTGTCCCCAAGCCCGCCCCGTGTCACATGAGGCCCTGCAGACT
CCCACCCTCCGTCAAGCTTGGCATTCCGGTACTGTTGGTAAAA 
Cbfa2t3h full promoter (restriction enzymes Nhe1/HindIII): chr8:122699004-122701098 
GGGAGGTACCGAGCTCTTACGCGTGCTAGCACCCTGGCATGGGAAGAGTGTGAGGGAACAGGAGGGAGCCC
CCAATCCCTGGCATAAAGCTGGGTGCAGACTGCAGACGGCCATGGTTTCTGCAGGGAACCGCGGCCCCTCA
AGCTCTCTGCAGCCACTTCCTTCCCCACTCCTTCCTTATCTATCGGACCACCCAGCGCAGAAAGCCACAAC
CAACGTCTACTTCCCCACAAACACCAACTGCCCTCCTGGGGGCATAGGGAGCGGATGATCACCCCCAGGTG
CTGGGGCAGTCCCCCACTTGTGAGCAACTTTCTTCTCTTTCAAACCCCACCTCCGTGAGACCTGCTGATTG
GAAAAGCATGCGGACAGGGCAGTAAGCAACGCCAGGCCTCCTCTTGAAAGCGGAAGTGTCCCATCTGTGGG
CCCCACAGGTGCAAGCCAGGAACATCTGCCTCGGAGCTGGTGGGGAGCCACCCACTCCCACCAGCCGCACC
CAGGGTCCAGCCCTGCTGCCTCTTGGGCTAGGGGCTGTTTTCAAAAACCCCTCACTGCCCCTGATCCAAAC
CCTTCCTTGGCTCACTCACTCACTCTGATATATTTGGGGGGAGGGGCTGTGGCTCAGCTGCACTGGTTCTG
GGGACCATGACACTGCTCTGTTCTTCAGAGGTCAAGGAGCCTGGCCCCTGCAGGACTGCTGGCACTGAAAA
TAAACAGACACAACCCAGTGCCCTCGTTGATCCCATGCTCCACCCTCATCAGAACACAGGGAACACAGTGA
CACTGGTGGACTGTCCTATCTCACAGCAGGGTCCTCTCTCCTCAAACCCTGAAGAGAACAGTCAGCCAGCA
GGGTAGAAGGGGCAAGCAGGACCCCATGTTTTGGAACTCAAGACCTAAGCTTGTAGCTTGTTGTATTACTC
TTAATTTCAAGACACTCAAGGCCAAGACAGTGACATCCAGGAAGACATGAAACAAGGGGTTTTTAGTAGCC
AACTATCTACATGAACAAGCTAAACGTTAAATCAAAGCAAAGCATAGTGGCCCTATTAGCATCCTAGGACC
ATGTCTGGGAACCCTTACCAGGTTTAAGAGAACATTATTCCTTCCCATGAAACCACCCTATAGTTTCATCA
CCGTTTAGTAAGTGGCTTTCTCTGGAACCTGAAGCTATAATAGCATTATTTCTACTGGGATTCACTTGGAA
AGGGGCCTGGAGTTTCTCCCAAGTAGACAGCCTTTCTAGCAAGCTCCAGGTCACTAGGCAGAGAGGCCAAC
TGCCTATGTGTGGCCTGTTTGGCTCAAGCTTCCTTTAAAGAAGGTAATATAGGATGGGGTTTCCACAGCTG
GGAGACTAGACTGTGACCCTGATCCTATCTGAGGCCAGGCACAACATGACAATGGAGATTCTTCCAGGCAA
GAGGTGACCAGAGAACCACTGATGGTGATGGAGAGACCACCTGAGCCATGGGTGGGCAGGAGGCTGGTCAG
AGTCCTGACCATGCTCACTCCTGACTCTGCCAGCACCCCCAATAGGTCGTTCATTGGAGGGCAAATAGAAA
GGGTTTCTTGGTCTTGGGCAAAGTGTGGCTGAAGGCAGGCAAAGTGGGTGGAGTCTCTGGACCTCCCAGGC
CACAGGAAGGGCTATGCCCCATGGGAAGATAGACAGATGAGCCAGAGGCTCTGGCCAGGATGGACATTACT
CCAGGGTGGAGGAAACACACTCCATGAGCCACACCAGATTGGGCCCAGTGGGAGGTCTCAGGGCTACAGGC
GGGATAGGAGGAAGTTGTTGGGAAGTCAGACCGGAATGGCATGGTGGAGGGAGAACCGGCAACCAGGCAGA
TGGTTCCTGACGAGGAAGCTCTGGGCACAGCTGCAGGCCCCCGACCCCCACCGCATTATCACTGTGACACA
GCTGGCTGCCTCACCCCTGAAGGCTGCAGGAGGACCTCCCCCATGCTGTCCCCAAGCCCGCCCCGTGTCAC
ATGAGGCCCTGCAGACTCCCACCCTCCGTCCAGGGCCACAACCCAGCTCTGCCGGCTGTAGTGACTAGAAA
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GGCCTGGAGCCTCCAAGGAACAGAGGCACGGGCTCCGAGACGCCAAAGCTCCTCCAGCCCTCCTGTAGATC
TAAGTAAGCTTGGCATTCCGGTACT 
Cbfa2t3h full promoter - mutated (restriction enzymes Nhe1/HindIII) 
GGGAGGTACCGAGCTCTTACGCGTGCTAGCACCCTGGCATGGGAAGAGTGTGAGGGAACAGGAGGGAGCCC
CCAATCCCTGGCATAAAGCTGGGTGCAGACTGCAGACGGCCATGGTTTCTGCAGGGAACCGCGGCCCCTCA
AGCTCTCTGCAGCCACTTCCTTCCCCACTCCTTCCTTGTCTGGCGGACCACCCAGCGCAGAAAGCCACAAC
CAACGTCTACTTCCCCACAAACACCAACTGCCCTCCTGGGGGCATAGGGAGCGGATGATCACCCCCAGGTG
CTGGGGCAGTCCCCCACTTGTGAGCAACTTTCTTCTCTTTCAAACCCCACCTCCGTGAGACCTGCTGATTG
GAAAAGCATGCGGACAGGGCAGTAAGCAACGCCAGGCCTCCTCTTGAAAGCGGAAGTGTCCCATCTGTGGG
CCCCACAGGTGCAAGCCAGGAACATCTGCCTCGGAGCTGGTGGGGAGCCACCCACTCCCACCAGCCGCACC
CAGGGTCCAGCCCTGCTGCCTCTTGGGCTAGGGGCTGTTTTCAAAAACCCCTCACTGCCCCTGATCCAAAC
CCTTCCTTGGCTCACTCACTCACTCTGCAATATTTGGGGGGAGGGGCTGTGGCTCAGCTGCACTGGTTCTG
GGGACCATGACACTGCTCTGTTCTTCAGAGGTCAAGGAGCCTGGCCCCTGCAGGACTGCTGGCACTGAAAA
TAAACAGACACAACCCAGTGCCCTCGTTGATCCCATGCTCCACCCTCATCAGAACACAGGGAACACAGTGA
CACTGGTGGACTGTCCTTTCTCACAGCAGGGTCCTCTCTCCTCAAACCCTGAAGAGAACAGTCAGCCAGCA
GGGTAGAAGGGGCAAGCAGGACCCCATGTTTTGGAACTCAAGACCTAAGCTTGTAGCTTGTTGTATTACTC
TTAATTTCAAGACACTCAAGGCCAAGACAGTGACATCCAGGAAGACATGAAACAAGGGGTTTTTAGTAGCC
AACTCGCTACATGAACAAGCTAAACGTTAAATCAAAGCAAAGCATAGTGGCCCTATTAGCATCCTAGGACC
ATGTCTGGGAACCCTTACCAGGTTTAAGAGAACATTATTCCTTCCCATGAAACCACCCTATAGTTTCATCA
CCGTTTAGTAAGTGGCTTTCTCTGGAACCTGAAGCTATAATAGCATTATTTCTACTGGGATTCACTTGGAA
AGGGGCCTGGAGTTTCTCCCAAGTAGACAGCCTTTCTAGCAAGCTCCAGGTCACTAGGCAGAGAGGCCAAC
TGCCTATGTGTGGCCTGTTTGGCTCAAGCTTCCTTTAAAGAAGGTAATATAGGATGGGGTTTCCACAGCTG
GGAGACTAGACTGTGACCCTGATCCTCTCTGAGGCCAGGCACAACATGACAATGGAGATTCTTCCAGGCAA
GAGGTGACCAGAGAACCACTGATGGTGATGGAGAGACCACCTGAGCCATGGGTGGGCAGGAGGCTGGTCAG
AGTCCTGACCATGCTCACTCCTGACTCTGCCAGCACCCCCAATAGGTCGTTCATTGGAGGGCAAATAGAAA
GGGTTTCTTGGTCTTGGGCAAAGTGTGGCTGAAGGCAGGCAAAGTGGGTGGAGTCTCTGGACCTCCCAGGC
CACAGGAAGGGCTATGCCCCATGGGAAGACAGACAGATGAGCCAGAGGCTCTGGCCAGGATGGACATTACT
CCAGGGTGGAGGAAACACACTCCATGAGCCACACCAGATTGGGCCCAGTGGGAGGTCTCAGGGCTACAGGC
GGGCGAGGAGGAAGTTGTTGGGAAGTCAGACCGGAATGGCATGGTGGAGGGAGAACCGGCAACCAGGCAGA
TGGTTCCTGACGAGGAAGCTCTGGGCACAGCTGCAGGCCCCCGACCCCCACCGCATTGGCACTGTGACACA
GCTGGCTGCCTCACCCCTGAAGGCTGCAGGAGGACCTCCCCCATGCTGTCCCCAAGCCCGCCCCGTGTCAC
ATGAGGCCCTGCAGACTCCCACCCTCCGTCCAGGGCCACAACCCAGCTCTGCCGGCTGTAGTGACTAGAAA
GGCCTGGAGCCTCCAAGGAACAGAGGCACGGGCTCCGAGACGCCAAAGCTCCTCCAGCCCTCCTGTAGATC
TAAGTAAGCTTGGCATTCCGGTACT 
Nfe2 enhancer (restriction enzymes SacI/XhoI): chr15:103258245-103258850 
AGCTAACATAACCCGGGAGGTACCGAGCTCTGGGAAAATCCTATCCACATGTAAACTGGAACACAAGGAAA
ATAACCGATGACTCTGGAGATCTGACTCCACTATCTAGCAAAGTTTTTACTTTATACTACCCCCACTCCCG
ACTTCATCAGGGGAGCGTGAGTATTCCTGGGTCCCAGGCGTCCTTCACCACCACCCCCATCCGGGGCAACC
GCCCTGCTCTGCTGCTTTGGATAACACCGGGCCCTCCCCCTATTCCCCCTGTGGCTGCCTCCCCCTTCCGT
CTGTTGAGAGAGGAAGCCAGGGGGTGGCGGGTGCAATGCTGTGGGGCACTGATAAAAGGCCAGTACTATCC
CCGCCCTCTGGGGCCACTGCGGTCACACCAGTAGGCAATCCAGCAAGGCAGCCAGTTCCCTGTGGGACCCA
TGGCCCTCCCCTGGTTCCACCTCTAGCCACCCCGCCCTGCTCACCCTTCTCGGGAAGCTGGTTGCATAACC
CAGTGGGGTGTTTGGCAACAATGCTTGTGGCTTGACCTGATGCTGCTGGTGGTGTGCACATACGTAGTGGA
GGTGGGTTGGACTGGGGTGACAGGTTAACTATTTAGGGGTTGGGTGAGCAGCAAAAGTGGAAAATGTTCTC
GAGATCTGCATCTCAATTAGTCAGCAA 
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Nfe2 enhancer - mutated (restriction enzymes SacI/XhoI) 
AGCTAACATAACCCGGGAGGTACCGAGCTCTGGGAAAATCCGGTCCACATGTAAACTGGAACACAAGGAAA
ATAACCGATGACTCTGGAGATCTGACTCCACTGTCTAGCAAAGTTTTTACTTTATACTACCCCCACTCCCG
ACTTCATCAGGGGAGCGTGAGTATTCCTGGGTCCCAGGCGTCCTTCACCACCACCCCCATCCGGGGCAACC
GCCCTGCTCTGCTGCTTTGGACAACACCGGGCCCTCCCCCTATTCCCCCTGTGGCTGCCTCCCCCTTCCGT
CTGTTGAGAGAGGAAGCCAGGGGGTGGCGGGTGCAATGCTGTGGGGCACTGACGAAAGGCCAGTACTGTCC
CCGCCCTCTGGGGCCACTGCGGTCACACCAGTAGGCAATCCAGCAAGGCAGCCAGTTCCCTGTGGGACCCA
TGGCCCTCCCCTGGTTCCACCTCTAGCCACCCCGCCCTGCTCACCCTTCTCGGGAAGCTGGTTGCATAACC
CAGTGGGGTGTTTGGCAACAATGCTTGTGGCTTGACCTGATGCTGCTGGTGGTGTGCACATACGTAGTGGA
GGTGGGTTGGACTGGGGTGACAGGTTAACTATTTAGGGGTTGGGTGAGCAGCAAAAGTGGAAAATGTTCTC
GAGATCTGCATCTCAATTAGTCAGCAA 
 
2.3.4.5. Plasmid List 
Table 2.7. List of plasmids used as backbones for various applications. 
Plasmid Name Source Chapter 
pGL2-Basic Vector Göttgens Lab 6 (Luciferase assays) 
pGL2-Promoter Vector Göttgens Lab 6 (Luciferase assays) 
pKLV2-U6gRNA5(BbsI)-
PGKpuro2AmAG-W 
Addgene #67976 4 (gRNA cloning) 
pMD2.G Göttgens Lab 4 (retrovirus production) 
∆R.89 Göttgens Lab 4 (retrovirus production) 
 
 
2.4. HSC retroviral transduction analysis: genotyping  
2.4.1. Genotyping primer design 
Primers were designed using Primer3 (Koressaar and Remm 2007; Untergasser et al. 2012). The 
gene sequence was looked up on Ensembl (Zerbino et al. 2018) and visualized in ApE Plasmid 
Editor. The guide sequences were identified in the gene and enclosed in square brackets in Primer3, 
to ensure they were included in the primer sequence. Table 2.8 shows the overhangs used in the 
primer design. The order in which the primers were used was determined by their proximity to the 
cleavage site. Primers were designed for all guides but only the ones listed in Table 2.9 were used. 
Specifications for primer design included: 
• The primer closest to the cleavage site must be between 70-200bp away from the cleavage 
site 
• Total product size including overhangs should be between 400-600bp 
• Avoid big differences in primer Tm within primer pairs by setting it between 56-63℃ in 
Primer3 
46  Materials & Methods 
 
 
• Avoid long stretches of single bases 
• Avoid big differences in GC% within primer pairs 
 
Table 2.8. Primer overhang sequences 
Proximity to cleavage site Overhang sequence (5' - 3') 
Closest TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG 
Furthest GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG 
 
Table 2.9. Genotyping primers 
Primer Name Sequence (5' - 3') 
Procr_sg1_geno1_L GTCTCGTGGGCTCGGAGATGTGTATAA 
GAGACAGTCCGATTGCAGACC TCAGTT 
Procr_sg1_geno1_R TCGTCGGCAGCGTCAGATGTGTATAA 
GAGACAGGGAGGATGGTGACGT TTTGG 
Trim47_sg3_geno1_L GTCTCGTGGGCTCGGAGATGTGTATAA 
GAGACAGAGGCCTCTGAAATCACCACA 
Trim47_sg3_geno1_R TCGTCGGCAGCGTCAGATGTGTATAA 
GAGACAGTGCGCTGTTCCTCTTGTCTA 
Wfdc2_sg3_geno1_L TCGTCGGCAGCGTCAGATGTGTATAA 
GAGACAGTTTAGGACCGAGCGAAGGAG 
Wfdc2_sg3_geno1_R GTCTCGTGGGCTCGGAGATGTGTATAA 
GAGACAGTTCCTGGTCCCTCTTTGTCC 
Gbp8_sg1_geno1_L TCGTCGGCAGCGTCAGATGTGTATAA 
GAGACAGCTTCACAGGCATAGCTCCCT 
Gbp8_sg1_geno1_R GTCTCGTGGGCTCGGAGATGTGTATAA 
GAGACAGCCTCCTCCTACCTTTTCCACA 
 
2.4.2. Isolating gDNA 
Genomic DNA was isolated from sorted GFP+ cells using the QIAamp DNA Micro Kit (Qiagen) 
following the suggested protocol. The carrier RNA diluted in Buffer AE was always added to 
Buffer AL to improve yield. The gDNA was eluted into 30µl water and stored at -4℃.  
2.4.3. Testing genotyping primers 
All genotyping primers used were first tested using HoxB8-FL gDNA, which was isolated by Iwo 
Kucinski. 
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To test the primers, the following PCR reaction mixture was prepared on ice: 1.25 µl of the forward 
and reverse primers (10mM), 5 µl of 5X Phusion® High-Fidelity Reaction Buffer (NEB), 0.5 µl of 
10 mM dNTP solution (NEB), 0.25 µl of Phusion ® High-Fidelity Polymerase (NEB), 10-20 ng/µl 
of the gDNA template and water up to a 25 µl total reaction volume. The following PCR program 
was used: 98℃ for 30s → 30 cycles of 98℃ for 10s, 59℃ for 20 s, 72℃ for 20 s → 72℃ for 7 
min. The product was then checked on an 0.9% agarose gel. 
A band corresponding to the expected product size was seen for all primers, indicating that all the 
primers worked at an annealing temperature of 59℃. 
2.4.4. Genotyping protocol 
The same PCR as described in Section 2.4.3 was used for genotyping the gDNA of interest. After 
the product was checked on a 0.9% agarose gel, a second PCR reaction was set up to anneal the 
indexing primers (Nextera XT Index Kit v2 Set A, Illumina) to the previous PCR product. 1 µl of 
the forward and reverse primers were mixed with 10 µl of KAPA HiFi HotStart PCR Mix (KAPA 
Biosystems, Roche), 2 µl of template from the previous PCR, and 6 µl of water for a total reaction 
volume of 20 µl. The following PCR program was then used: 98℃ for 3 min → 20 cycles of 98℃ 
for 20s, 55℃ for 15s, 72℃ for 1min → 72℃ for 5 min. The product was again checked on an 
0.9% agarose gel. After confirming that the product was as expected, it was cleaned up using 
Agencourt AMPure XP Beads (Beckman Coulter). 4 µl of each sample was pooled in a 1.5 ml 
Eppendorf tube. The beads were added to the sample in a 1:0.7 ratio (sample: beads). The mixture 
was incubated at room temperature for 5 minutes and then placed on a magnetic stand (Invitrogen) 
for 2 minutes. The supernatant was carefully removed, and the beads were washed twice with 
freshly prepared 80% ethanol. Once the beads were dry, 20 µl of EB was added to each tube. The 
samples were vortexed and incubated at room temperature for 2 minutes before being placed on 
the magnetic stand for 2 minutes. The entire volume of supernatant was then transferred to another 
1.5 ml Eppendorf tube without disturbing the remaining beads. The product was run on the 
BioAnalyzer system (Agilent Genomics) using the Agilent High Sensitivity DNA Kit (Agilent 
Genomics) to visualize the product size and quality. Finally, the product was quantified using the 
KAPA Library Quantification Kit (KAPA Biosystems, Roche) following the suggested protocol. 
The quantified sample was diluted to the appropriate concentration (10 nM) and sent for sequencing 
at the Genomics Core, CRUK CI (University of Cambridge) on the MiSeq Nano System (Illumina). 
 
48  Materials & Methods 
 
 
2.5. Single Cell Gene Expression Analysis 
2.5.1. Single cell gene expression analysis (Fluidigm BioMark™ HD) 
The protocol for isolating single bone marrow HSPCs is detailed above (Section 2.2.1). Cell 
processing for single cell gene expression analysis was performed as previously described 
(Moignard et al. 2013). TaqMan® assays (Table 2.11, Applied Biosystems) in TE Buffer (Life 
Technologies) were pooled in a 1:100 dilution of each assay, constituting a 0.2X TaqMan® assay 
mix. This mix was aliquoted and stored at -20℃. 
Single cells were sorted directly into a 96-well PCR plate by FACS. Each well contained 5 µl of 
2X Reaction Mix (CellsDirect One-Step qRT-PCR kit, Life Technologies), 0.1 µl SUPERase 
RNase Inhibitor (Ambion), 2.5 µl of the 0.2X assay mix, 1.2 µl TE buffer and 1.2 µl Superscript 
III/Platinum Taq (CellsDirect One-Step qRT-PCR kit, Life Technologies) for a total volume of 10 
µl per well. After sorting, the plates were vortexed then centrifuged at 700 g for 2 minutes at 8℃. 
The plates were stored at -80℃. 
2.5.1.1. Specific Target Amplification 
Reverse transcription and preamplification were performed using the conditions listed in Table 
2.10. Victoria Moignard previously determined the optimum number of preamplification cycles for 
haematopoietic cells to be 22 cycles, which brings the gene expression within the dynamic range 
of the Fluidigm BioMark™ HD platform. The cDNA was then stored at -20℃.  
 
Table 2.10. Thermocycler conditions for synthesis and specific target amplification of cDNA from single cells. 
Step Temperature (℃) Time Cycles 
cDNA synthesis 50 15 min --- 
Inactivation of SuperScript III/ Activation of 
Platinum Taq 
95 2 min --- 
Specific target amplification 
95 15 s 
22 
60 4 min 
Hold 4 ∞ --- 
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2.5.1.2. qRT-PCR on the Fluidigm BioMark™ HD platform 
After preamplification, qRT-PCR was performed on the Fluidigm BioMark™ HD platform using 
a 48:48 Dynamic Array integrated fluidics chip (Fluidigm). The cDNA was diluted 1:5 in TE 
buffer.  
A 96-well plate was used to prepare the reagents for loading onto the 48:48 Dynamic Array. On 
one half of the plate, 2.7 µl of the diluted cDNA was mixed with 3 µl of a TaqMan® Universal 
Mastermix (Applied Biosystems) and 0.3 µl Gene Expression Sample Loading Reagent 
(Fluidigm). Each well contained a different sample. On the other half of the plate, 3 µl of each 
FAM-labelled TaqMan® assay was mixed with 3 µl Gene Expression Assay Loading Reagent 
(Fluidigm). Each well contained a different assay. 4.5 µl of each assay or sample was loaded into 
individual assay or sample inlets on the 48:48 Dynamic Array. Samples and assays were loaded 
into integrated fluidics chip using the IFC Controller MX (Fluidigm). The 48:48 Dynamic Array 
was then transferred to the Fluidigm BioMark™ HD for qRT-PCR. The following qRT-PCR 
program was used: 95℃ for 10 minutes → 40 cycles of 95℃ for 15 seconds, 60℃ for 1 minute. 
 
Table 2.11. List of TaqMan® assays used for single cell gene expression analysis. 
Gene name  Assay ID Gene name Assay ID 
Bptf  Mm01251151_m1 Ldb1  Mm00440156_m1 
Cbfa2t3h  Mm00486780_m1 Lmo2  Mm01281680_m1 
Cdkn2a  Mm00494449_m1 Lyl1  Mm01247198_m1 
Csf1r  Mm01266652_m1 Mecom  Mm01289155_m1 
Dnmt3a  Mm00432881_m1 Meis1  Mm00487659_m1 
Egfl7  Mm00618004_m1 Mitf  Mm01182480_m1 
Eif2b1  Mm01199614_m1 Mpl  Mm00440310_m1 
Erg  Mm01214246_m1 Myb  Mm00501741_m1 
Ets1  Mm01175819_m1 Nfe2  Mm00801891_m1 
Ets2  Mm00468977_m1 Nkx2-3  Mm01199403_m1 
Etv6  Mm01261325_m1 Notch1  Mm00435249_m1 
Fli1 Mm00484409_m1 Pbx1  Mm04207617_m1 
Gata1  Mm00484678_m1 Polr2a  Mm00839493_m1 
Gata2  Mm00492300_m1 Prdm16  Mm00712556_m1 
Gata3  Mm00484683_m1 Procr  Mm00440992_m1 
Gfi1  Mm00515855_m1 Runx1 Mm01213405_m1 
Gfi1b  Mm00492318_m1 Spi1  Mm00488142_m1 
Hhex  Mm00433954_m1 Sh2b3  Mm00493156_m1 
HoxA5  Mm00439362_m1 Smarcc1  Mm00486224_m1 
HoxA9  Mm00439364_m1 Tal1  Mm01187033_m1 
HoxB4  Mm00657964_m1 Tcf7  Mm00493445_m1 
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Gene name  Assay ID Gene name Assay ID 
Ikzf1  Mm01187882_m1 Tet2  Mm00524395_m1 
Itga2b  Mm00439768_m1 Ubc Mm01201237_m1 
Kit  Mm00445212_m1 Vwf  Mm00550376_m1 
 
2.5.2. Single cell gene expression analysis (single-cell RNA sequencing) 
The protocol for isolating single bone marrow HSPCs is detailed above (Section 2.2.1). scRNA-
seq analysis was performed as described previously (Picelli et al. 2014). All centrifugation steps 
occurred at 8℃ for 1 minute at 700 g. Volumes for all mixtures mentioned are for a single 96-well 
plate, unless otherwise stated. 
2.5.2.1. Single cell lysis 
Single cells were sorted by FACS directly into 96-well PCR plates. Each well contained 2.3 µl 
lysis buffer. The lysis buffer contained 1 µl of SUPERase RNase Inhibitor (Invitrogen) to 19 µl of 
0.2% (vol/vol) Triton X-100 (Sigma). Once the cells were sorted, the plate was vortexed and spun 
down. The plates were stored at -80℃ for up to 6 months. 
2.5.2.2. Reverse transcription and preamplification 
ERCC (External RNA Controls Consortium) RNA Spike-In Mix (Invitrogen) was diluted 
1:300,000 in water containing SUPERase RNAse Inhibitor. 10 µl of the diluted ERCCs were mixed 
with 10 µl of 100 µM oligo-dT (Table 2.14), 100 µl of 10 mM dNTP mix (ThermoFisher), and 80 
µl of water to make up the annealing mixture. Once the plate of sorted cells had thawed on ice, 2 
µl of the annealing mixture was added to each well. The plate was centrifuged before being 
incubated for 3 minutes at 72℃. 
A reverse transcription (RT) mix was prepared with the following reagents: 50 µl of Superscript II 
RT (Invitrogen), 200 µl of 5X Superscript II First Strand Buffer (Invitrogen), 50 µl of 100 mM 
DTT (Invitrogen), 25 µl of SUPERase RNAse Inhibitor, 200 µl of 5M Betaine (Sigma), 6 µl of 1 
M MgCl2 (Ambion), 10 µl of 100 µM TSO (Table 2.14) and 29 µl of water. 5.6 µl of the reverse 
transcription mixture was added to each well and the plate was centrifuged before being transferred 
into the thermocycler. RT was performed using the conditions detailed in Table 2.12. 
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Table 2.12. Thermocycler conditions for reverse transcription (Smart-seq2* protocol). 
Step Temperature (℃) Time (min) Cycles 
RT and template switching 42 90 --- 
Unfolding of RNA secondary structures 50 2 
10 Completion/continuation of RT and template 
switching 
42 2 
Enzyme inactivation 70 15 --- 
Hold 4 ∞ --- 
*(Picelli et al. 2014) 
 
A PCR preamplification mix was made with the following reagents: 1250 µl of 2X KAPA HiFi 
HotStart Ready Mix (KAPA Biosystems), 25 µl of 10 µM IS PCR primer (Table 2.14) and 225 µl 
of water. After reverse transcription, 15 µl of the PCR preamplification mix was added to each 
well. The plate was centrifuged and preamplification was performed using the conditions detailed 
in Table 2.13. 
Table 2.13. Thermocycler conditions for preamplification (Smart-seq2* protocol). 
Step Temperature (℃) Time Cycles 
Denature 
98 3 min --- 
98 20 sec 
21 Anneal 67 15 sec 
Extend 
72 6 min 
72 5 min --- 
Hold 4 ∞ --- 
*(Picelli et al. 2014) 
 
Table 2.14. Oligo sequences. 
Oligo Source Sequence 
TSO (LNA oligo) Exiqon AAGCAGTGGTATCAACGCAGAGTACATrGrG+G 
Oligo-dT30VN Biomers.net AAGCAGTGGTATCAACGCAGAGTAC(T30)VN 
IS PCR Biomers.net AAGCAGTGGTATCAACGCAGAGT 
All oligos are HPLC purified. 
 
After preamplification, the plates of cDNA were stored at -20℃. The cDNA was cleaned up using 
the Beckman Coulter Biomek FXP (Beckman Coulter). A 1:0.8 ratio of sample to Agencourt 
AMPure XP beads was used for PCR purification. After being washed with 80% ethanol, the 
samples were eluted in 22 µl of EB buffer. 20 µl of the supernatant was collected and transferred 
to a new 96-well plate. The cDNA library was then checked for quality and size distribution on the 
BioAnalyzer system using an Agilent High Sensitivity DNA Kit.  
52  Materials & Methods 
 
 
2.5.2.3. Library preparation 
The following steps were performed using the Nextera XT DNA Library Preparation Kit (Illumina) 
and the Nextera XT 96-Index Kit (384 samples, Illumina). All reagents, unless otherwise 
mentioned, are contained in this kit. The protocol is based on the Tagmentation protocol from 
Fluidigm.  
A pre-mix was made using 264 µl of Tagmentation DNA Buffer (warmed to room temperature) 
and 132 µl Amplicon Tagment Mix. 3.75 µl of the pre-mix was added to each well of a fresh 96-
well plate (“library prep” plate). 1.25 µl of each sample from the cDNA library plate was then 
added to individual wells of the “library prep” plate. The plate was then centrifuged and incubated 
at 55℃ for 10 minutes, after which 1.25 µl of NT buffer was immediately added to each well to 
neutralize the samples.  
Once the plate was centrifuged again, 3.75 µl of the Nextera PCR Master Mix was added to each 
well. 1.25 µl each of Index Primer 1 (N701-N712) and Index Primer 2 (S517, S502-S508) were 
added to each well, creating unique combinations of the indexes in each well. It was essential to 
know the order of the indexes for data analysis. 
After the addition of the indexes, the plate was centrifuged before being transferred into the thermal 
cycler for PCR amplification (Table 2.15). After amplification, the plates could be stored at -20℃ 
long-term. 
Table 2.15. Thermocycler conditions for amplification of cDNA libraries. 
Temperature (℃) Time Cycles 
72 3 min --- 
95 30 sec --- 
95 10 sec 
12 55 30 sec 
72 60 sec 
72 5 min --- 
10 ∞ --- 
 
For clean-up, 2 µl of sample from each well was pooled together into one 1.5 ml Eppendorf tube 
and the total pooled volume was measured. Agencourt AMPure XP beads were added at 0.9% of 
the total pooled library volume. The mixture was incubated at room temperature for 5 minutes and 
then placed on a magnetic stand (Invitrogen) for 2 minutes. The supernatant was then carefully 
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removed, and the beads were washed twice with freshly prepared 80% ethanol. Once the beads 
were dry, 50 µl of EB was added to each tube. The samples were vortexed and incubated at room 
temperature for 2 minutes before being placed on the magnetic stand for 2 minutes. The entire 
volume of supernatant was then transferred to another 1.5 ml Eppendorf tube without disturbing 
the remaining beads. 
The library size distribution was checked using the BioAnalyzer system with an Agilent High 
Sensitivity DNA Kit. The library was then quantified using the KAPA Library Quantification Kit 
and diluted to the appropriate concentration (10 nM). Libraries were sequenced at the Genomics 
Core, CRUK CI (University of Cambridge) using the Illumina HiSeq 2500 or Illumina HiSeq 4000 
system (single-end 125bp reads). 
 
2.6. Computational Analysis 
2.6.1. Single cell gene expression data analysis (Fluidigm BioMark™ HD) 
All analysis of qPCR data from the Fluidigm BioMark™ was performed using R (www.r-
project.org). Most scripts used were written by Fiona Hamey or Victoria Moignard and Fernando 
Calero-Nieto, and Fiona Hamey and Wajid Jawaid helped with some coding aspects. All analyses 
were carried out by Sonia Shaw unless otherwise stated. Fiona Hamey performed the pseudotime 
inference, network construction and stable state analyses. Specific details are provided in Chapters 
5 and 6. 
2.6.1.1. Data processing and filtering 
Single-cell gene expression data was collected using Fluidigm Data Collection software and 
analysis was performed as previously described (Moignard et al. 2013; N. K. Wilson et al. 2015). 
ΔCt values were calculated by normalising mean expression levels to housekeeping genes Ubc and 
Polr2a (G. Guo et al. 2010). Where a gene could not be detected, the maximum ΔCt value for a 
gene/assay was calculated and 3.5 was added.  
2.6.1.2. Downstream analyses 
All housekeeper genes (Ubc, Polr2a, Eif2b1), Cdkn2a, Egfl7, Gfi1, and Spi1 were removed from 
the dataset for downstream analysis. Cdkn2a was not expressed in any of the cell types, and Egfl7, 
Gfi1 and Spi1 were removed due to technical issues. 
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The data collected for FSR-HSC2, MPP and PreMegE cells in this investigation were projected 
onto a principal component analysis (PCA) plot together with data collected by Wilson et al. for 
the following populations: LMPPs, CMPs, GMPs, MEPs, FSR-HSCs, and HSCs. The data were 
also re-analysed with data from Wilson et al. (N. K. Wilson et al. 2015). Since the projected PCA 
plot and the re-analysed PCA plot showed similar correlations between the cell populations, 
analysis was continued using the re-analysed data set containing all 12 populations.  
Hierarchical clustering was performed using the hclust function and heatmap.2 from the gplots 
package. Spearman rank correlations and ward linkage were used. PCA was performed using the 
default settings for the prcomp() function. T-distributed Stochastic Neighbour Embedding (t-SNE) 
analysis was performed using the tsne package. Diffusion maps dimensionality reductions were 
calculated using the destiny package using centred cosine distance and σ = 0.3 (Angerer et al. 2016). 
Cells were retrospectively coloured based on clusters or the population to which they belonged. 
Subsequent analyses in which MolO cells were projected onto the data were performed using the 
roots package. 
2.6.1.3. Additional information 
Single cell gene expression data were also collected for HoxB8-FL cells. These data were 
processed by Fiona Hamey. All the single cell gene expression data from the Fluidigm BioMark™ 
platform can be downloaded from: 
http://blood.stemcells.cam.ac.uk/single_cell_qpcr.html  
2.6.2. Single cell gene expression data analysis (scRNA-seq) 
All analysis of the scRNA-seq data was performed using R (www.r-project.org) unless otherwise 
stated. The script used for the analysis was written by Fiona Hamey. All analyses were carried out 
by Sonia Shaw unless otherwise stated.  
2.6.2.1. Aligning reads and quality control 
Reads were aligned using G-SNAP (T. D. Wu and Nacu 2010) and the mapped reads were assigned 
to Ensembl genes (release 81) (Zerbino et al. 2018) by HTSeq (Anders, Pyl, and Huber 2015). This 
was done by Evangelia Diamanti.  
Quality control and data normalization was performed by Fiona Hamey. To pass quality control, 
cells had to meet the following requirements: 
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• Cells need to have at least 200,000 reads mapping to nuclear genes 
• Cells need to have at least 4,000 genes detects 
• Less than 10% of mapped reads should map to mitochondrial genes 
• Less than 50% of mapped reads should map to ERCC spike-ins. 
The reads were normalised using the method of Lun et al. (Lun, Bach, and Marioni 2016). 
Technical variance was estimated using ERCC spike-ins, as described by Brennecke et al. 
(Brennecke et al. 2013). The data were normalized in R using flowCore (Hahne et al. 2009) and 
ComBat (Johnson, Li, and Rabinovic 2007). 
2.6.2.2. Assigning population thresholds 
Population thresholds were assigned retrospectively by comparing normalised index data with 
published literature (A. Wilson et al. 2008; Pronk et al. 2007; Pietras et al. 2015; Cabezas-
Wallscheid et al. 2014). The index data was plotted in FlowJo (Treestar) and gated to define HSPC, 
MPP and progenitor populations. CD45 was not available in the index data; therefore, E-SLAM 
cells were gated using the following strategy: EPCR+ CD48- CD150+. The set gates either covered 
all cells (broad gating) or left unclassified cells in between populations to prevent overlap between 
gates (narrow gating). 
2.6.2.3. Downstream analyses 
Hierarchical clustering was performed using the hclust function with average linkage and (1 – 
Spearman’s correlation)/2 distance. Clusters were identified using the cutreeDynamic function 
from the dynamicTreeCut package using a minimum cluster size of 10 and the deepSplit parameter 
set at 1. Wilcoxon rank sum tests with Benjamini-Hochberg correction tested for differential 
expression in genes expressed in at least half of the cells in a cluster. Diffusion maps dimensionality 
reductions were calculated using the destiny package with cosine distance and Gaussian kernel 
width = 0.3 (Angerer et al. 2016). Pseudotime analysis was performed by Fiona Hamey. 
2.6.2.4. Haematopoietic differentiation landscape – Online resource 
An interactive website was designed by Blanca Pijuan-Sala, which allows other researchers to view 
the expression of their genes of interest on the HSPC differentiation landscape. The website also 
contains the surface marker and cell phenotype visualisations. The raw data was also made 
available for others to use the HSPC differentiation atlas in their research. This interactive website 
can be found following this link:  
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http://blood.stemcells.cam.ac.uk/single_cell_atlas.html 
2.6.2.5. STREAM analysis 
STREAM analysis (Single-cell Trajectories Reconstruction, Exploration and Mapping) was 
performed on the scRNA-seq dataset by Huidong Chen from the Pinello lab at Harvard University 
(H. Chen et al. 2018). The data was made available at: 
http://stream.pinellolab.org/ 
Within this online resource, Sonia Shaw visualized the expression of various genes and made 
observations about genes involved in branching and transitioning points in the pseudotime 
ordering. 
2.6.2.6. SPRING analysis 
SPRING analysis was performed on the scRNA-seq dataset by Caleb Weinreb from the Klein lab 
at Harvard University (Weinreb, Wolock, and Klein 2018). The data was made available at: 
https://kleintools.hms.harvard.edu/tools/springViewer.html?cgi-
bin/client_datasets/gottgens_prenorm  
Within this online resource, Sonia Shaw visualized the expression of various genes and proteins 
and made observations about the discernible cell populations. 
2.6.3. Analysis of genotyping data 
Genotyping results were analysed in R studio. The genotyping protocol is described in Section 2.4. 
Evangelia Diamanti mapped the reads to the mouse genome and generated .fastq files for each 
library sequenced using MiSeq Nano. The first 10,000 reads of each .fastq file were aligned to the 
appropriate reference sequence using custom functions created by Iwo Kucinski. The output of the 
script included the fraction of indels and frameshift mutations for each sample, which were 
compared to the empty vector controls to determine whether the CRISPR gRNAs successfully 
targeted the genes of interest. 
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Chapter 3: A single-cell atlas of adult murine haematopoiesis 
 
Parts of this section have been modified from Nestorowa et al. (2016). Isolation of primary mouse 
bone marrow cells and scRNA-seq analysis were carried out by Sonia Shaw. Blanca Pijuan-Sala 
performed index data normalisation and designed the interactive website associated with the 
publication (http://blood.stemcells.cam.ac.uk/single_cell_atlas.html). Sonia Shaw performed the 
computational analysis described in this chapter, except for the pseudotime ordering on the 
diffusion map, which was performed by Fiona Hamey. 
 
3.1. Background 
The haematopoietic system is formed through a series of cell-fate decisions, in which 
haematopoietic stem cells (HSCs) differentiate towards multiple mature cell types through dynamic 
gene expression. It is necessary to study populations at various stages of maturation together to 
gain insights into cell-fate decision making. Researchers have developed increasingly pure 
isolation strategies for haematopoietic stem and progenitor cells (HSPCs), providing many 
significant advances for the haematopoietic community (Beerman et al. 2010; D. G. Kent et al. 
2009; Kiel et al. 2005; Morita, Ema, and Nakauchi 2010; Challen et al. 2010). Purification 
protocols require the use of increasingly restrictive gates to optimise purity. These strict gates 
exclude ‘contaminating cells,’ which may in fact be transitional cells moving from one cellular 
state to another. 
Bulk-expression studies have helped improve our understanding of the haematopoietic system; 
however, it is a very heterogeneous system and bulk-expression profiling will only capture average 
expression states within cells, inadequately representing individual cells. Single-cell analysis is 
therefore required to resolve heterogeneity within HSPC populations. Advances in flow cytometry 
have allowed for the collection of surface marker expression data for single-cells during 
fluorescence-activated cell sorting (FACS) (Osborne 2011). The surface marker expression can be 
coupled with single-cell gene expression profiling, making it possible to use broader sorting 
strategies to capture a wider range of cell types while retaining the ability to classify cells into well-
defined haematopoietic populations (Schulte et al. 2015).  
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Recently, over 2,700 cells were profiled using massively parallel single-cell RNA sequencing 
(MARS-seq) coupled with index sorting to investigate heterogeneity within the common myeloid 
progenitor (CMP) population. The investigation spanned CMPs, granulocyte-monocyte 
progenitors (GMPs), and megakaryocyte-erythroid progenitors (MEPs), and collected surface 
marker and gene expression data to create a reference mouse model of haematopoiesis (Paul et al. 
2015). While this study demonstrates the power of index-sorting coupled with FACS, it is restricted 
by sequencing depth, limiting the information gained from the dataset. In fact, although single-cell 
gene expression studies of HSPCs were published prior to this investigation, they were limited by 
inadequate coverage of the haematopoietic hierarchy, or were restricted in the number of genes 
profiled when using quantitative real-time PCR (qRT-PCR) (Grover et al. 2016; Moignard et al. 
2013; Paul et al. 2015; Kowalczyk et al. 2015; Wilson et al. 2011, 2015; Hamey et al. 2016). Where 
the number of genes quantified was restricted, bias would be introduced as the investigator selected 
the genes to profile, potentially missing dynamic genes and limiting the opportunity for discovering 
novel gene expression patterns. As such, at the time of this investigation, a single-cell HSPC 
transcriptomic atlas that covered all cell types in early haematopoiesis was not available, and the 
creation of such an atlas would be a powerful resource for investigating gene expression changes 
during differentiation.  
3.1.1. Aims 
The aims of this chapter were to: 
• Generate a comprehensive atlas of murine HSPC differentiation at the single-cell level 
• Interrogate the HSPC atlas to better understand differentiation trajectories 
These aims were addressed by profiling over 1,600 HSPCs from mouse bone marrow using single-
cell RNA sequencing (scRNA-seq). Cells were isolated using broad sorting strategies to capture 
cells that may represent important transitional stages in haematopoietic differentiation, normally 
excluded by narrow gating strategies. The scRNA-seq profiles were used to visualise 
differentiation from HSCs to more mature haematopoietic progenitor cells. Using various analysis 
methods, the data was interrogated to show gene and surface marker expression trends, as well as 
the breadth of information that can be obtained from transcriptomic profiling. 
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3.2. Isolation of haematopoietic stem and progenitor cells for single-cell analysis 
To comprehensively sample cells across the HSPC transcriptional landscape, cells were isolated 
from mouse bone marrow. The cells were sorted by single-cell FACS coupled with index sorting, 
which collects the surface marker expression data for every cell sorted (Fig. 3.1A). Two broad 
gates based on c-Kit and Sca1 expression were used to capture cells from the HSPC gate (Lin- 
Sca1+ c-Kit+) and Progenitor (Prog) gate (Lin- Sca1- c-Kit+). The HSPC gate encompassed long-
term HSCs (LT-HSCs), finite self-renewal HSCs (FSR-HSCs), multipotent progenitors (MPPs), 
and lymphoid multipotent progenitors (LMPPs), whereas the Prog gate included CMPs, MEPs and 
GMPs (Fig. 3.1B). LT-HSCs are much less frequent than the other cell types in the HSPC gate 
(Fig. 3.1C). LT-HSCs were sorted separately to ensure sufficient coverage of the population, using 
the Lin- Sca1+ c-Kit+ Flk2- CD34- sorting strategy.  
The cells were sorted into twenty 96-well PCR plates with HSPC, Prog and LT-HSC cells 
represented on each plate (Fig 3.1A) for a total of 1,920 cells (840 HSPC cells, 840 Prog cells, and 
240 LT-HSCs). This layout was used to account for possible batch effects that may arise from only 
one cell type being represented per plate, and to decrease the number of cells of a particular cell 
type lost if there was a plate issue. The cells were processed for scRNA-seq as previously described 
(Picelli et al. 2014). Quality control (QC) removed empty wells and low-quality profiles, leaving a 
total of 1,654 cells suitable for further analysis (701 HSPC cells, 798 Prog cells, and 155 LT-
HSCs). A high sequencing depth resulted in a median of over 8,600 genes per cell detected for each 
cell passing QC (Fig 3.1A). Technical variance analysis was performed to remove genes that were 
affected by technical noise or showed low variation across cell types (Brennecke et al. 2013). 
ERCC spike-ins were used to estimate technical variance, finding 4,290 genes with variance 
exceeding the estimated threshold. These highly variable genes were used for downstream analysis. 
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Figure 3.1. Isolation and profiling of HSPCs at the single cell level. (a) Schematic of the experimental design. Bone 
marrow cells isolated from mice were sorted using three broad gates based on surface marker expression. Index sorting 
data was collected during FACS. The cells were processed for scRNA-seq; the table summarises the number of cells 
and median number of genes detected for the three sorted populations after quality control. HSPC: Lin- Sca1+ c-Kit+; 
LT-HSC: Lin- Sca1+ c-Kit+ CD34- Flk2-; Prog: Lin- Sca1- c-Kit+. (b) Breakdown of the populations encompassed 
in the broad sorting gates, indicated by coloured boxes. (c) Flow cytometry plots showing the gating strategy used for 
FACS. Numbers above each gate indicate the percentage of those cells present in its parent population. Gate colours 
correspond to cell/well colour in Fig 3.1A, and box colour in Fig 3.1B. L-S-K+: Lin- Sca1-c-Kit+ (Prog parent gate); 
L-S+K+: Lin- Sca1+ c-Kit+ (LT-HSC and HSPC parent gate). 
 
3.3. Single-cell gene expression analysis reveals distinct HSPC clusters 
Unsupervised hierarchical clustering was performed using the expression of the 4,290 highly 
variable genes to investigate heterogeneity between the cell populations. Clustering allows the data 
to be grouped based solely on gene expression and can be used to gain insights about similarities 
and differences between groups of cells. Unsupervised learning does not require the input of any 
classifications by the investigator, and therefore finds commonalities within the data without the 
investigator’s bias.  
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The clustering partitioned the 1,654 cells into 5 broad clusters (Fig. 3.2). Cell populations were 
retrospectively assigned based on traditional sorting strategies using the index data collected during 
sorting, which is further explained in Section 3.6. The cell types making up each cluster and their 
gene expression patterns can therefore be distinguished on the heatmap. Cluster 1 is made up of 
mainly LT-HSCs and is represented by genes such as Procr, Trim47 and F11r (Sugano et al. 2008; 
Schulte et al. 2015; Gerrits et al. 2009). Cluster 2 contains mostly LT-HSCs and LMPPs, as well 
as a small proportion of FSR-HSCs, MPP3, and CMPs. Clusters 3 and 4 are both composed of all 
the cell types investigated and share expression of many of the representative genes. However, they 
are differentiated by higher expression of certain genes, such as Ccl9, Clec12a, and Tyrobp in 
Cluster 3, or Apoe in Cluster 4. Cluster 5 is mainly made up of MEPs and is characterized by the 
expression of erythroid genes such as alpha-haemoglobin (Hba-a1) (Stadhouders et al. 2015).  
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Figure 3.2. Unbiased hierarchical clustering reveals heterogeneity in the gene expression of HSPC clusters. Heatmap showing gene expression across clustered 
scRNA-seq data. Differential expression ranked genes by fold-change between cells within a cluster versus other clusters. Only the top 10 genes most specific for 
each cluster are displayed. Colour bars indicate the cluster identity and population identity for each cell. Cell types are coloured based on retrospective gating; the 
legend explains the colour-coding of cell populations: LT-HSC – purple; LMPP – blue; MPP1 – brown; MPP2 – pink; MPP3 – yellow; FSR-HSC – orange; MEP 
– red; CMP – light green; GMP – dark green. Grey cells represent cells unassigned to any cell population. Cluster colours: 1 – blue; 2 – turquoise; 3 – yellow; 4 – 
pink; 5 – purple 
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3.4. Transcriptional profiling reveals a differentiation continuum 
Clustering is a useful tool to characterise gene expression patterns within a dataset but forces the 
data into discrete groups, which does not adequately represent the differentiation continuum 
occurring in haematopoiesis. To visualise the data as a continuum, dimensionality-reduction 
methods were implemented. These methods condense the high-dimensionality data into a low-
dimensionality plot and emphasise key differences in the dataset.  
Principal component analysis (PCA) was performed to visualise the distribution of the clusters in 
relation to each other based on their gene expression (Fig. 3.3A). These clusters were previously 
determined by unsupervised hierarchical clustering (Section 3.3). The PCA grouped Clusters 1, 2 
and 4 together and separated Cluster 5 from the rest of the data as a more distinct cluster. The cells 
in Cluster 3 overlapped with Clusters 2 and 4, but also formed a projection in the data, indicating 
some differentiating gene expression patterns, consistent with the pattern seen on the heatmap (Fig. 
3.2). While PCA is an informative method of dimensionality-reduction and pulls out variations in 
the data, it assumes the data has a linear structure and may therefore miss any non-linear patterns 
(Lever, Krzywinski, and Altman 2017). Furthermore, PCA can only take into consideration two or 
three principal components at a time, whereas other methods consider all components and try to 
plot them in two dimensions. As this scRNA-seq dataset has many dimensions and has a complex 
structure, PCA may be unable to capture all the lineage differentiation patterns in the dataset.  
Diffusion maps have been successful as a non-linear dimensionality-reduction method to capture 
continuous differentiation processes from single-cell snapshot data (Coifman et al. 2005; 
Haghverdi, Buettner, and Theis 2015). The diffusion map method was applied to this dataset and 
the plot was visualised in the first three diffusion components after determining these components 
were optimal for showing the continuous nature of the data (Fig. 3.3B). The PCA and diffusion 
map both separated Clusters 3 and 5 from the remaining clusters. However, in the diffusion map, 
Clusters 1 and 2 also form a separate projection together. This gives a better resolution of the 
haematopoietic hierarchy, as Cluster 1 represents the most immature cells, the LT-HSCs, and 
Cluster 2 consists of LT-HSCs and early progenitors. Furthermore, the structure of the diffusion 
map suggests a continuum in which the cells of Cluster 1 give rise to three main trajectories, 
represented by Clusters 2, 3 and 5. The dataset was visualised using the diffusion map for all 
downstream analyses, unless otherwise stated. 
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Figure 3.3. Multidimensional analysis shows a differentiation continuum towards different blood lineages. (a) 
PCA calculated on the expression of 4,290 variable genes measured by scRNA-seq. PC: Principal Component. The 
plot is coloured by the clusters identified in Section 3.3. (b) Diffusion map calculated on the expression of 4,290 
variable genes measured by scRNA-seq. DC: Diffusion Component. The plot is coloured by the clusters identified in 
Section 3.3. Cluster colours: 1 – blue; 2 – turquoise; 3 – yellow; 4 – pink; 5 – purple. 
 
3.5. Visualising gene expression on the HSPC differentiation continuum 
Expression levels of individual genes can be plotted on the diffusion map to show their expression 
across the HSPC differentiation landscape (Fig. 3.4) This can be a useful tool to not only identify 
characteristics of the projections seen on the diffusion map, but also to visualise a gene of interest 
and understand how its expression differs among the HSPC populations.  
Procr and Mpl are known to be important in HSCs and are mainly expressed at the top of the 
diffusion map, corresponding with Clusters 1 and 2 (Balazs et al. 2006; Kimura et al. 1998). 
Additionally, the expression of recently reported LT-HSC markers HoxB5 and Fgd5 is 
concentrated at the top of the diffusion map (J. Y. Chen et al. 2016; Gazit et al. 2014). These genes 
highlight the HSC region. The lymphoid genes Ccl3 and Dntt are highly expressed in Cluster 2, 
highlighting cells of the early lymphoid trajectory (Rothenberg 2014). Cluster 3 consists of cells 
expressing the myeloid marker genes Mpo and Ctsg, representing the myeloid trajectory (Olsson 
et al. 2016). Similarly, the expression of Cebpa, which is involved in cell-fate decisions during 
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myeloid differentiation, is mostly concentrated to Cluster 3 (L. Scott et al. 1992). Gata1, a 
transcription factor important in erythroid and megakaryocytic differentiation, has concentrated 
expression in Cluster 5 (Evans and Felsenfeld 1989). Klf1 and Gypa are also highly expressed in 
cluster 5 but further along in the projection, marking the erythroid trajectory (Dzierzak and 
Philipsen 2013). Therefore, scRNA-seq analysis of cells isolated using broad sorting gates captured 
the transcriptional profiles of cells from HSCs through to erythroid, myeloid, and lymphoid 
trajectories. 
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Figure 3.4. Gene expression in the HSPC differentiation atlas. Diffusion map of all cells coloured based on the 
expression of selected genes. The genes were chosen based on published literature or were identified computationally 
as highly expressed in specific cell populations. The colour corresponds to a log2 scale of expression ranging between 
0 and the maximum value for each gene. The diffusion map coloured by clusters from Figure 3.3B is included for 
reference. Cluster colours: 1 – blue; 2 – turquoise; 3 – yellow; 4 – pink; 5 – purple. DC: Diffusion Component 
 
67  A single-cell atlas of murine haematopoiesis 
 
 
3.6. Linking cell phenotypes with the transcriptome 
Index-sorting data was collected during FACS, meaning that surface marker expression data was 
available for all cells along with the transcriptional profiles made available by scRNA-seq. Surface 
marker expression data could therefore be visualised on the diffusion map (Fig. 3.5). These 
visualisations were performed to confirm that the transcriptome recapitulates the well-
characterised structure of the cell surface phenotypes of haematopoietic differentiation.  
Along with the antibodies required to isolate the HSPC, Prog and LT-HSC populations, all cells 
were also stained with antibodies against CD48, CD150 and EPCR. The surface markers Sca1, 
Flk2, CD34, CD16/32, CD48, CD150, and EPCR marked coherent territories on the diffusion map 
(Fig. 3.5A). These territories were consistent with the separation of HSCs and more mature 
progenitors and matched the gene expression patterns described in Section 3.5. EPCR expression 
was highest at the top of the diffusion map, consistent with the expression pattern of Procr, the 
gene encoding EPCR (Fig. 3.4). The lineage cocktail (Lin) is made up of antibodies against CD5, 
CD11b, CD19, CD45R, Gr-1, TER119, and 7-4, which are markers of mature haematopoietic cells. 
Lin, c-Kit and Sca1 were the main surface markers used for sorting and their expression, as 
visualised on the diffusion map, reflects the sorting strategies used. All cells were sorted as c-Kit 
positive and Lin negative; the colours in Figure 3.5 are normalised between the minimum and 
maximum expression value for each marker, and therefore regions of the c-Kit and Lin expression 
plots may appear varied based on cell marker expression within a defined gate. Overall, c-Kit and 
Lin expression were consistent throughout the landscape (Fig. 3.5B), whereas Sca1 is not expressed 
in the erythroid and myeloid projections (Fig. 3.5A). Forward-scattered light-height (FSC-H), 
which represents cell size, was higher in myeloid and erythroid cells than in the HSCs and early 
lymphoid cells. This is consistent with the larger size of more mature cells compared to immature 
HSCs.  
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Figure 3.5. Surface marker expression on the HSPC differentiation atlas. Diffusion map of all cells coloured based 
on surface marker expression data collected using index-sorting. Surface markers in (a) mark territories on the diffusion 
map, whereas surface markers in (b) do not mark any territories due to their global expression. The colour corresponds 
to normalised expression values ranging between the minimum and maximum value for each marker. Flow cytometry 
data were normalised across two sort days. FSC-H: forward-scattered light-height; Lin: Lineage cocktail (CD5, 
CD11b, CD19, CD45R, Gr-1, TER119, 7-4); DC: Diffusion Component 
 
Three broad sorting strategies were used to isolate the HSPC, Progenitor and LT-HSC populations. 
Using strict gates could limit the information gained for creating a differentiation continuum; they 
are limited by the investigator’s knowledge of existing populations and may miss stepwise 
processes occurring between known HSC and progenitor populations. By using a liberal gating 
strategy, it could be possible to capture cells in the differentiation continuum that would normally 
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be missed by using strict sorting gates. The index sorting data collected during FACS was used to 
retrospectively assign cells into the cell populations outlined in Fig. 3.1B using common sorting 
strategies (Fig. 3.6A). By additionally staining for CD150, CD48 and EPCR, cells could be 
retrospectively assigned to other populations, such as E-SLAM (D. G. Kent et al. 2009) or the MPP 
subpopulations (A. Wilson et al. 2008; Pietras et al. 2015). The index data was visualised on the 
diffusion map to show the cell type distributions (Fig. 3.6B). The expression of marker genes 
correlated with the unsupervised clustering and transcriptional profiling of cells.  
Three sorting strategies were visualised for LT-HSCs using retrospective gating, ordered in Fig. 
3.6B by decreasing stringency: E-SLAM (CD48- CD150+ EPCR+), Lin- Sca1+ c-Kit+ CD34- Flk2- 
CD48- CD150+, and the LT-HSC sorting strategy (Lin- Sca1+ c-Kit+ CD34- Flk2-). The sorting 
strategy stringency has a reverse correlation with heterogeneity, as E-SLAM cells occupy the least 
heterogeneous space at the top of the diffusion map.  
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Figure 3.6. Visualising HSPC populations on the HSPC differentiation atlas. (a) Schematic of the strategies used 
for retrospectively gating the cells using the index-sorting data. The 96-well plate is coloured by a possible distribution 
of cell types sorted. The colours are consistent with those shown in the gating strategy diagram. Purple – LT-HSC; 
grey – MPP; blue – LMPP; red – MEP; light green – CMP; dark green – GMP. (b) Diffusion maps of all cells coloured 
based on cell types assigned by retrospective gating. The population of interest is coloured in purple; all other cells are 
in grey. DC: Diffusion Component. 
71  A single-cell atlas of murine haematopoiesis 
 
 
3.7. Capturing changes in gene and protein expression using pseudotime 
ordering 
Pseudotime ordering links cells together to order each transcriptional profile by its progress through 
differentiation (Bendall et al. 2014; Trapnell et al. 2014). Pseudotime analysis assumes gene and 
protein expression constantly change throughout differentiation, and that the dataset includes a 
large sample of cells broadly covering the differentiation process. In pseudotime ordering, the 
position of a cell corresponds to its progress in differentiation.  
Fiona Hamey performed pseudotime ordering on the diffusion map to capture changes in both gene 
and surface marker protein expression during differentiation, and to identify differentiation 
lineages towards mature haematopoietic cells. Differentiation trajectories were identified from 
HSCs towards erythroid (E), granulocyte-macrophage (GM), and lymphoid (L) lineages (Fig. 
3.7A). Changes in index-sorting parameters along these pseudotime trajectories were visualised 
(Fig. 3.7B). The surface markers used for isolating cells showed changes in expression consistent 
with the sorting strategies used. FSC-H increased along all three trajectories, indicating an increase 
in cell size, as seen previously when the index sorting data was visualised on the diffusion map 
(Fig. 3.5). The increase in FSC-H occurred more gradually along the L lineage than along either 
the E or GM lineage. EPCR, which was not used for sorting but was included in the antibody 
staining panel, showed decreased expression along all three trajectories, consistent with EPCR 
being a marker for HSCs (Balazs et al. 2006). 
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Figure 3.7. scRNA-seq profiles can be computationally ordered along pseudotime trajectories. (A) Diffusion map 
highlighting cells in three differentiation trajectories. Cells were ordered from HSCs along erythroid (E), granulocyte-
macrophage (GM) and lymphoid (L) lineages. The pseudotime value for each cell indicates its position in the 
differentiation trajectory, moving from blue to red. DC: Diffusion Component. (B) Surface marker and FSC-H 
dynamics along the pseudotime trajectories. Index data is scaled so that each variable ranges from 0 (low) to 1 (high) 
in each trajectory. The colour bar at the top of each heatmap indicates the cell type. LT-HSC – purple; LMPP – blue; 
MPP1 – brown; MPP2 – pink; MPP3 – yellow; FSR-HSC – orange; MEP – red; CMP – light green; GMP – dark green. 
Grey cells represent cells unassigned to any cell population. Figure was created by Fiona Hamey and modified by 
Sonia Shaw. 
 
Gene set enrichment analysis (GSEA) interrogates a given dataset for biological processes, 
molecular functions, or phenotypes in which the genes are known to be involved. GSEA can be 
used to gain a better understanding of statistically significant biological processes occurring along 
a differentiation trajectory. Gene sets that were up- or down-regulated throughout pseudotime were 
identified for each trajectory (Fig. 3.8A). GSEA revealed enrichment terms for these gene sets that 
corresponded to the relevant trajectory (Fig. 3.8B). The L trajectory showed an increase in genes 
involved in B-cell lineage commitment, genes involved in megakaryocyte-erythrocyte progenitor 
phenotypes were upregulated along the E trajectory, and neutrophil degranulation genes were 
upregulated along the GM trajectory. Both the E and GM trajectories had significant terms related 
to cell-cycle, such as “mitotic cell cycle” and “DNA replication.” However, the L trajectory did 
not show any significant upregulation of genes related to cell cycle, which may be due to the low 
number of genes up- (n=29) and down-regulated (n=23) in this trajectory. 
73  A single-cell atlas of murine haematopoiesis 
 
 
 
Figure 3.8. Pseudotime ordering reveals changes in gene expression during differentiation. (a) Normalised 
expression of genes up- or down-regulated along pseudotime for erythroid (E), granulocyte-macrophage (GM), and 
lymphoid (L) trajectories. Gene expression was smoothed by a sliding window of size 20 along pseudotime. Mean 
normalised expression is shown as a black line ± standard deviation (grey shading). n indicates the number of genes in 
each subset. (b) Gene set enrichment analysis terms for the above gene sets. Adjusted p-value is shown for significant 
terms (Benjamini-Hochberg). Figure was created by Fiona Hamey and modified by Sonia Shaw.  
 
3.8. Ordering cells along differentiation trajectories using STREAM 
The diffusion map is a useful non-linear dimensionality reduction method to visualise continuous 
differentiation processes within the scRNA-seq dataset. The analysis informed on gene and surface 
marker expression throughout the HSPC atlas and was used to identify three differentiation 
trajectories within the data using pseudotime ordering. However, the visualisation lacks 
information about cell density and cell type composition.  
Recently, a new trajectory inference tool called STREAM (Single-cell Trajectories Reconstruction, 
Examination and Mapping) was developed to reconstruct differentiation trajectories and capture 
gene expression changes during differentiation using pseudotime ordering (Trapnell et al. 2014; H. 
Chen et al. 2018). STREAM uses a non-linear dimensionality reduction method called Modified 
Local Linear Embedding (MLLE) and infers trajectories using a novel method called ElPiGraph 
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(Lever, Krzywinski, and Altman 2017; Z. Zhang and Wang 2006). ElPiGraph differs from other 
methods as it does not require drastic dimensionality reduction or pre-clustering to infer 
trajectories. In addition to capturing trajectories within a dataset, STREAM uses a visualisation 
method which includes density information throughout pseudotime. This is a useful tool to track 
cell population composition changes along a trajectory.  
The Pinello lab used our scRNA-seq dataset to demonstrate STREAM and their interactive web-
tool. The online interface allows the user to manipulate the data to interrogate branching and gene 
expression patterns. STREAM is available at the following link: 
http://stream.pinellolab.org/MNoPZ/  
HSCs were selected as the start of the branching structure and the scRNA-seq dataset was 
visualised on a “subway plot” (Fig. 3.9A) and a “stream” plot (Fig. 3.9B). The subway plot orders 
cells according to their pseudotime score and distance from their assigned branch. The purpose of 
the subway plot is to visualise the branching structure of the data to understand the pseudotime 
progression. The stream plot also orders cells based on their pseudotime score but incorporates 
information on the density and composition of cell types along the different trajectories. The stream 
plot visualisation requires the user to input cell type information and is made from the subway plot 
using a sliding window approach. The length of the plot represents a cell’s location along 
pseudotime, whereas the width of the plot is proportional to the number of cells.  
The subway plot showed that STREAM analysis identified three lineages in the data: erythroid, 
myeloid, and lymphoid. The analysis suggests the lymphoid cells entered their trajectory before 
the myeloid and erythroid cells. The stream plot showed that the lymphoid branch was composed 
mostly of LMPPs, the erythroid branch of MEPs, and the myeloid branch of CMPs and GMPs. The 
lymphoid trajectory stopped before the other lineages, which is due to there being fewer lymphoid 
cells in the analysis as more mature lymphoid cells were excluded from the sorting gates. The 
expression of the genes Procr, Klf1, Ctsg and Dntt were visualised on stream plots to represent the 
HSCs, the erythroid, myeloid, and lymphoid lineages, respectively (Fig. 3.9C). The branching and 
gene expression patterns were consistent with the diffusion map visualisation. Dntt expression was 
observed in the lymphoid branch as well as in cells heading towards the erythroid and myeloid 
lineages. The stream plot (Fig. 3.9B) showed LMPPs are present in the trajectory at this stage (S1-
S3 on the subway plot), accounting for the observed Dntt expression pattern. 
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STREAM analysis also detects genes important in defining branching points in the data (Fig. 3.9D). 
The user can identify which branch they want to investigate using the annotations marked on the 
subway plot, and STREAM identifies genes differentially expressed between the diverging 
branches. Cd63 and Hlf were highly expressed on the HSC branch compared to cells after the first 
bifurcation event. Cd63 encodes for an endosome-associated protein that has previously been 
identified as a marker of HSCs in cultured human CD34+ HSCs, and Hlf has recently been shown 
to be a key regulator in HSC quiescence (Komorowska et al. 2017; Beckmann et al. 2007). 
Conversely, Il12a and Cst7 were more highly expressed after the bifurcation event than in HSCs. 
Il12a encodes for a subunit of the IL-12 cytokine, a main activator of natural killer cells, and Cst7 
is involved in normal eosinophil function (Seaman 2000; Halfon et al. 1998). Ltb and Uhrf1 were 
identified as differentially expressed between the lymphoid and erythroid/myeloid lineages, 
respectively. Ltb is involved in the development of normal lymphoid tissue, whereas Uhrf1 is an 
epigenetic regulator required for establishing DNA methylation patterns of erythroid genes (Koni 
et al. 1997; J. Zhao et al. 2017). STREAM also found genes marking the second bifurcation event. 
Gimap6, which encodes a protein required for T-cell maintenance, was more highly expressed in 
cells before the differentiation point (Pascall et al. 2018). Conversely, Sdsl and Rab44, which are 
associated with the erythroid and myeloid lineages, respectively, were more highly expressed in 
their respective lineages (Poczobutt et al. 2016; Khoramian Tusi et al. 2018). Finally, when the 
erythroid and myeloid lineages were directly compared, Mfsd2b and Hk3 were differentially 
expressed in the two trajectories. Mfsd2b is involved in red cell morphology, whereas Hk3 is 
involved with neutrophil differentiation, supporting the notion that these genes may mark a 
branching point between the lineages (Vu et al. 2017; Federzoni et al. 2012).  
STREAM analysis was also used to look for transition genes, defined as genes for which the 
expression correlated with the pseudotime ordering on a given branch (Fig. 3.9E) (H. Chen et al. 
2018). These genes were selected by the STREAM interface based on their differential expression 
across the stream plot. This analysis can also give insight into cell-fate decision making and has 
the potential to discover novel genes. Tgm2 had increasing expression towards the tip of the HSC 
branch, whereas Tespa1 showed increased expression moving away from HSCs. Tgm2 is an 
extracellular matrix protein previously suggested to be a regulator of LT-HSCs (Forsberg et al. 
2005). Tespa1, on the other hand, is a signalling molecule that plays a wide range of roles in more 
differentiated cells, including T-cells and mast cells (Liang et al. 2017; D. Wang et al. 2012). Igsf6, 
which is involved in myeloid differentiation, and Ctla2a were inversely correlated with the myeloid 
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branch (Stein and Baldwin 2013). The expression of Smim1, which encodes an erythroid 
transmembrane protein, marked the tip of the erythroid trajectory, while Coro1a expression was 
higher in the less differentiated cells (Storry et al. 2013). Finally, Tyms, a gene involved in DNA 
replication and repair, was identified as a transition gene moving away from the lymphoid 
trajectory (Ozer et al. 2015). Ltb (Fig. 3.9D), involved in normal lymphoid organogenesis, was the 
transition gene identified towards the lymphoid trajectory (Koni et al. 1997). Except for Ltb, these 
genes were not identified in previous analyses, such as hierarchical clustering, demonstrating that 
STREAM can be used to find novel genes of interest. 
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Figure 3.9. STREAM analysis reveals information about pseudotime ordering in the HSPC differentiation 
landscape. (a) Subway plot of the scRNA-seq data visualised based on its pseudotime ordering. Cells are coloured 
based on cell type. The trajectories are ordered and coloured for the user to easily manipulate the data. S2-S1 (blue) – 
HSC to first branching point; S1-S0 (green) –lymphoid trajectory; S1-S3 (orange) – branch into myeloid and erythroid 
trajectories; S3-S4 (purple) – myeloid trajectory; S3-S5 (red) – erythroid trajectory (b) Stream plot of the scRNA-seq 
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data visualised based on its pseudotime ordering. The width of each branch is proportional to the total number of cells. 
Branches are coloured based on cell type composition. HSCs – turquoise; CMP – red; MEP – blue; MPP – yellow; 
GMP – green; LMPP – brown. (c) Stream plots of all cells coloured based on the expression of selected genes. The 
genes chosen were previously used in Figure 3.4 to mark branches within the diffusion map. (d) Stream plots of genes 
identified to be differentially expressed between erythroid and myeloid branches. (e) Stream plots of genes identified 
to be correlated with the pseudotime ordering on the HSC branch. Genes are ordered based on which branch they are 
associated with (moving from HSCs to erythroid). 
 
3.9. Visualising HSPCs and capturing rare populations using SPRING 
The diffusion map and STREAM analysis both revealed three differentiation trajectories within 
the scRNA-seq dataset. However, neither method is able to capture the full complexity of the data 
in a two-dimensional plot. A new visualisation method, SPRING, uses a force-directed layout of 
k-nearest neighbour graphs to capture long-distance relationships between cells (Weinreb, Wolock, 
and Klein 2018). SPRING brings similar cells together and repels cells which differ based on their 
gene expression while ensuring all cells remain connected via nodes. SPRING can visualise 
continuous expression topologies and could be a useful tool for uncovering biological processes 
that were not captured by previous approaches.  
The Klein lab used our scRNA-seq dataset to demonstrate SPRING using their interactive web-
tool. The online interface allows the user to compare gene expression profiles, focus on 
subpopulations within the data, and potentially discover marker genes. SPRING is available at the 
following link: https://kleintools.hms.harvard.edu/tools/spring.html 
Cell populations, determined by retrospective gating using index-sorting data, were visualised 
using the SPRING web-tool (Fig. 3.10). The SPRING plot recapitulated a similar pattern compared 
to the diffusion map, with LT-HSCs, LMPPs, GMPs and MEPs forming distinct branches. LT-
HSCs and LMPPs were found close together and MEPs formed a long protrusion from the dataset. 
GMPs, however, formed a branch that is more separated and elongated than in the diffusion map. 
Furthermore, the presence of five additional small branches on the SPRING plot suggests that there 
are other lineages represented in the data that were not captured by the diffusion map or STREAM 
(Fig. 3.11). 
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Figure 3.10. Visualising HSPC populations using the SPRING interface. SPRING plots of all cells coloured based 
on cell types assigned by retrospective gating of the index-data. The population of interest is coloured in purple; all 
other cells are in grey. 
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The expression of the genes Procr, Klf1, Ctsg and Dntt was visualised on SPRING plots to 
represent HSCs, erythroid, myeloid, and lymphoid lineages, respectively (Fig. 3.11A). The cell 
surface marker data and gene expression profiles separate the HSPC populations well. The 
SPRING interface allows the user to select cells of interest to reveal their expression profiles. This 
tool was used to identify the additional branches and to better determine genes involved in 
differentiation towards these lineages. Differential expression analysis was performed on the 
remaining branches and the top differentially expressed gene for each branch was visualised (Fig. 
3.11B). Gb1pp is a gene encoding for part of a platelet complex and may mark the megakaryocyte 
lineage (Savoia et al. 2011). Ltf, which encodes for an iron-binding protein, has been previously 
identified as a late-stage differentiation marker of neutrophils, macrophages, and subtypes of 
dendritic cells (Kovacic et al. 2014). Ltf may therefore be marking a myeloid lineage. Ms4a2 is 
expressed in mast cells and basophils and its presence in a distinct branch on the SPRING plot 
could indicate an early point in the mast cell/basophil lineage (Dwyer et al. 2016). Ly6c2 was 
expressed at the tip of the GMP branch and encodes for Ly6C, a marker for inflammatory 
monocytes (J. Yang et al. 2014). Cd19 is a reliable B-cell marker, which is expressed from pre-B 
cells until differentiation into plasma cells (K. Wang, Wei, and Liu 2012). Its expression was close 
to the LMPP population, and its presence in a distinct branch of the SPRING plot could indicate 
cells differentiating into B-cells. Il7r marks a cell’s entry into the lymphoid lineage and is expressed 
in common lymphoid progenitors (J. Wang et al. 2012). Finally, Ifit3b is an uncharacterised gene 
within the IFIT family, which are induced by interferon and have anti-viral functions (Vladimer, 
Górna, and Superti-Furga 2014). IFIT3 expression is induced in human dendritic cells in response 
to viral infections (Y.-L. Hsu et al. 2013). Therefore, the branch of cells expressing Ifit3b could 
indicate an early point in differentiation towards dendritic cells. 
The genes identified by SPRING analysis to be the top differentially expressed genes in each 
branch were also plotted on the diffusion map for comparison (Fig. 3.11C). Except for Il7r and 
Ly6c2, the expression of the selected genes is more disperse. Gb1pp has concentrated expression 
at the start of the erythroid lineage branch and Ms4a2 is expressed in the CMP/MEP regions. Ltf 
and Cd19 are expressed by few cells and are difficult to identify on the diffusion map. SPRING 
analysis therefore appears to capture more of the biological relationships within the data and reveals 
lineages previously obscured within the bulk of the landscape, allowing for deeper interrogation of 
trajectories along the HSPC differentiation landscape. 
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Figure 3.11. SPRING analysis captures rare populations in the HSPC differentiation atlas. (a) SPRING plot of 
all cells coloured based on the expression of selected genes. The genes chosen were previously used in Figure 3.4 to 
mark branches within the diffusion map. (b) SPRING plot of all cells coloured based on the expression of selected 
genes. The genes chosen were identified by SPRING analysis to be the top differentially expressed gene for each 
branch. (c) Diffusion map of all cells coloured based on the expression of selected genes. The genes chosen were 
identified by SPRING analysis to be the top differentially expressed gene for each branch. The colour corresponds to 
a log2 scale of expression ranging between 0 and the maximum value for each gene. DC: Diffusion Component. 
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3.10. Conclusions 
The main aim of this chapter was to generate a comprehensive atlas of HSPC differentiation. This 
was achieved by isolating individual cells from mouse bone marrow and profiling them by scRNA-
seq. The isolated cells encompassed HSCs and early progenitor populations to create a thorough 
depiction of the transcriptional landscape of early HSPC differentiation. The resulting landscape 
was then interrogated by pseudotime ordering and differential expression analysis to better 
understand the differentiation trajectories captured in the data. 
The cells were isolated using two broad sorting gates and an additional LT-HSC sorting gate. The 
gates used captured HSC and progenitor populations from known sorting strategies without 
specifying narrow restrictions. In doing so, the aim was to capture stepwise processes that may 
exist outside of narrowly defined population gates and may fill in gaps within the differentiation 
continuum. Surface marker and gene expression showed that retrospective gating using the index 
sorting data correctly placed all the HSPC populations. The data was visualised using a diffusion 
map, a recently developed non-linear dimensionality reduction method that was particularly 
designed to capture the branching structure in single-cell data (Haghverdi, Buettner, and Theis 
2015). Previously defined HSPC populations were restricted to distinct regions on the diffusion 
map, with the exception of the CMP population. Unsupervised clustering grouped the data into five 
broad clusters. CMPs were represented mostly in clusters 3 and 4 which consisted of cells of all 
populations, and in total were present in four of the five clusters. The clustering and diffusion map 
visualisation show CMPs are a highly heterogeneous population, and in fact previous investigations 
have also suggested that CMPs are mainly erythroid- or myeloid-committed cells (Paul et al. 2015; 
Perié et al. 2015).  
Pseudotime ordering was performed on the diffusion map, ordering cells during differentiation 
based on their gene expression profiles. The ordering revealed three trajectories through the data 
from stem cells to erythroid, myeloid/granulocyte-macrophage, and lymphoid lineages. Surface 
marker expression was ordered along pseudotime and showed cells increased in cell size as they 
differentiated, particularly in the erythroid and granulocyte-macrophage lineages. This was 
consistent with MEP, CMP and GMP cells representing more mature cells compared to LMPPs, 
which are earlier progenitors along the lymphoid trajectory. GSEA was performed on genes up- 
and down-regulated along the lineages and showed that the erythroid and myeloid lineages had an 
upregulation in cell-cycle related terms, whereas the lymphoid trajectory did not. This suggests that 
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cell-fate specification occurred independently of cell cycling. However, there were few genes 
associated with the lymphoid trajectory. Cell cycle analysis was performed and reported in the 
Nestorowa et al. (2016) publication, in which cells were assigned to G0/G1, S and G2/M cell cycle 
categories (Scialdone et al. 2015). The distribution of cells across these cell cycle categories 
correlated well with the enrichment of cell cycle terms in genes upregulated in the E and GM 
trajectories. The analysis also showed that the large-scale transitioning of cells to S and G2/M 
phases occurred after the divergence of the L trajectory from the E and GM trajectories, supporting 
the evidence presented in this thesis suggesting that the transition to rapid cell cycling is secondary 
to transcriptional diversification (Nestorowa et al. 2016). Overall, the diffusion map was a useful 
tool for visualising the branching structure of the data and identifying differentiation lineages, 
which differ in their cell type composition as well as surface marker and gene expression patterns. 
Since the publication of the paper associated with this chapter, a number of interactive web-tools 
were developed for analysing and visualising scRNA-seq data. One of the great advantages of these 
web-tools is their accessibility for researchers with limited bioinformatics knowledge; on the 
flipside, these tools limit the investigator’s input into the analysis of the data and can be difficult 
to use if issues arise. STREAM and SPRING are two recently developed web-tools which were 
used in this chapter to elucidate more information about the differentiation trajectories (Weinreb, 
Wolock, and Klein 2018; H. Chen et al. 2018). STREAM analysis defined three trajectories within 
the data but suggested that the bifurcation event towards myeloid and erythroid trajectories occurs 
after the lymphoid branch is formed, consistent with the classic view of the haematopoeitic 
hierarchy. Uniquely, STREAM inputs cell composition data into its pseudotime ordering 
visualisation. This clearly represents the cell types present and their density at any given point in 
the pseudotime ordering, which is useful for understanding the structure of the lineages. This is, 
however, limited to the data provided by the user. The data analysed in this chapter was 
precomputed by Chen et al. to demonstrate the use of STREAM (H. Chen et al. 2018). They 
classified the cells into HSCs, LMPPs, CMPs, MEPs and GMPs, leaving out FSR-HSCs and the 
subpopulations of MPPs. It would be useful to see how the density of cell types would be affected 
if the data was fully annotated. Using STREAM, genes involved in branching points within the 
data were identified. Furthermore, genes that correlated with pseudotime along the myeloid, 
erythroid, and lymphoid branches were identified, which may be useful for recognising patterns of 
gene up- and down-regulation that result in particular cell phenotypes. The genes found by 
84  A single-cell atlas of murine haematopoiesis 
 
 
STREAM were not identified using the hierarchical clustering or diffusion map, suggesting that 
STREAM has the potential to identify novel markers for HSPC populations. 
STREAM and diffusion map analysis are both informative methods for analysing scRNA-seq data 
but are limited in the dimensions used for capturing the structure of the data. Although using more 
dimensions may increase the power to decipher which genes may be driving lineage decisions, it 
can also introduce noise into the analysis as the high-dimensional space is sparser. As such, neither 
STREAM nor diffusion map analyses are able to fully capture the structure within a dataset. In 
contrast, SPRING captures long-distance relationships in the data. Using a force-directed layout 
algorithm, SPRING can visualise continuous expression topologies within an interactive web 
interface (Weinreb, Wolock, and Klein 2018). SPRING analysis separated the HSPC atlas into 
eight branches. The main erythroid, myeloid and lymphoid trajectories were represented in the 
dataset. Additionally, SPRING identified branches into megakaryocyte, neutrophil, mast 
cell/basophil, and B-cell lineages. These lineages were obscured in the bulk of the HSPC atlas in 
both STREAM and diffusion map visualisations but were captured using SPRING. This tool allows 
for more specificity when looking at the differential expression of genes in a specific lineage, and 
therefore may be superior for interrogating the HSPC differentiation landscape. 
3.10.1. Limitations & future work 
As previously mentioned, the diffusion map and STREAM analyses were unable to fully represent 
the differentiation lineages in the HSPC landscape. This shortcoming was addressed by SPRING, 
which captured five additional trajectories in the data. Future work should include exploring 
pseudotime ordering on the SPRING plot to capture gene expression changes occurring towards 
more specific blood lineages. 
In every visualisation method used to show the HSPC landscape, the lymphoid branch was shorter 
than the myeloid and erythroid branches. This is due to the sorting gates being focused on capturing 
cells of the myeloid and erythroid lineages, only including LMPPs as representatives of the 
lymphoid branch. A lack of lymphoid cells resulted in a limited analysis of transition genes in the 
lymphoid branch using STREAM, where only Ltb was identified as transitioning towards the 
lymphoid trajectory. To full recapitulate the landscape of HSC differentiation into early blood 
progenitors, more cells of the lymphoid lineage would need to be represented. 
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Limitations also exist in the transcriptional profiling method itself. scRNA-seq profiling is 
associated with a substantial cost of sequencing, limiting the number of cells profiled based on 
budget. Furthermore, scRNA-seq has a limited quantitative range and can suffer from dropout 
events which cause technical and biological noise. To investigate the regulatory relationships 
controlling cell-fate decisions, a more directed approach could be taken. High-throughput 
quantitative real-time PCR could be used to further interrogate single cell data and identify dynamic 
gene expression through differentiation within a specific subset of genes. This will be further 
explored in Chapters 5 and 6. 
The HSPC atlas is a great tool for visualising the expression of specific genes to guide in vitro 
investigations. It could be used to interrogate genes important to characteristics of populations of 
interest, such as HSCs. This will be further explored in Chapter 4. 
3.10.2. Summary 
In summary, scRNA-seq analysis of 1,654 HSPCs resulted in a comprehensive atlas of 
haematopoietic differentiation. The investigation showed how single-cell profiling can give insight 
into many aspects of differentiation, identifying genes involved in branch points and transitions 
through pseudotime. Furthermore, SPRING analysis demonstrated the breadth of biological 
relationships present in the HSPC differentiation landscape. 
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Chapter 4: CRISPR screening of HSC-enriched genes 
 
4.1. Background 
Haematopoietic stem cells (HSCs) sit at the apex of the haematopoietic differentiation hierarchy 
and have the capacity to self-renew as well as differentiate into all adult blood cells (Morrison, 
Uchida, and Weissman 1995). For three decades, there have been intense efforts to molecularly 
and functionally characterise HSCs, and researchers have developed protocols to isolate 
increasingly refined haematopoietic stem and progenitor cell (HSPC) populations (Beerman et al. 
2010; Challen et al. 2010; D. G. Kent et al. 2009; Kiel et al. 2005; Morita, Ema, and Nakauchi 
2010). The HSPC atlas described in Chapter 3 contributed to these efforts by providing a 
comprehensive web interface of single-cell transcriptomic data, which can be used to analyse gene 
and surface marker expression in HSPC populations (Nestorowa et al. 2016). 
The HSPC atlas is a great resource to visualise population-specific gene expression trends. Chapter 
3 focused on identifying an appropriate visualisation of the high-dimensionality dataset, as well as 
categorising the differentiation lineages that are captured by the HSPC atlas. The focus of this 
chapter is to identify which genes are important in HSC biology, using the HSPC atlas to identify 
candidate targets specific to long-term HSCs (LT-HSCs).  
In their paper focused on resolving HSC heterogeneity, Wilson et al. identified a subpopulation of 
HSCs that were molecularly similar and included cells isolated by four commonly used sorting 
strategies (N. K. Wilson et al. 2015). This subpopulation was termed the molecularly overlapping 
(MolO) population. Single-cell RNA-sequencing of Lin- Sca1+ c-Kit+ CD34- Flt3- CD48- CD150+ 
HSCs led to the identification of 29 genes that were positively associated with the MolO population 
(Table 4.1). The gene set included Cdkn1c, Ptpn14, and Ifitm1, which are negative regulators of 
cell proliferation, suggesting that the MolO genes are involved in maintaining the HSC state. 
Wilson et al. also performed single-cell transplantation experiments of CD48+ CD150- (SLAM) 
Sca1hi HSCs and recorded the surface marker expression during FACS paired with index sorting. 
This analysis permitted the integration of functional and transcriptional information from cells that 
were sorted on the same day using the same parameters. These cells were compared based on their 
surface phenotype. Cells with similar phenotypes were called SuMO cells (surface marker overlap) 
and analysis of this population revealed 21 genes that were positively associated with repopulating 
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HSCs (Table 4.1) (N. K. Wilson et al. 2015). There was a large degree of overlap between the 
MolO and SuMO gene lists, which gave a high degree of confidence; therefore, the lists were 
combined, resulting in a list of 44 genes associated with functional HSCs.  
Table 4.1. List of all MolO and SuMO genes identified by Wilson et al. (2015). 
MolO Genes SuMO Genes Shared Genes 
Cd82 Cdkn1c Cldn10 Ablim1 Cd74 Ifitm1 
Ctsf Fads3 Fgfr3 Cyp27a1 Gbp6 Ly6a 
Gimap1 Gimap6 Gstm1 Gbp8 Gm4951 Mllt3 
Limd2 Ltb Mettl7a1 Ifitm3 Inhba Procr 
Neil2 Neo1 Pde1b Ly6e Mapk12 Ramp2 
Pdzk1ip1 Ptpn14 Smtnl1 Ndnf Ralgapa1 Sult1a1 
Sox18 Sqrdl Trim47 St8sia4 Tgtp2 
 
Ubl3 Vwf 
 
Wfdc2 
  
 
The Streptococcus pyogenes-derived type II clustered regularly interspaced short palindromic 
repeats (CRISPR)-Cas9 system has become a very successful tool for genome editing (Mali et al. 
2013; Cong et al. 2013). CRISPR sequences, or guide RNAs (gRNA), locate matching target DNA, 
which is cut by Cas9, effectively perturbing the target gene. This tool has been widely used for 
genetic research in many organisms, including genetic screens for essential genes or therapeutic 
targets (T. Wang et al. 2014; Shi et al. 2015; Shalem et al. 2014; Koike-Yusa et al. 2014). Recently, 
Tzelepis et al. used a Cas9 transgenic mouse to interrogate the genomes of acute myeloid leukaemia 
cells for potential therapeutic targets (Tzelepis et al. 2016). The investigation described in this 
chapter uses CRISPR-Cas9 technology to examine whether perturbing the candidate genes 
implicated in HSC biology influences HSC characteristics or function. 
4.1.1. Aims 
The aims of this chapter were to: 
• Identify MolO and SuMO genes uniquely expressed in HSCs using the HSPC atlas 
(Chapter 3) 
• Interrogate the effect of perturbing candidate genes using CRISPR-Cas9 by analysing 
EPCR expression, apoptosis, and differentiation 
These aims were addressed by designing a study that took advantage of CRISPR-Cas9 technology 
and gene profiling previously performed by Wilson et al. (2015). Using flow cytometry and colony-
forming unit (CFU) assays, the impact of perturbing candidate genes on HSPC biology was 
interrogated. 
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4.2. Study design to investigate genes implicated in HSC biology 
To investigate genes implicated in HSC biology, a CRISPR perturbation study was designed (Fig. 
4.1A). Candidate genes were identified from the MolO and SuMO gene sets previously described 
(N. K. Wilson et al. 2015). The list of 44 genes was refined by selecting genes that were more 
highly expressed in LT-HSCs (Section 4.3). First, the expression of each gene was visualised on 
the HSPC scRNA-seq atlas to determine whether it had widespread expression or was concentrated 
in HSCs. Violin plots were drawn for each gene to quantify its expression across all the cell 
populations, only selecting the genes that were most highly expressed in LT-HSCs. Three gRNA 
constructs were designed for each candidate gene using gRNAs from the Brie library or the Broad 
Institute sgRNA designer (Doench et al. 2016). All guides were cloned into a CRISPR gRNA 
expression vector with a GFP marker (pKLV2-U6gRNA5(BbsI)-PGKpuro2AmAG-W). E-SLAM 
HSCs (Lin- CD48- CD150+ CD45+ EPCR+) were isolated from 18-20 week old Cas9 transgenic 
mice, kindly gifted to the Göttgens lab by Dr George Vassiliou (Tzelepis et al. 2016). The E-SLAM 
HSCs were isolated by FACS and aliquots of 250 cells were sorted directly into individual wells 
of a U-bottom 96-well plate containing HSC medium. Cells were transduced with the CRISPR 
gRNA viruses and kept in culture for 10 days; on day 7, approximately half of the cells of each 
well were analysed by flow cytometry for EPCR expression changes (Sections 4.5-4.7). On day 
10, the remaining cells were pooled and sorted for GFP+ Lin- cells, which were put into M3434 
methylcellulose to study colony outputs (Section 4.8). In later experiments, cells were also sorted 
to be used for genotyping analysis (Section 4.9). 
To confirm whether the CRISPR study design was valid, a trial experiment was performed in the 
same conditions as planned for the screen but looking at CD45 expression. CD45 is a 
haematopoietic cell-specific antigen and is expressed in most haematopoietic cell types (Ogata et 
al. 2005). A CRISPR gRNA expression vector with gRNA targeting the Ptprc gene (encoding the 
CD45 antigen) was provided by Iwo Kucinski. The gRNA expression vector was identical to that 
used for the remainder of the study but contained an alternative reporter gene, mCherry, instead of 
GFP. E-SLAM cells were sorted into HSC medium in a 96-well U-bottom plate and kept in culture 
for 7 days, after which they were analysed by flow cytometry (Fig. 4.1C). In the empty vector 
control, all mCherry+ cells were CD45+ (100.00±0.00% of mCherry+ cells). In contrast, cells that 
were mCherry+ after treatment with the Ptprc gRNA expression vector were predominantly CD45- 
(94.70±8.67% of mCherry+ cells). These results demonstrated that the CRISPR gRNA successfully 
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perturbed the Ptprc gene in E-SLAM cells; furthermore, it indicated that the culture conditions 
were suitable for the CRISPR screen. 
 
Figure 4.1. Study design to investigate genes implicated in HSC biology. (A) Schematic of study design. Candidate 
genes were identified from the MolO and SuMO gene sets based of their expression patterns. gRNAs for each candidate 
gene were cloned into a CRISPR gRNA expression construct and transduced into E-SLAM HSCs from Cas9 transgenic 
mice. On day 7, cells were analysed for EPCR expression by flow cytometry. On day 10, cells were placed into CFU 
assays, which were analysed on day 20. (B) CD45 expression in E-SLAM cells treated with empty vector (control) or 
a Ptprc gRNA expression vector, analysed by flow cytometry after 7 days. CD45 is plotted against mCherry to 
distinguish cells that were not successfully infected with the mCherry vectors. A representative plot is shown. Table 
below the flow cytometry plots denotes the percentage of mCherry+ cells expressing CD45 in both samples (n = 3; 
mean ± SD). 
 
4.3. Identifying candidate genes important to HSC characteristics 
To identify potential regulators of the HSC state, candidate genes were selected from the MolO 
and SuMO gene sets identified by Wilson et al., as these represented genes associated with a 
molecularly similar HSC population and repopulating HSCs (N. K. Wilson et al. 2015). Initially, 
the expression of each gene was plotted on the HSPC atlas described in Chapter 3 (Fig. 4.2-4.4). 
The HSPC atlas was structured based on the gene expression of 1,654 single cells describing HSPC 
populations. The LT-HSCs (Lin- Sca1+ c-Kit+ Flk2- CD34-) were found at the top of the branching 
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structure, and the E-SLAM HSCs (Lin- CD48- CD150+ CD45+ EPCR+) formed a more 
homogenous sub-cluster of the LT-HSC population (Fig. 4.2A). Twelve of the 44 genes were 
specifically expressed in the LT-HSCs only (Fig. 4.2B) including the recently suggested HSC 
marker Neo1 (de Haan et al. 2017; Balazs et al. 2006). Seven more genes were most highly 
expressed in LT-HSCs but also expressed in neighbouring populations (Fig. 4.2C). This group of 
genes included the HSC marker Procr, the expression of which minimally extended outside the 
LT-HSCs, and Pdzk1ip1, which was also expressed in MEPs.  
The genes which were also expressed in early progenitor cells were not outright eliminated as 
candidates; instead, their expression in the individual HSPC populations was quantified and 
assessed using violin plots (Fig. 4.3/4.4). All genes had varying expression in the HSPC 
populations; however, all the selected candidate genes had highest expression in LT-HSCs, and 
more specifically, E-SLAM cells (Fig. 4.3/4.4A). Some genes were also expressed in MPPs, 
including Pdzk1ip1 and Trim47, but as their expression was still highest in the HSC populations, 
they were not excluded from the study. Gbp6, Mapk12, and Neil2, on the other hand, appeared to 
have relatively LT-HSC specific expression, yet the violin plots revealed their expression was 
similar across all populations, most likely due to very few cells expressing these genes at high 
levels (Fig. 4.4B). These genes were excluded from the study, along with 25 genes that were 
eliminated outright based on their expression outside the LT-HSC population (Fig. 4.5). 
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Figure 4.2. Expression plots of potential candidate genes for the CRISPR study. (A) Diffusion map of the HSPC 
atlas described in Chapter 3. LT-HSCs (Lin- Sca1+ c-Kit+ Flk2- CD34-) and E-SLAM cells (Lin- CD48- CD150+ CD45+ 
EPCR+) are coloured in purple and were assigned by retrospective gating. (B-C) Diffusion map of all cells coloured 
based on the expression of selected genes from the MolO and SuMO gene sets. Genes in (B) are specifically expressed 
in LT-HSCs, whereas genes in (C) are also expressed outside of the LT-HSC population to a varying extent. The colour 
corresponds to a log2 scale of expression ranging between 0 and the maximum value for each gene. Genes are ordered 
alphabetically. DC: Diffusion Component. 
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Figure 4.3. Violin plots for selected candidate genes. Violin plots detailing the expression of selected genes in 
specific HSPC populations. The width of each bar corresponds to the number of cells expressing the gene at the 
corresponding expression level; the red dot denotes the median expression of the gene in each population. Genes are 
ordered alphabetically.  
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Figure 4.4. Violin plots for selected and discarded candidate genes (continued). Violin plots detailing the 
expression of selected genes in specific HSPC populations. The width of each bar corresponds to the number of cells 
expressing the gene at the corresponding expression level; the red dot denotes the median expression of the gene in 
each population. Genes are ordered alphabetically. (A) Continuation of candidate genes selected for the CRISPR study. 
(B) Expression of Gbp6, Mapk12 and Neil2 in HSPC populations. Although these genes appeared relatively HSC-
specific on the HSPC atlas, they were excluded from further analysis based on their relatively constant expression 
across the atlas. 
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Figure 4.5. Expression plots of MolO and SuMO genes eliminated as candidates for the CRISPR study. Diffusion 
map of all cells coloured based on the expression of selected genes from the MolO and SuMO gene sets. These genes 
had broader expression across the HSPC atlas and were therefore excluded from the study. The colour corresponds to 
a log2 scale of expression ranging between 0 and the maximum value for each gene. DC: Diffusion Component. 
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4.4. CRISPR screen candidate genes 
The gene list was narrowed down to 16 candidates based on their expression across the HSPC atlas. 
These 16 remaining candidates were more highly expressed in LT-HSCs and were therefore a good 
starting point for investigating the effect of perturbing HSC-enriched genes on HSC biology. These 
candidates are described in Table 4.2. As these genes were identified from a scRNA-seq 
experiment, rather than a curated haematopoiesis-specific list, many of the genes are poorly 
characterised and currently do not have a reported functional role in HSC biology. It may therefore 
be possible to discover novel HSC regulator candidates from this gene list. 
 
Table 4.2. Properties of candidate genes selected for the CRISPR screen. Genes are ordered alphabetically. 
Gene Summary 
Cdkn1c • Cyclin dependent kinase inhibitor (p57) 
• Implicated in HSC quiescence 
• HSCs deficient in p57 have deficits in self-renewal and maintenance (Matsumoto et al. 
2011; Zou et al. 2011) 
Fgfr3 • Fibroblast growth factor (FGF) receptor 
• Involved in the negative regulation of definitive haematopoiesis during embryonic 
development (Pouget et al. 2014) 
• FGF signalling positively regulates adult HSCs (de Haan et al. 2003; Yeoh et al. 2006) 
Gbp8 • Guanylate binding protein 
• Induced by interferon (Olszewski, Gray, and Vestal 2006) 
• Highly expressed in HSCs compared to the progenitor compartment (Ali et al. 2017) 
Gm4951 • Interferon-gamma inducible GTPase 
• Higher expression in HSCs than progenitors 
• Induced by macrophages (Gautier et al. 2012) 
Inhba • Inhibin beta A 
• Differentially expressed in megakaryopoiesis during human HSC differentiation 
(Komor et al. 2005) 
Ndnf • Neuron-derived neurotrophic factor 
• Downregulated during differentiation towards MPP1 (Cabezas-Wallscheid et al. 2014) 
Neo1 • Neogenin-1 
• Recently identified as a marker and key regulator of HSC function (de Haan et al. 
2017) 
• Regulates HSC quiescence and maintenance (Renders et al. 2017) 
Pde1b • Phosphodiesterase in the PDE1 family 
• Downregulated during differentiation towards MPP1 (Cabezas-Wallscheid et al. 2014) 
• The splice isoform PDE1B2 is upregulated after monocyte to macrophage 
differentiation (Lerner and Epstein 2006) 
Pdzk1ip1 • PDZK1-interacting protein 1/Map17 
• Expressed in HSCs but reduced in more differentiated cells (Cabezas-Wallscheid et al. 
2014) 
• Preferentially expressed in HSCs with the most undifferentiated phenotype and lowest 
proliferation rate (Sawai et al. 2016) 
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Gene Summary 
Procr • Endothelial protein C receptor (EPCR) 
• Marker of haematopoietic stem cells (Balazs et al. 2006) 
Ramp2 • Receptor activity modifying protein 
• Essential in vasculogenesis (Ichikawa-Shindo et al. 2008) 
Smtnl1 • Smoothelin-like 1 
• Modulates smooth muscle contraction and relaxation (Borman, MacDonald, and 
Haystead 2004) 
Sox18 • SRY-box 18 transcription factor 
• Upregulated in LT-HSCs compared to MPPs (Forsberg et al. 2005) 
• Implicated in vascular development (Hosking et al. 2004) 
Sult1a1 • Sulfotransferase 
• Knockout mice are viable and have normal HSC function (Gazit et al. 2014) 
Trim47 • Tripartite motif containing protein (GOA) 
• Trim47 is not functionally described in HSCs but has been identified as a candidate 
HSC gene (Gerrits et al. 2009; N. K. Wilson et al. 2015) 
Wfdc2 • WAP four-disulphide core domain protein (HE4) 
• Protease inhibitor that may function in innate immunity (Chhikara et al. 2012) 
• Increased expression in ovarian carcinomas (Drapkin et al. 2005) 
 
4.5. Isolation and analysis of E-SLAM HSCs using flow cytometry 
Flow cytometry was used throughout this investigation to both isolate and analyse HSCs before 
and after treatment with gRNA expression vectors. Cells were isolated directly into a 96-well U-
bottom plate using FACS (Fig. 4.6A). E-SLAM HSCs (Lin- CD48- CD150+ CD45+ EPCR+) were 
sorted as this isolation strategy enriches for cells that have multilineage and self-renewal potential 
at a high purity (D. G. Kent et al. 2009). Cells were isolated from both female and male Cas9 
transgenic mice between 18 and 20 weeks old; 250 cells were sorted per well directly into HSC 
medium. Three replicate wells for each construct, including empty vector and cell-only controls, 
were obtained for each experiment. Once the cells were transduced with the individual gRNA 
expression vectors, they were kept in culture for 10 days with regular medium changes. 
On day 7, approximately half of the cells in each well were stained with antibodies for flow 
cytometric analysis (Fig. 4.6B). Many surface makers change their expression in in vitro culture 
due to the culturing process as well as biological changes occurring to the cells; therefore, the full 
panel of stem cell and progenitor markers could not be used. The study focused on EPCR 
expression as it is an established marker of functional HSCs; a change in EPCR expression would 
suggest than the gene perturbations affected the proportion of cells in a primitive HSC state in 
culture. To determine whether treatment with the various gRNA expression vectors influenced 
EPCR expression, cells were first gated based on GFP expression. The percentage of EPCR+ 
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Sca1+ cells (EPCR+) in the GFP+ Lin- population was initially recorded. However, gating on the 
EPCR+ population is subjective as the investigator decides where to set the gates. Furthermore, 
there is only a small number of EPCR+ cells in culture, and integration of the different experiments 
across different days is challenging due to the differences in the intensity of fluorescent markers. 
Therefore, median EPCR expression in GFP+ Lin- cells was also recorded for a more objective 
measure of the effect of perturbing genes implicated in HSC biology. 
Later in the experiment, Annexin V BUV395 was added to the day 7 staining panel. Annexin V is 
a Ca2+-dependent phospholipid binding protein that binds membrane phosphatidylserine that has 
translocated to the cell surface, an early event occurring during cell apoptosis (Hingorani et al. 
2011). Annexin V was included to determine whether the CRISPR gRNAs caused apoptosis in the 
perturbed cells. To determine whether the cells were dying or already dead, 7-AAD was also used: 
apoptosing cells were Annexin V positive but 7-AAD negative, whereas dead cells were positive 
for both markers (Fig. 4.6C).  
The cells that were not analysed on day 7 were pooled for each replicate and kept in culture for 
three more days to be sorted for CFU assays and genotyping (Section 4.8-4.9). On day 10, cells 
were sorted based on GFP expression only. For CFU assays, 100, 200 or 400 cells were sorted into 
HSC medium, transferred into M3434 methylcellulose, and plated in 6-well SmartDishTM plates, 
to be kept in culture for an additional 10 days. Where possible, the remaining cells were sorted into 
FACS buffer (2%FBS/PBS) to be used for genotyping analysis. 
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Figure 4.6. Flow cytometry sorting and analysis strategies for E-SLAM cells. (A) Sorting strategy for isolating E-
SLAM cells (Lin- CD48- CD150+ CD45+ EPCR+) (B) Gating strategy for analysing EPCR expression on day 7 after 
treatment of E-SLAM cells with gRNA expression vectors. Cells were gated based on GFP, Lineage marker (Lin), 
EPCR and Sca1 expression. The percentage of EPCR+ Sca1+ cells in the Lin- and GFP+ gates was recorded, along with 
the median EPCR expression of Lin- cells. (C) Gating strategy for analysing apoptosis on day 7 after treatment of E-
SLAM cells with gRNA expression vectors. Cells were gated on GFP, 7-AAD and Annexin V expression. Apoptosing 
cells were negative for 7-AAD and positive for Annexin V. 
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4.6. Effect of candidate gene perturbations on EPCR expression in E-SLAM 
cells 
To investigate the effect of perturbing the candidate genes on HSC characteristics, EPCR 
expression was analysed by flow cytometry after culturing the cells for seven days. EPCR has been 
shown to be representative of HSC activity even after in vitro culture, and was therefore the focus 
of this investigation (Balazs et al. 2006).  
The investigation was performed over twelve separate screens due to the rarity of E-SLAM cells, 
as well as limitations in the numbers of mice and FACS time available. The percentage of 
EPCR+ cells in the GFP+ Lin- population was recorded for each gRNA used and normalised to the 
empty vector control (Fig. 4.7A). The percentage of EPCR+ cells does not significantly change 
compared to the empty vector for the majority of candidate genes. Two Ramp2 gRNAs, Ramp2_g1 
and Ramp2_g2, appeared to cause a significant increase in EPCR+ cells (p<0.0001). In one screen, 
there were technical issues with the empty vector, but the cell-only control, which was a sample of 
EPCR+ cells that was not treated with any gRNAs, was consistent with the cell-only controls and 
empty vector controls in the other eleven screens. The samples from this screen were therefore 
normalised against the cell-only control (denoted with a ^ in Fig. 4.6A). All Pdzk1ip1 gRNAs and 
one Wfdc2 gRNA caused a significant increase in the percentage of EPCR+ cells.  
However, it is difficult to have confidence in these percentages when gating on small numbers of 
cells. Visualising the flow cytometry results showed that large differences in percentages could 
actually be caused by very small changes in cell numbers (Fig. 4.7B). All gRNAs targeting 
Pdzk1ip1 caused a significant increase in the percentage of EPCR+ cells compared to the cell-only 
control. However, the figures clearly show that the cell-only control had more cells than any of the 
Pdzk1ip1 samples. Furthermore, the numbers of cells that contribute to the EPCR+ population 
varies greatly between replicates for each individual gRNA: for the Pdzk1ip1_g1 samples, the 
EPCR+ population includes 10, 2 and 4 cells in the individual replicates (an average of 5.33±4.16 
EPCR+ cells overall). Therefore, it is difficult to draw conclusions from these percentages and be 
confident that the statistical significance reflects biologically significant results. 
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Figure 4.7. Changes in the percentage of EPCR+ cells after candidate gene perturbation. (A) EPCR expression 
after candidate gene perturbation, represented by the normalised percentage of EPCR+ cells. All results are normalised 
to the empty vector, except for those marked with a ^, which were normalised against the cell-only control due to a 
technical issue with the empty vector. Samples are shown according to the gRNA with which they were treated. The 
dotted line marks the normalised EPCR expression of the empty vector for easy comparison. Flow analysis was 
performed seven days after E-SLAM cells were transduced with CRISPR gRNAs targeting HSC candidate genes. 
Significance was determined using a one-way ANOVA and Dunnett’s multiple comparisons test. Mean ± SD (n = 3); 
* p<0.05; ** p<0.01; *** p<0.001; ****p<0.0001 (B) Example flow cytometry plots of the percentage of EPCR+ cells 
present in culture seven days after candidate gene perturbation. The gating strategy for these cells was: GFP+ Lin- 
EPCR+ Sca1+, as described in Fig. 4.6. The numbers in each plot denote the percentage of EPCR+ Sca1+ cells in the 
GFP+ Lin- population. 
 
Compared to measuring expression changes using percentages, median fluorescence intensity 
measurement is a more objective approach to visualising changes in surface marker expression that 
is also less affected by fluctuations in cell numbers. Within a selected gate, the median fluorescence 
of any fluorophore used in the antibody-staining panel can be calculated. The results can then be 
compared to an empty vector or untreated control to determine whether there was a shift in surface 
marker expression.  
Median EPCR expression was measured for GFP+ Lin- cells in the perturbed samples. Normalising 
the median EPCR expression to the empty vector showed that the perturbations did not significantly 
affect EPCR expression for most candidates, and previous candidates, identified from the 
percentages of EPCR+ cells, are no longer valid (Fig. 4.8A). Procr encodes the EPCR protein and 
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was included as this gene is highly expressed in HSCs and serves as a control as perturbation of 
Procr should significantly reduce EPCR expression. Two Procr guides, Procr_g1(p<0.0001) and 
Procr_g2 (p<0.01) showed decreased median expression. The Ramp2 guide Ramp2_g1 caused a 
significant increase in median expression (p<0.01), as did the Wfdc2 guide, Wfdc2_g2 (p<0.0001). 
Wfdc2_g3 (p<0.01), on the other hand, significantly decreased EPCR expression in GFP+ Lin- 
cells. The significant increase in EPCR+ cells caused by perturbing Pdzk1ip1 was not reflected in 
the median EPCR expression. 
The significant results observed were caused by only one or two gRNAs for each gene. In the case 
of Wfdc2, the gRNAs caused opposing results. The median EPCR expression caused by each gRNA 
was pooled for each gene to determine whether their effects remained significant (Fig. 4.8B). Only 
Procr caused a significant perturbation and reduced the median EPCR expression by 33% 
compared to the empty vector (0.67±0.28, p<0.0001). The results obtained by pooling the 
individual gRNA results demonstrate that overall, the candidate gene perturbations did not impact 
EPCR expression and that the effect caused by one gRNA is not enough to draw a conclusion, as 
it could be caused by an off-target effect and may not accurately represent the perturbed phenotype. 
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Figure 4.8. Changes in median EPCR expression after candidate gene perturbation. (A) EPCR expression after 
candidate gene perturbation, represented by the median EPCR expression in GFP+ Lin- cells. All results are normalised 
to the empty vector, except for those marked with a ^, which were normalised against the cell-only control due to a 
technical issue with the empty vector. Samples are shown according to the gRNA with which they were treated. The 
dotted line marks the normalised EPCR expression of the empty vector for easy comparison. Flow analysis was 
performed seven days after E-SLAM cells were transduced with gRNAs targeting HSC candidate genes. Mean ± SD 
(n = 3) (B) Median EPCR expression after candidate gene perturbation, grouped by target gene. The results from 
perturbing cells using three gRNAs for each target gene were pooled. The dotted line marks the normalised EPCR 
expression of the empty vector for easy comparison. Significance was determined using a one-way ANOVA and 
Dunnett’s multiple comparisons test. Mean ± SD (n = 9); * p<0.05; ** p<0.01; *** p<0.001; ****p<0.0001 
 
4.7. Candidate gene perturbation does not influence apoptosis in E-SLAM cells 
All wells started with 250 sorted E-SLAM HSCs; however, on day 7, it was often observed that 
the cells treated with CRISPR gRNAs had variable cell counts. To determine whether the candidate 
gene perturbations were causing apoptosis, which could also contribute to the lack of significant 
change in EPCR expression, Annexin V was added to the staining panel. Annexin V staining 
detects cells in the early stages of apoptosis by binding to membrane phosphatidylserines that have 
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translocated to the cell surface (Hingorani et al. 2011). As it was added to the panel in later screens, 
not all candidate gene perturbations have recorded results for apoptosis (Fig. 4.9). 
Apoptosing cells were marked by a negative 7-AAD and positive Annexin V profile. The 
percentage of live, dead, or apoptosing cells were normalised to the empty vector control in each 
case. No significant differences were observed in all categories (Fig. 4.9A). The number of cells 
that were dead or dying in all samples was variable and contributed to by small cell numbers, 
resulting in large standard deviations for each sample.  
The cells that were perturbed with gRNAs targeting Gbp8 are shown separately due to the great 
amount of variation in the percentage of dead cells in these samples (Fig. 4.9B). Gbp8_g3 appeared 
to increase cell death 284 times more than the empty vector (283.91±491.74); however, visualising 
the data reveals that very few cells are contributing to these results (Fig. 4C). The Gbp8_g3 gRNA 
only had 0.53% efficiency, effectively transducing 77 cells, most of which were live cells. The 
dead cell counts for the Gbp8_g3 replicates show that only one repeat is contributing to the large 
number of dead cells observed (Fig. 4D).  
Overall, there is a great degree of variation in the number of dead and dying cells in the perturbed 
samples; however, this variation appears to be the result of very few cells contributing to these 
populations. Based on these observations, perturbing the candidate genes did not cause a reliably 
detectable change in apoptosis, and therefore an increase in cell death or apoptosis is not the main 
reason for a lack of significant changes in EPCR expression. 
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Figure 4.9. Candidate gene perturbation does not influence apoptosis in E-SLAM cells. (A) Normalised 
percentage of live (left), apoptosing (middle), and dead (right) cells after candidate gene perturbation in E-SLAM cells, 
recorded after seven days in culture. All results are normalised to the empty vector. The dotted line marks the 
percentage of each cell population in the empty vector sample for easy comparison. Mean ± SD (n = 3). (B) Normalised 
percentage of live (left), apoptosing (middle), and dead (right) cells after Gbp8 perturbation in E-SLAM cells, recorded 
after seven days in culture. The percentage of cells in each gate is normalised to the empty vector. These results are 
pictured separately due to the variation in dead cells after Gbp8 perturbation. Mean ± SD (n = 3). (C) Flow cytometry 
plots of the percentage of GFP+ live/apoptosing/dead cells after Gbp8 perturbation with Gbp8_g1 and Gbp8_g2. These 
results are compared to the empty vector. (D) Table showing the number of cells contributing to the dead cell gate in 
the three Gbp8_g3 replicates compared to the empty vector. 
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4.8. Changes in lineage output after candidate gene perturbation in E-SLAM 
cells 
Although significant changes in EPCR expression were not observed for most candidate genes, it 
was still possible that the perturbations may cause a change in colony output due to changes in 
transcriptional networks governing differentiation lineages.  
After E-SLAM HSCs were sorted into 96-well U-bottom plates, they were transduced with 
CRISPR gRNAs targeting the candidate genes and kept in culture for 10 days. On day 10, GFP+ 
cells were sorted from the perturbed samples and cultured in MethoCultTM GF M3434 
(StemCellTechnologies). Either 100, 200 or 400 cells were sorted, resuspended in MethoCult, and 
split between two wells for culturing. On average, these starting cell counts represented 5.5%, 11%, 
and 22% of all GFP+ cells in each sample, respectively. The methylcellulose is supplemented with 
cytokines which support the growth of primitive erythroid progenitors (BFU-E), granulocyte-
macrophage progenitor cells (CFU-G/M/GM), and multi-potential granulocyte, erythroid, 
macrophage, megakaryocyte progenitor cells (CFU-GEMM) (C. L. Miller and Lai 2005). The 
cultures were analysed after 10 days using the STEMvisionTM system, which automatically images 
and counts colonies in haematopoietic CFU assays.  
As CFU assays were added to the protocol for later screens, not all candidate gene perturbations 
have recorded results for colony output (Fig. 4.10). Low cell numbers in the GFP+ Lin- gate and 
limitations in the initial sort (i.e. number of mice available and length of sorting time) meant that 
the assays could not be repeated. The empty vector and cell-only controls were included in every 
screen (n=3). Furthermore, Procr_g1 and Gbp8_g1 were included in two screens (n=2) and give an 
indication of whether the colony output results are reliable. Due to low cell numbers, a 400 starting 
cell culture was not included for Sult1a1 and two Trim47 gRNAs. 
Although all three colony types were measured, there were very few CFU-GEMM and BFU-E 
colonies in all samples, with little variation observed between the perturbations (Fig. 4.10A). The 
predominant colony type was CFU-G/M/GM. The remaining analyses looked at the total colony 
counts only. Visualising the total number of colonies demonstrated a proportional increase in 
colonies produced from increasing numbers of starting cells in all perturbation samples (Fig 
4.10B). This was consistent among the individual gRNAs targeting each candidate gene. Therefore, 
the colony counts for the gRNAs were pooled to compare the lineage output in perturbed samples 
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versus the empty vector control (Fig. 4.10C). These results were collected in three separate 
experiments and the colony counts were normalised against the relevant empty vector for each 
individual screen. Pooling the results for each gRNA made it possible to perform statistical 
analyses, which showed that there were no statistically significant differences in colony output in 
all perturbed samples compared to the empty vector. Therefore, it appears that perturbing the 
candidate genes had no effect on lineage output. 
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Figure 4.10. Changes in lineage output after candidate gene perturbation. GFP+ cells were sorted 10 days after 
infection of E-SLAM HSCs with CRISPR gRNA expression vectors against candidate genes. The cells were sorted at 
100, 200 or 400 starting cell densities and cultured for 10 days in MethoCultTM GF M3434. Only Gbp8_g1 was repeated 
(n = 2), as well as cell-only and empty vector controls, which were included in each individual experiment (n = 3). (A) 
Colony count of BFU-E (left) and CFU-GEMM (right) for all perturbations, resulting from 100, 200 or 400 starting 
cell densities. (B) Total colony output for all perturbations from 100, 200 or 400 starting cell densities. (C) Total colony 
counts normalised to empty vector from 100, 200, and 400 starting cell densities. A dotted line shows the normalised 
colony count for the empty vector sample for easy comparison. The results from each individual gRNA perturbations 
were pooled for each candidate gene (n=3; mean ± SD). Statistical analysis was performed using a one-way ANOVA 
and Dunnett’s multiple comparison test. 
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4.9. Genotyping confirms CRISPR gRNAs are correctly targeting the candidate 
genes 
As the flow analysis and colony assays did not yield significant results, genotyping analysis was 
performed on a sample of perturbed candidate genes to confirm whether the CRISPR gRNAs are 
correctly targeting the genes of interest. 
On day 10 post-infection with CRISPR gRNA expression vectors, GFP+ cells were sorted from 
cells treated with Procr, Trim47 and Wfdc2 gRNAs, as well as an empty vector (WT) control. Procr 
was included because it was used as a control for flow analysis, and therefore it was important to 
confirm whether it was correctly perturbed, whereas Trim47 and Wfdc2 were analysed as a random 
subsample of the candidate genes. The genomic DNA (gDNA) was isolated from each sample and 
prepared for genotyping. Briefly, each target sequence was amplified with specifically designed 
primers, one of which was designed to be 60-100bp away from the 20bp cut site, and the other was 
up to 320bp away, for a total PCR product length of 300-500bp. The sequencing libraries were 
then prepared by adding a unique combination of index primers to each sample. The libraries were 
then pooled and cleaned up, after which they were sent for sequencing on the MiSeq Nano. 
The sequencing results were analysed against a reference sequence for the correct starting 
sequence, perfect matches with the reference sequence, indels and frameshift mutations (Fig. 4.11). 
All samples had at least 60% reads with the correct starting sequence. In the WT samples, at least 
47% of the reads starting with the correct sequence were a perfect match to the reference sequence, 
whereas less than 10% of reads in all CRISPR perturbations (CRISPR KO) matched the reference. 
The CRISPR KOs all had a higher fraction of indels and frameshift mutations than the WT, 
indicating that the genes were successfully targeted by the gRNAs. It was expected that roughly 
two-thirds of the indels would cause frameshift mutations, which is reflected in the results. The 
WT Wfdc2 sample had a relatively high fraction of indels and frameshift mutations, at 31% and 
21%, respectively, which may be due to PCR clean-up issues as well as a high GC content in the 
sequence that may have caused sporadic PCR amplification errors. Overall, it appears that the 
gRNAs designed to perturb the HSC candidate genes were correctly targeting the genes of interest. 
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Figure 4.11. Genotyping analysis indicates the CRISPR gRNAs are correctly targeting the candidate genes.  
Results from genotype sequencing of three candidate gene perturbations samples (CRISPR KO/grey) and a control 
sample (WT/black). (A) Percentage of indels in sequenced samples. (B) Percentage of frameshift mutations in 
sequenced samples. 10,000 reads were analysed for each sample.  
 
4.10. Conclusions 
The main aim of this chapter was to investigate the effect of perturbing genes that were implicated 
in HSC biology. This was attempted by designing a CRISPR screen for a curated gene list and 
assessing changes in HSC characteristics using flow cytometry and CFU-assay analysis.  
Chapter 3, in which the single-cell HSPC atlas was introduced, focused on using different 
dimensionality-reduction methods to best represent the data, as well as ordering cells through 
pseudotime to elucidate lineage trajectories. However, the HSPC atlas could be further used to 
guide in vitro investigations into genes of interest. Gene expression can be visualised across the 
entire HSPC trajectory to determine whether a gene is specific to an HSPC population or expressed 
throughout the entire HSPC compartment; doing so can identify genes from an existing list that 
may be interesting to investigate further. 
To study HSC-specific genes, the gene list used for this investigation was defined from the MolO 
and SuMO gene lists previously described (N. K. Wilson et al. 2015). These genes were positively 
associated with an HSC subpopulation with similar gene expression and in vivo repopulation 
activity, respectively, and were therefore an ideal dataset for investigating genes involved in HSC 
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characteristics. The 16 candidate genes were perturbed in primary E-SLAM cells from Cas9 
transgenic mice using CRISPR gRNA expression vectors with GFP markers. The treated cells were 
cultured and analysed by flow cytometry for changes in EPCR expression and induction of 
apoptosis. CFU-assays were performed to determine whether the gene perturbations influenced 
colony output. 
EPCR is a well-established marker of HSCs and its expression in HSC marks cells with long-term 
bone marrow reconstitution potential (Balazs et al. 2006; Hiroko Iwasaki et al. 2010). To determine 
whether the gene perturbations influenced HSC function, the study focused on changes in EPCR 
expression. EPCR retention in culture is indicative of a more primitive cell that should not express 
lineage markers and should be less proliferate; therefore, a decrease in EPCR positive cells could 
indicate a loss of cells that are in a primitive HSC state and a potential skewing towards more 
mature progenitor populations. Changes in EPCR expression were assessed as both a percentage 
of GFP+ Lin- cells, as well as the median EPCR expression in the same population. The number of 
EPCR+ cells after seven days in culture was variable but generally very low, and therefore 
percentages were determined by a small number of cells and difficult to compare between 
experiments. Median EPCR expression was considered a more objective measure, as it did not 
require any gate setting by the investigator and was a more accurate representation of EPCR 
expression in the perturbed cells. Interestingly, no significant decreases in EPCR expression were 
noted, except for in the Procr treated cells. Procr encodes the EPCR protein; therefore, it was 
reassuring to see that perturbing this gene significantly reduced EPCR expression in this study 
design. 
The effect of candidate gene perturbation on apoptosis was also interrogated to determine whether 
an increase in apoptosis influenced the lack of significant results observed. Apoptosing cells were 
marked by positive Annexin V and negative 7-AAD expression; however, none of the perturbations 
caused a significant change in the percentage of live, dead, or apoptosing cells. Overall, it appears 
that after 10 days in culture, the gene perturbations did not impact EPCR expression nor apoptosis.  
Although there was a lack of significant changes in surface marker expression, it was possible that 
the candidate gene perturbations do not influence EPCR expression but may impact the overall 
colony output of GFP+ cells. CFU assays cultured over 10 days were used to investigate whether 
there was a shift in differentiation potential after perturbing the genes, demonstrated by changes in 
total colony count. The CFU assays were performed using 100, 200, and 400 starting cell densities, 
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which showed a proportional increase in the number of colonies. The results from the gRNAs 
targeting each gene were pooled, allowing for statistical analysis, which showed that the gene 
perturbations did not influence lineage output.  
Due to the lack of significant results observed during flow cytometry and CFU-assay analysis, 
genotyping analysis was performed on a small sample of perturbed candidate genes and confirmed 
that the designed gRNAs were successfully causing indels and frameshift mutations in the treated 
cells.  
The results suggest that while the CRISPR gRNAs were effectively targeting the candidate genes, 
their perturbation did not significantly impact HSC biology when assayed with the in vitro tests 
used in this investigation. Loss of function of a single gene may not necessarily influence the 
overall function of a cell due to genetic compensation or gene redundancies (El-Brolosy and 
Stainier 2017; Velten et al. 2017). However, the lack of significant results also suggests that there 
are weaknesses in the study design, which are discussed below.  
4.10.1. Limitations 
Flow analysis and CFU assays were performed seven and ten days after the initial perturbation, 
respectively. Due to low cell numbers in the Sult1a1 and Trim47 samples, a 400 starting cell culture 
was not included. The reduced cell count may suggest that the gRNAs were killing the cells, which 
may have occurred during an earlier time point and therefore the cells that managed to survive to 
day 10 were less effected. Furthermore, it is possible that analysing the cells at day 7 or day 10 is 
too late and the perturbations may have exerted their effect at an earlier point in the culture. 
However, earlier time points were not measured, and therefore it is not possible to determine 
whether the analyses were performed on the optimal day.  
In analysing the data, it was determined that gating on the EPCR+ population was too subjective, 
as the investigator decided where to set the gates. A Fluorescence Minus One (FMO) control for 
EPCR should have been included to accurately determine the EPCR+ gate. This would have made 
the analysis of the gated population more reliable. 
In each well, 250 cells were transduced with the CRISPR gRNA expression vectors to analyse the 
different perturbations using flow cytometry and CFU assays. Doing bulk studies with HSCs makes 
analysis of changes in surface marker protein expression and colony outputs difficult, as it is 
unclear which HSC gives rise to which cells, and only records the effect of candidate gene 
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perturbations on the population average. Redesigning the study to instead culture single-cells and 
optimise flow cytometry protocols for low cell number analysis may reveal trends in the data that 
were indiscernible at bulk level. Smaller bulk cultures of 10-50 cells may have also helped to make 
out differences in the perturbations. However, a problem with both of these approaches is that the 
perturbation efficiencies would have been greatly reduced. An alternative approach could be to re-
sort the cells into individual wells after the infection, making it possible to efficiently perturb the 
cells and study the effect on HSC function in single cells or small bulk populations. 
The study focused on the loss of EPCR expression, a protein that is already rarely expressed. 
Investigating a negative outcome is always challenging, whereas looking for retention of EPCR 
expression or the gain of a different HSPC marker may have been easier to score. A previous study 
showed that EPCR+ cells lose their long-term repopulation potential and have significantly reduced 
Procr expression after two days in culture (Hiroko Iwasaki et al. 2010). The cells used in this study 
were cultured in different medium conditions, but still call into question whether the study needs 
to be redesigned to interrogate genes important in HSC biology differently.  
Possible suggestions for redesigning the study will be further explored in the thesis discussion 
(Chapter 7). 
4.10.2. Summary 
This chapter aimed to study genes implicated in HSC biology by perturbing them in primary E-
SLAM cells using CRISPR/Cas9 technology. Flow cytometry was used to analyse changes in 
EPCR expression and apoptosis, and CFU-assays interrogated changes in differentiation output. 
Genotyping analysis confirmed that the CRISPR gRNAs were successfully targeting the candidate 
genes and causing indels and frameshift mutations; however, EPCR expression and lineage output 
were not significantly affected by the perturbations. These results suggest that a single gene 
perturbation may not influence a cell’s phenotype due to compensatory mechanisms, or that the 
study design was flawed and requires improvement.  
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Chapter 5: Resolving heterogeneity in HSPC populations 
 
Parts of this chapter have been modified from Hamey et al. (2017). Isolation of HSPCs was 
performed by Sonia Shaw, David Kent and Nicola Wilson. Sonia Shaw and Nicola Wilson 
processed the single cells using the Fluidigm BioMarkTM platform. Sonia Shaw performed the 
quality control and normalisation of single-cell data, as well as all analyses described in this chapter 
unless otherwise stated. Fiona Hamey carried out the pseudotime ordering analysis. 
 
5.1. Background 
In the adult mammalian blood system, haematopoietic stem cells (HSCs) differentiate into all 
mature blood cell types and self-renew to maintain the HSC pool. Individual cells make fate 
choices, but the overall balance of cell types is regulated at the population level. An imbalance in 
the regulation processes can cause biased production of cell types and result in severe blood 
disorders. It is therefore important to understand cell fate decision making and its regulation during 
normal blood cell development. 
Transcriptional regulation is a key process in cell fate decision making, in which the primary 
players are transcription factors that function in complex networks of interactions to regulate gene 
expression (Gottgens 2015; Peter and Davidson 2015). Many existing studies use bulk expression 
data to study transcriptional regulation within the haematopoietic system; however, it is a highly 
heterogeneous system and the intricacies of cell fate regulation may be missed at the population 
level. Recent developments in high-throughput single-cell technologies make it possible to 
investigate how heterogeneity in haematopoietic stem and progenitor cell (HSPC) populations is 
related to fate choices (Paul et al. 2015; N. K. Wilson et al. 2015). Gene expression profiles can be 
obtained at the single-cell level using methods such as scRNA-seq and quantitative real-time PCR 
(qRT-PCR) (Hamey et al. 2016). 
This chapter investigates how HSPC fate decisions are controlled by exploring HSPC heterogeneity 
and using pseudotime ordering to order cells through differentiation (Bendall et al. 2014; Trapnell 
et al. 2014). To provide a sufficient number of cells for this investigation and to ensure that the 
haematopoietic hierarchy is represented comprehensively, a previously published dataset was 
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extended. Wilson et al. used the Fluidigm BioMarkTM platform to profile single HSPCs using qRT-
PCR (N. K. Wilson et al. 2015). They aimed to design an unbiased sorting strategy that enriched 
for functional HSCs at a higher purity, which at the time hovered around 50% for existing strategies 
(Beerman et al. 2010; Morita, Ema, and Nakauchi 2010; Dykstra et al. 2007; Goodell et al. 1996). 
They isolated long-term HSCs using four common sorting strategies, as well as a finite self-renewal 
HSC (FSR-HSC) fraction, lymphoid-primed multipotent progenitors (LMPP), common myeloid 
progenitors (CMP), megakaryocyte-erythroid progenitors (MEP), and granulocyte-monocyte 
progenitors (GMP) (Adolfsson et al. 2005, 2001; D. G. Kent et al. 2009; Kiel, Radice, and Morrison 
2007; Weksberg et al. 2008; Akashi et al. 2000). The expression of 48 genes involved in HSPC 
biology was quantified using single-cell qRT-PCR. The analysis was extended in this investigation 
to include three intermediate progenitor populations to obtain a comprehensive coverage of the 
haematopoietic hierarchy. FSR-HSCs were isolated from murine bone marrow using an alternative 
sorting strategy by fluorescence activated cell sorting (FACS), in addition to multipotent 
progenitors (MPP) and pre-megakaryocyte-erythroid progenitors (PreMegE) (Pronk et al. 2007). 
These populations were profiled using the same single-cell qRT-PCR assays and combined with 
the earlier profiles to provide extensive coverage of murine HSC populations.  
5.1.1. Aims 
The aims of this chapter were to: 
• Isolate intermediate progenitor populations at the single-cell level to compliment the qRT-
PCR data generated by Wilson et al. (2015) and extend coverage of the haematopoietic 
hierarchy 
• Interrogate the qRT-PCR data to better understand heterogeneity and regulatory 
relationships in HSPC populations  
These aims were addressed by profiling FSR-HSCs, PreMegEs, and MPPs from mouse bone 
marrow using qRT-PCR on the Fluidigm BioMarkTM platform. The gene expression profiles 
generated were analysed together with qRT-PCR HSPC data previously generated and published 
by the lab. Using various dimensionality reduction methods and computational analyses, regulatory 
relationships and heterogeneity were explored in the HSPC dataset. 
5.2. Isolation of haematopoietic stem and progenitor cell populations 
To study the transcriptional control of HSPC differentiation, a dataset previously published by the 
Göttgens lab was used as a starting point for this investigation. Wilson et al. used single-cell FACS 
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paired with index sorting to resolve heterogeneity within four LT-HSC populations (N. K. Wilson 
et al. 2015). They isolated 1,975 cells from HSC, FSR-HSC, LMPP, CMP, MEP and GMP 
populations and profiled their gene expression using the Fluidigm BioMarkTM platform (Fig. 5.1A). 
The focus of this study was to identify an enriched HSC population by pairing single-cell functional 
assays with gene expression analysis. As such, most cells collected were part of different HSC 
isolation strategies and the dataset did not provide comprehensive coverage of intermediate 
progenitor populations.  
The results of Chapter 3 demonstrated the value of including intermediate progenitor populations 
to study differentiation trajectories. Additional populations were isolated in this chapter to 
supplement the Wilson et al. dataset and to be able to explore regulatory networks within the 
haematopoietic hierarchy, specifically focused on known regulators of the stem cell compartment. 
205 cells from each of the following populations were isolated using single-cell FACS: FSR-HSC2 
(Lin- Sca1+ c-Kit+ Il7Ra- CD34+ Flk2-), MPP (Lin- Sca1+ c-Kit+ Il7Ra- CD34+ Flk2+) (Fig. 5.1B), 
PreMegE (Lin- Sca1- c-Kit+ CD41- CD150+ FcγRII/IIIlow) (Fig. 5.1C). Each population was isolated 
during separate FACS experiments due to time restrictions and complexity of the antibody panels 
(Pronk et al. 2007). Single cells were sorted directly into a 96-well PCR plate containing 10 µl of 
reaction mixture (Section 2.5) and profiled by Fluidigm BioMarkTM analysis (Moignard et al. 
2013). 
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Figure 5.1. Isolation of HSPCs for single-cell gene expression analysis. (A) Schematic of the haematopoietic 
hierarchy and the different sorting strategies used to isolate HSPCs. Nine populations were previously isolated and 
published (N. K. Wilson et al. 2015). * indicates the populations sorted specifically for this investigation: FSR-HSC2, 
MPP, and PreMegE. (B) Flow cytometry plots of the sorting strategies used to isolate MPP (Lin- Sca1+ c-Kit+ Il7Ra- 
CD34+ Flk2+) and FSR-HSC2 (Lin- Sca1+ c-Kit+ Il7Ra- CD34+ Flk2-) populations. Both pseudocolour and contour 
plots are shown for the final isolated populations; the gates are coloured according to the colour scheme in Fig. 5.1A. 
Green – FSR-HSC2; turquoise – MPP. (C) Flow cytometry plots of the sorting strategy used to isolate PreMegEs (Lin- 
Sca1- c-Kit+ CD41- CD150+ FcγRII/IIIlow). The gate is coloured according to the colour scheme in Fig. 5.1A (brown).  
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5.3. Selection of a gene set for HSPC analysis 
As Fluidigm BioMarkTM is a qRT-PCR approach for single-cell gene expression analysis, it was 
necessary to select genes to investigate. The gene-set includes 48 genes and is identical to that used 
by Wilson et al. in their published analysis, and builds upon the gene-set used by Moignard et al., 
which included 18 transcription factors (N. K. Wilson et al. 2015; Moignard et al. 2013). The 
Wilson et al. gene set was designed to investigate HSC heterogeneity and transcriptional networks. 
It included 33 transcription factors important for HSCs and haematopoiesis, 12 additional genes 
that are involved in HSC biology, and three housekeeping genes (Table 5.1). The housekeeping 
genes (Eif2b1, Polr2a and Ubc) were included for normalisation purposes and are used as a 
reference to control for differences in cell size and RNA quantities (G. Guo et al. 2010; Pina et al. 
2012). The cell surface marker c-Kit, which was used to isolate all the populations, was also 
included. 
Table 5.1. Properties of genes selected for single-cell gene expression analysis. Genes are ordered alphabetically. 
Gene Summary 
Bptf • Bromodomain PHD finger transcription factor 
• Regulates thymocyte maturation (Landry et al. 2011) 
• Involved in the maintenance and function of regulatory T-cells (B. Wu et al. 2016) 
Cbfa2t3h • Encodes the repressor ETO2 
• Functions in protein complexes to recruit histone deacetylases and repress gene 
expression 
• Regulates cell proliferation and differentiation to determine terminal erythroid 
maturation (Goardon et al. 2006) 
• Involved in repressing megakaryocyte differentiation (Hamlett et al. 2008) 
Cdkn2a • Tumour suppressor gene encoding for p16INK4a 
• Cell cycle gene 
• Inactivation of p16INK4a has been observed in various cancers (R. Zhao et al. 2016), 
including B-cell lymphomas (Jardin et al. 2010) and childhood acute lymphoblastic 
leukaemia (ALL) (Sulong et al. 2009) 
Csf1r • Receptor for colony-stimulating factor 1 
• Regulates the development of macrophages 
• Expressed at low levels in HSCs (Sarrazin et al. 2009; Mossadegh-Keller et al. 2013) 
• Expressed at higher levels in monocytes and macrophages (Guilbert and Stanley 1980; 
Byrne, Guilbert, and Stanley 1981) 
• High levels of CSF1R are associated with poor survival in acute myeloid leukaemia 
(AML) (Rashid et al. 2016) 
Dnmt3a • Encodes DNA methyltransferase 3 alpha 
• Important for HSC differentiation (Challen et al. 2011) 
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Gene Summary 
• Loss of murine Dnmt3a is associated with haematological malignancies, including 
myelodysplastic syndromes (Walter et al. 2011) and AML (Ley et al. 2010) 
Egfl7 • Epidermal growth factor-domain gene 
• Expressed in endothelial cells (Fitch et al. 2004) 
• Regulates the migration of endothelial cells and is involved in vasculogenesis (Schmidt 
et al. 2007) 
• EGFL7 protein and mRNA expression is increased in AML and is associated with worse 
outcome (Rashid et al. 2016) 
Eif2b1 • Encodes a subunit of the translation initiation factor eIF2B 
• Housekeeping gene (Pfister, Tatabiga, and Roser 2011) 
Erg • Transcription factor belonging to the ETS family 
• Potent oncogene through chromosomal translocation (Salek-Ardakani et al. 2009) 
• Required for HSC function and maintenance 
• Involved in late-stage megakaryocyte maturation (Loughran et al. 2008) 
• Causally related to Down syndrome-associated megakaryocytic leukaemia (Rainis et al. 
2005) 
• Involved in oncogenesis in AML and Ewing sarcoma (H. Ichikawa et al. 1994; Sorensen 
et al. 1994) 
Ets1 and 
Ets2 
• Transcription factors belonging to the ETS family 
• Reciprocal activity during T-cell activation (Bhat et al. 1990) 
• ETS1: maintains T-cell quiescence 
• ETS2: T-cell activation and proliferation 
• ETS1 is upregulated in chronic myeloid leukaemia (CML) (Rashid et al. 2016) 
• High ETS2 expression is associated with a worse outcome in AML (L. Fu et al. 2017) 
Etv6 • Transcription factor belonging to the ETS family (Tel) 
• Transcriptional repressor 
• Controls the survival of HSCs and is required for late-stage megakaryopoiesis (Hock, 
Meade, et al. 2004) 
• ETV6-RUNX1 fusion is common in childhood ALL and enhances the self-renewal of B-
lineage progenitor cells (Rashid et al. 2016) 
Fli1 • Transcription factor in the ETS family 
• Highly expressed in HSCs and endothelial cells (Klemszs et al. 1993; Melet et al. 1996; 
Ben-David et al. 1991) 
• Abnormal expression of FLI1 is associated with poor prognosis in AML (Kornblau et al. 
2011) 
Gata1 • Transcription factor in the GATA family 
• Essential for normal erythropoiesis 
• Expressed in erythroid cells, megakaryocytes, eosinophils, and mast cells (Leonard et al. 
1993; Martin et al. 1990; Zon et al. 1993) 
• GATA1 mutations are seen in Down’s syndrome-associated AML and transient abnormal 
myelopoiesis (Hitzler et al. 2003) 
Gata2 • Transcription factor in the GATA family 
• Required for the expansion of multipotent haematopoietic progenitors 
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Gene Summary 
• Required for the generation of mast cells (Tsai and Orkin 1997) 
• Mutated in paediatric AML and a subset of adult CML (S.-J. Zhang et al. 2008; Luesink 
et al. 2012) 
Gata3 • Transcription factor in the GATA family 
• Contributes to the development of T-lymphocytes (Pandolfi et al. 1995; Vicente et al. 
2011) 
• GATA3 polymorphisms are significantly associated with susceptibility to B-lineage 
ALL (Q. Hou et al. 2017) 
Gfi1 • Transcriptional repressor 
• Involved in the development of HSCs, B- and T-cells, dendritic cells, granulocytes, and 
macrophages (Karsunky et al. 2002; Zeng et al. 2004; Rathinam et al. 2005) 
• Preserves HSC quiescence (Zeng et al. 2004; Hock, Hamblen, et al. 2004) 
• Gfi1 is frequently mutated in T-cell lymphomas and T-cell ALL (Q. Hou et al. 2017) 
Gfi1b • Transcriptional repressor 
• Essential in megakaryocytic and erythroid development (Saleque, Cameron, and Orkin 
2002; Osawa et al. 2002; Vassen, Okayama, and Möröy 2007; Vassen et al. 2014) 
Hhex • Haematopoietically expressed homeobox 
• Expressed in B-lymphocyte and myeloid lineages and MPPs (Bedford et al. 1993) 
• Overexpressed in AML cells and essential for their propagation (Shields et al. 2016) 
Hoxa5 • Transcription factor in the HOX family 
• Preferentially expressed in expanding HSCs; key regulator of HSC cell cycle (D. Yang 
et al. 2015) 
• Constitutive expression inhibits erythropoiesis and causes a shift towards myeloid 
differentiation (Crooks et al. 1999; Fuller et al. 1999) 
• Hypermethylated in AML; associated with progression to blast crisis in CML (Kim et al. 
2010) 
Hoxa9 • Transcription factor in the HOX family 
• Preferentially expressed in early HSCs (Sauvageau et al. 1994; Pineault et al. 2002) 
• Important in differentiation of myeloid, lymphoid, and erythroid lineages (Lawrence et 
al. 1997) 
• Loss of function perturbs early T-cell development (Izon et al. 1998) 
• Overexpressed in AML; associated with poor prognosis (Collins and Hess 2016) 
Hoxb4 • Transcription factor in the HOX family 
• Predominantly expressed in HSCs 
• Essential to HSC expansion (Sauvageau et al. 1995) 
• Significantly overexpressed in bone marrow of de novo AML patients and inversely 
correlated with the expression of the multidrug-resistance gene ABCB1 (Umeda et al. 
2012) 
Ikzf1 • Transcription factor in the IKAROS family (Ikaros) 
• Regulator of lymphoid differentiation (Georgopoulos et al. 1994) 
• Frequently deleted or mutated in B-cell precursor ALL (Mullighan et al. 2009) 
Itga2b • Encodes CD41, part of the CD41/CD61 integrin complex 
• Upregulated during megakaryopoiesis 
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Gene Summary 
• Required for platelet aggregation and clotting (Ginsberg et al. 1995; Emambokus and 
Frampton 2003) 
• Its expression marks myeloid-biased HSCs (Gekas and Graf 2013) 
Kit • Encodes a receptor tyrosine kinase (Yarden et al. 1987) 
• Key in regulating HSC function 
• Critical for proliferation, survival and differentiation (Edling and Hallberg 2007) 
• Aberrant activity is associated with AML pathogenesis (Malaise, Steinbach, and 
Corbacioglu 2009) 
Ldb1 • Encodes the LIM-domain binding protein LDB1; closely related to SCL (Visvader et al. 
1997) 
• Expressed in HSCs, with lower levels in myeloid and megakaryocyte progenitor cells 
• Expressed at all stages of erythroid development (L. Li et al. 2010) 
• Interacts with LMO1 and LMO2 in human T-cell ALL (Valge-Archer, Forster, and 
Rabbitts 1998; Layer et al. 2016) 
Lmo2 • Encodes the LIM-domain protein LMO2 
• Discovered by its association with chromosomal translocations in T-cell leukaemia 
(Boehm et al. 1991). 
• Activates an erythroid-specific gene expression program  
• Lmo2 downregulation is essential for terminal erythroid differentiation (Kornblau et al. 
2011)  
Lyl1 • Basic helix-loop-helix transcription factor 
• A Lyl1-deficient mouse is viable but has impaired LT-HSC reconstitution and a reduced 
number of B-cells (Capron et al. 2006) 
• Required for HSC function and maintenance of early T-cell lineage progenitors (Zohren 
et al. 2012; Souroullas et al. 2009) 
• Involved in adult angiogenesis (Pirot et al. 2010) 
• Overexpressed in AML (Meng et al. 2005) 
Mecom • Zinc finger transcription factor (Evi1) 
• Associated with myeloid leukaemia (Russell et al. 1993; Morishita et al. 1992) 
• Predominantly expressed in HSCs and regulates HSC proliferation (Goyama et al. 2008) 
Meis1 • Encodes a homeobox protein 
• Loss of Meis1 is embryonic lethal (Azcoitia et al. 2005) 
• Required for HSC maintenance and self-renewal (Ariki et al. 2014; Kocabas et al. 2012; 
Unnisa et al. 2012; M. E. Miller et al. 2016) 
• Co-expressed with HOXA9 in human myeloid leukaemia (Lawrence et al. 1999)  
Mitf • Basic helix-loop-helix transcription factor 
• Expressed in mast cells 
• Mutations in Mitf result in phenotypic abnormalities and a decrease in mast cells 
(Kitamura et al. 2002) 
Mpl • Encodes the receptor for thrombopoietin (Kaushansky 1995) 
• Involved in regulation of HSC production and function (Kimura et al. 1998; Solar et al. 
1998)  
• Involved in maintenance of HSC quiescence (Yoshihara et al. 2007) 
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Gene Summary 
• Important in differentiation towards megakaryocytes and platelets (Plo et al. 2017) 
• Mutations occur in myeloproliferative neoplasms (MPN) (Plo et al. 2017) 
Myb • Transcription factor in the MYB family 
• Required for B-cell and T-cell development (Thomas et al. 2005; Lieu et al. 2004) 
• Regulator of HSC quiescence and self-renewal (Cooke, Sutton, and Parker 2010; Lieu 
and Reddy 2009) 
• Driver of leukemogenesis in birds and mice; expressed at high levels in AML and ALL 
(Pattabiraman and Gonda 2013)  
Nfe2 • Basic-leucine zipper transcription factor 
• Expressed in HSCs and erythroid and megakaryocytic lineages (Andrews et al. 1993) 
• Important for megakaryocyte maturation and platelet production (Shivdasani et al. 1995) 
Nkx2-3 • Transcription factor in the NKX family 
• Important in lymphoid tissue development (Pabst, Zweigerdt, and Arnold 1999; Pabst et 
al. 2000) 
Notch1 • Encodes a transmembrane receptor 
• Important in cell fate decision making in haematopoiesis (Radtke et al. 2004)  
• Influences B versus T-cell differentiation (Pui et al. 1999) 
• Mutations causing continuous activation of Notch signalling occur frequently in T-cell 
ALL (Liu, Zhang, and Ji 2013) 
Pbx1 • Transcription factor in the PBX family 
• Important in B-cell lineage commitment (Sanyal et al. 2007) 
• Discovered in pre-B cell ALL in a reciprocal translocation between chromosomes 1 
(Pbx1) and 19 (E2A); causes AML in mice (A. J. Carroll et al. 1984; Kamps and 
Baltimore 1993) 
Polr2a • Encodes a subunit of RNA polymerase II 
• Housekeeping gene (Radonić et al. 2004) 
Prdm16 • Zinc finger transcription factor 
• Involved in HSC renewal, quiescence, apoptosis, and differentiation (Aguilo et al. 2011) 
• Frequently involved in translocations in AML (Corrigan et al. 2018) 
Procr • Encodes endothelial protein C receptor (EPCR) 
• Marker of haematopoietic stem cells (Balazs et al. 2006) 
Runx1 • Transcription factor in the RUNX family 
• Expressed in HSCs, myeloid, and lymphoid cells 
• Downregulated during erythroid differentiation (North et al. 2004) 
• Involved in translocations in AML and paediatric ALL (Sood, Kamikubo, and Liu 2017) 
Spi1 • Encodes the transcription factor PU.1 (ETS family transcription factor) 
• Expressed in HSCs, CLPs and CMPs (Nutt et al. 2005) 
• Required for the generation of both myeloid and lymphoid lineages (E. W. Scott et al. 
1994; McKercher et al. 1996) 
• Decreased PU.1 expression is linked to AML in mice and humans (Verbiest et al. 2015) 
Sh2b3 • Encodes lymphocyte adaptor protein (LNK) 
• Negative regulator of normal haematopoiesis 
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Gene Summary 
• Expressed in HSCs, myeloid and lymphoid progenitors (Takaki et al. 2000; Velazquez 
et al. 2002) 
• Controls HSC quiescence and self-renewal through Mpl (Bersenev et al. 2008) 
• Recently identified as a possible genetic predisposition gene to B-precursor ALL 
• Genetic variations identified in MPN and lymphoid leukaemia (Perez-Garcia et al. 2013; 
Maslah et al. 2017) 
Smarcc1 • Encodes a subunit of the SWI/SNF remodelling complex 
• Involved in HSC activity through chromatic modification (Deneault et al. 2009) 
• Important in murine embryonic stem cell differentiation (Schaniel et al. 2009) 
Tal1 • Encodes the transcription factor stem cell leukaemia (SCL) 
• Important in HSC specification (Porcher et al. 1996; Robb et al. 1996) 
• Expressed in normal HSCs and along erythroid, mast cell and megakaryocytic lineages 
(Gottgens et al. 1997) 
• Gain of function mutation in T-cell ALL (O’Neil et al. 2004) 
Tcf7 • Essential for normal T-cell development (Weber et al. 2011) 
• Expressed in naïve T-cells and memory T-cells, but downregulated in effector T-cells 
(D. M. Zhao et al. 2010)  
• Key regulator of the switch between self-renewal and differentiation in HSCs (Choi et 
al. 2017) 
Tet2 • Enzyme in the TET family 
• Involved in DNA methylation: converts 5-methylcytosine to 5-hydroxymethylcytosine 
(Pastor, Aravind, and Rao 2013) 
• Regulator of HSC homeostasis (Nakajima and Kunimoto 2014) 
• Frequently mutated in haematopoietic malignancies; loss of TET2 leads to induction of 
leukemogenesis by DNA hypermethylation of active enhancers (Rasmussen et al. 2015)  
Ubc • Encodes polyubiquitin-C 
• Housekeeping gene (Silver et al. 2008; Chua et al. 2011) 
Vwf • Encodes Von Willebrand factor (vWF) 
• Mediates platelet adhesion and platelet aggregation (Peyvandi, Garagiola, and 
Baronciani 2011) 
• vWF expression marks HSCs with durable self-renewal capacity (D. G. Kent et al. 2009) 
• vWF expression selects for platelet-biased HSCs (Sanjuan-Pla et al. 2013) 
 
5.4. Processing single cells using the Fluidigm BioMarkTM platform 
The Fluidigm BioMarkTM platform was used to investigate gene expression in HSPC populations. 
Fluidigm BioMarkTM is a qRT-PCR approach that is sensitive at the single-cell level. In addition 
to single cells, 10-cell controls and empty well controls were collected for each experiment. Cells 
were processed as previously described and the single-cell expression data was collected using the 
Fluidigm Data Collection software. Cells were normalised against the housekeeper genes Ubc and 
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Pol2ra. The expression of all three housekeeper genes was analysed and showed that most cells 
expressed Ubc and Polr2a, whereas Eif2b1 expression was more variable and therefore excluded 
from normalisation. After filtering and normalising the data, only retaining cells that expressed at 
least 23 genes as well as both housekeeper genes, a total of 2,167 cells remained that were 
representative of the 8 cell types sorted (Table 5.2). All housekeepers (Ubc, Polr2a and Eif2b1) 
were removed from the dataset for downstream analysis. Wilson et al. also removed Cdkn2a and 
Egfl7 from their downstream analysis due to a lack of expression and technical issues, respectively 
(N. K. Wilson et al. 2015). This was carried forward in this investigation for consistency. In 
addition, Gfi1 and Spi1 were expressed in the empty well controls for the PreMegE, FSR-HSC2 
and MPP populations. As this expression was visible on all integrated fluidics circuits (IFCs) run 
through the Fluidigm BioMarkTM for this experiment, it indicated a technical issue and these genes 
were also removed from downstream analysis. After quality control, the expression of 41 genes, 
including 31 transcription factor genes, was retained. 
 
Table 5.2. Table indicating number of cells included in this study. 
Cell Type 
Cell Count 
Cells Lost % Cells Used 
Before filtering After filtering 
HSC1 210 198 12 94 
HSC2 210 166 44 79 
HSC3 210 197 13 94 
HSC4 210 198 12 94 
FSR-HSC1 294 233 61 79 
FSR-HSC2* 205 199 6 97 
MPP* 205 188 17 92 
PreMegE* 205 154 51 75 
LMPP 210 178 32 85 
CMP 210 147 63 70 
MEP 211 124 87 59 
GMP 210 185 25 88 
Total 2590 2167 423 84 
* indicates the populations sorted specifically for this investigation: FSR-HSC2, MPP, PreMegE. 
5.5. Resolving populations using multidimensionality analysis 
Dimensionality reduction was required to investigate how the cell populations related to each other 
based on their gene expression. Dimensionality reduction methods are useful for visualising large 
datasets in a lower dimensionality space. In this investigation, they were used to evaluate the 
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heterogeneity and structure of the haematopoietic bone marrow compartment in an unsupervised 
fashion. 
Principal component analysis (PCA) was used to visualise relationships between cell populations 
(Fig. 5.2). PCA is a linear dimensionality method in which principal component (PC) 1 has the 
largest variance, followed by PC2. Therefore, the data was plotted in the first two components to 
demonstrate the variance between the cell populations. The new data collected for this investigation 
was integrated into the Wilson et al. dataset and analysed together (Fig. 5.2A). PreMegEs, MPPs 
and FSR-HSC2 cells are intermediate populations in the haematopoietic hierarchy, which is 
recapitulated by their location on the PCA plot. 
The four HSC populations were clustered together at the top of the graph (Fig. 5.2B). HSC1 showed 
the most dispersed expression; however, the four strategies enriched for cells with an overall 
similar expression profile. The FSR-HSC populations were located between the HSCs, MPPs and 
LMPPs, consistent with the classical view of the haematopoietic hierarchy. For greater visual 
clarity, the four HSC populations and the two FSR-HSC populations were coloured together (Fig. 
5.2C). Although there were no clear projections in the PCA visualisation, the HSCs, MEPs and 
LMPPs were found at distinct edges of the structure, indicating these populations were the most 
different from one another. PreMegEs clustered closely to the MEPs whereas the GMPs were in 
between MEP and LMPP populations, albeit more concentrated near the LMPPs. The CMPs were 
disperse among the progenitor populations, consistent with previous observations about their 
heterogeneity (Paul et al. 2015).  
The PCA loadings show which genes contributed to the separation of the data (Fig. 5.2D). At the 
top of the PCA plot, Mpl, Mecom and Procr contributed to the variance that separated HSCs from 
the other populations, consistent with these genes being important to HSC characteristics (Table 
5.1). Gata1 and Gfi1b contributed to the separation on the left side of the PCA plot, and Notch and 
Csf1r contributed to the variance on the right, consistent with these regions of the PCA plot being 
made up of MEPs, LMPPs and GMPs, respectively. 
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Figure 5.2. Visualisation of single-cell qRT-PCR data using principal component analysis. (A) PCA plot showing 
the integration of the new data with the data from Wilson et al. (2015). New data – black; Wilson et al. data – grey. 
(B) PCA plot of all populations, calculated on the expression of 41 genes measured by qRT-PCR. The plot is coloured 
by sorting gate. HSC1 – purple, HSC2 – dark purple, HSC3 – pink, HSC4 – cyan, FSR-HSC1 – forest green, FSR-
HSC2 – olive green; MPP – yellow green; PreMegE – dark brown; LMPP – blue; CMP – orange; MEP – red; GMP – 
yellow. (C) PCA plot of all populations, coloured by cell type. The four HSC populations are grouped together (purple) 
and the two FSR-HSC populations are grouped together (olive green). MPP – light blue, PreMegE – dark brown, 
LMPP – blue, CMP – yellow green; MEP – red; GMP – orange. (D) PCA loading plots, showing genes that contribute 
to the variance in PC1 and PC2. PC: Principal Component. 
 
Although PCA is an informative dimensionality-reduction method, it can only capture linear 
structures in the data. More recently, non-linear dimensionality reduction methods such as t-
distributed stochastic neighbour embedding (t-SNE) and diffusion maps have been applied to 
single-cell data (Maaten and Hinton 2008; Haghverdi, Buettner, and Theis 2015). These methods 
are able to capture more complex structures in the data. t-SNE aims to conserve the local distances 
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of the high-dimensionality data in a low-dimensionality structure, so that cells with similar gene 
expression are nearby on the plot.  
The qRT-PCR data was visualised using t-SNE (Fig. 5.3), which recapitulated the structure seen 
using PCA. The HSCs were located at the top of the landscape. The HSC1 cells showed the most 
heterogeneity and the HSC4 population appeared more molecularly different from the other HSC 
sorting strategies than seen in the PCA plot (Fig. 5.3A). As the sorting strategies were different, it 
was assumed that the functional HSCs would be similar, and each strategy would differ in the 
phenotype of contaminating cells that it captured. The t-SNE separated the data into two distinct 
branches, separating MEPs and LMPPs, which is clearly shown when the four HSC populations 
and two FSR-HSC populations are coloured together (Fig. 5.3B). The CMPs and GMPs were both 
dispersed among the progenitor cells; on the LMPP branch, GMPs were at the tip of the branch, 
but in between MEPs and HSCs on the MEP branch.  
 
Figure 5.3. Visualisation of single-cell qRT-PCR data using t-distributed stochastic neighbour embedding. (A) 
t-SNE plot of all populations, calculated on the expression of 41 genes measured by qRT-PCR. The plot is coloured 
by sorting gate. HSC1 – purple, HSC2 – dark purple, HSC3 – pink, HSC4 – cyan, FSR-HSC1 – forest green, FSR-
HSC2 – olive green; MPP – yellow green; PreMegE – dark brown; LMPP – blue; CMP – orange; MEP – red; GMP – 
yellow. (B) t-SNE plot of all populations, coloured by cell type. The four HSC populations are grouped together 
(purple) and the two FSR-HSC populations are grouped together (olive green). MPP – light blue, PreMegE – dark 
brown, LMPP – blue, CMP – yellow green; MEP – red; GMP – orange.  
 
A disadvantage of t-SNE analysis is that it is a stochastic model, which means that while the overall 
conclusions from the analysis do not change, the t-SNE visualisation will be altered every time it 
is generated. It is therefore necessary to generate t-SNE plots multiple times to confirm that 
structure of the dataset is reproducible, and then set the seed parameter to be able to reproduce the 
same figure every time. Furthermore, both PCA and t-SNE dimensionality reduction methods are 
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designed to detect differences in the data rather than continuous relationships (Haghverdi, Buettner, 
and Theis 2015). As haematopoiesis involves the differentiation of an HSC towards a mature cell 
fate while passing through intermediate progenitor phenotypes, it would be beneficial to visualise 
the data using a dimensionality-reduction method that is better able to determine more complex 
structures in the data. Diffusion maps use the length of diffusion-like random walks through the 
data in high-dimensional space to determine a projection of the cells, and have been adapted to 
successfully display single-cell data (Coifman et al. 2005). 
The qRT-PCR data was visualised on a diffusion map (Fig. 5.4). As in the PCA and t-SNE plots, 
the HSCs sat at the top of the structure and HSC1 showed the most disperse expression pattern of 
the four HSC sorting strategies. Furthermore, the diffusion map recapitulated the pattern seen in 
the t-SNE plot, in which HSC4 was most distinct from the four HSC sorting strategies (Fig. 5.4A). 
When the HSC and FSR-HSC populations are coloured together, it is easier to visualise that the 
structure roughly segregated the cells into two projections, separating MEPs and LMPPs (Fig. 
5.4B). The LMPPs were located closer to the FSR-HSCs than the MEPs, suggesting their gene 
expression was closer to that of the early progenitors. The distinct gene expression of PreMegEs 
and MEPs was more clearly visualised in the diffusion map than using the other methods.  
 
 
Figure 5.4. Visualisation of single-cell qRT-PCR data using diffusion maps. (A) Diffusion map of all populations 
calculated on the expression of 41 genes measured by qRT-PCR. The plot is coloured by sorting gate. HSC1 – purple, 
HSC2 – dark purple, HSC3 – pink, HSC4 – cyan, FSR-HSC1 – forest green, FSR-HSC2 – olive green; MPP – yellow 
green; PreMegE – dark brown; LMPP – blue; CMP – orange; MEP – red; GMP – yellow. (B) Diffusion map of all 
populations coloured by cell type. The four HSC populations are grouped together (purple) and the two FSR-HSC 
populations are grouped together (olive green). MPP – light blue, PreMegE – dark brown, LMPP – blue, CMP – yellow 
green; MEP – red; GMP – orange. DC: Diffusion Component. 
 
128  Resolving heterogeneity in HSPC populations 
 
 
5.6. Single-cell gene expression analysis reveals cell population clusters 
Unsupervised hierarchical clustering was performed to investigate heterogeneity between cell 
populations using the expression of the 41 genes that passed quality control. Clustering analysis 
can be used to gain insights about groups of cells, which are clustered based on their gene 
expression patterns without the input of any classifications by the investigator. 
The clustering partitioned the cells into two broad clusters, both of which had multiple sub-clusters 
(Fig. 5.5). Roughly, Cluster 1 included HSCs and the earliest progenitor populations, whereas 
Cluster 2 was made up of the later progenitor populations. These clusters were differentiated by 
the expression of HSC-specific genes such as Mpl, Mecom, and Procr (Yoshihara et al. 2007; 
Goyama et al. 2008; Balazs et al. 2006). Further sub-clustering Cluster 1 divided it based on the 
four sorting strategies used to isolate HSCs. HSC4 made up the majority of Cluster 1F and was 
characterised by the expression of Gata3, indicating these cells may contribute to a lymphoid 
lineage (Pandolfi et al. 1995; Vicente et al. 2011). Cluster 1E was a mixture of cell types, but 
predominantly contained HSC2 and HSC3 cells, similar to Cluster 1C. However, Cluster 1C also 
included CMP and GMP populations, whereas Cluster 1E contained FSR-HSCs, MPPs, and 
PreMegEs. Procr was expressed in more cells of Cluster 1E, whereas Cluster 1C contained cells 
expressing Itga2b and Gata1, possibly indicating a myeloid-erythroid bias (Gekas and Graf 2013; 
Leonard et al. 1993). Cluster 1D was made up of mostly LMPPs, as well as a mixture of FSR-
HSCs, GMPs, and MPPs, whereas Clusters 1A and 1B were the most heterogeneous and included 
all cell types in varying proportions. The separations in the sub-clusters of Cluster 2 were clearer. 
Cluster 2A was made up of predominantly PreMegEs and MEPs and was characterised by the 
expression of Gata1, Gata2, Tal1 and Gf1b, which are all genes involved in myeloid and erythroid 
differentiation (Leonard et al. 1993; Tsai and Orkin 1997; Osawa et al. 2002; Gottgens et al. 1997). 
Cluster 2B predominantly contained GMPs, but also included LMPPs and FSR-HSCs. Csf1r was 
most highly expressed in this cluster, consistent with it having a major GMP component (Guilbert 
and Stanley 1980). As expected, Kit was expressed in all cells as it was used to sort all populations. 
The clustering analysis shows that the 2,167 cells can be subdivided into distinct clusters that 
correspond with their sorted identities, based solely on their gene expression. Furthermore, the four 
HSC populations generally overlap with each other, although individual patterns can be observed, 
which may indicate lineage biases and/or the presence of “contaminating” cells in the sorting 
strategy. 
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Figure 5.5. Unsupervised clustering of HSPC populations reveals clusters in single-cell gene expression data. 
Heatmap showing unsupervised clustering of 2,167 cells profiled by qRT-PCR according to the expression of 41 genes. 
The distances of the population dendrogram are not proportional to the dissimilarity. The bar above the dendrogram 
indicates the clusters to which the cells belong. Cluster 1 – green; Cluster 2 – blue. The colour bar indicates the 
population/sorting gates of origin. Sorting gate colours: HSC1 – purple; HSC2 – dark purple; HSC3 – pink; HSC4 – 
cyan; FSR-HSC1 – forest green; FSR-HSC2 – olive green; MPP – yellow green; LMPP – blue; PreMegE – dark brown; 
MEP – red; CMP – orange; GMP – yellow.  
 
5.7. Pairwise correlation analysis reveals putative relationships between genes 
The dimensionality reduction and clustering analyses indicate that the HSPC populations are 
characterised by different gene expression patterns, with some overlap between populations. Genes 
that share regulatory mechanisms may have similar expression patterns, whereas genes that have 
130  Resolving heterogeneity in HSPC populations 
 
 
very different expression profiles may have unrelated mechanisms governing their expression 
(Ståhlberg and Bengtsson 2010). Correlation analysis can be used to gain insight into these 
mechanisms, where a positive correlation suggests a factor may activate another, and negative 
correlation suggests antagonism.  
Pairwise correlation analysis was performed across all 2,167 HSPCs by hierarchical clustering of 
Spearman Rank correlations between pairs of transcription factors. The analysis revealed both 
positive and negative correlations between pairs of transcription factors (Fig. 5.6). A positive 
correlation was observed between Gata2, Gf1b, Tal1, and Gata1. This is consistent with literature 
as positive interactions have previously been described between Scl and Gata2, as well as between 
Gata2 and Gf1b (Moignard et al. 2013; J. E. Pimanda et al. 2007). A negative correlation was 
observed between Gata1, a key regulator of erythropoiesis, and Nkx2.3 and Notch, both of which 
are important in lymphoid tissue development (Pabst et al. 2000; Pabst, Zweigerdt, and Arnold 
1999; Martin et al. 1990). A strong positive correlation was observed between Myb and Runx1. A 
recent study observed that RUNX1 regulates Myb in mouse T-cell ALL, in which a RUNX1 
deficiency reduced transcription factor binding at the Myb +15kb enhancer (Choi et al. 2017). In 
normal haematopoiesis, Myb and Runx1 cooperate to induce expression of lineage-specific genes 
in HSPCs; however, a direct regulatory relationship between these two genes has not been reported, 
suggesting their interaction may be mediated by coactivating proteins (Friedman 2002).  
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Figure 5.6. Pairwise correlations reveal regulatory relationships between transcription factors. Hierarchical 
clustering of Spearman Rank correlations between pairs of transcription factors for all 2,167 HSPCs. Positive 
correlations are shown in red and negative correlations are shown in blue.  
 
To establish whether the identified regulatory relationships changed during differentiation, the 
correlation analysis was repeated for the eight cell types separately (Fig. 5.7). The HSC and FSR-
HSC cells from different sorting strategies were analysed together to see which relationships were 
strongly shared between the strategies, revealing the correlations of true HSCs or FSR-HSCs rather 
than the contaminating cells. The correlations observed in HSC and FSR-HSC populations were 
most consistent to those seen when analysing all cells together (Fig. 5.6). This reflects the greater 
number of these cells included in the dataset, as well as the bias of the gene set towards genes 
involved in HSC biology. Many of the strong positive correlations identified in the whole dataset 
remained stable; in particular, a positive correlation between Fli1, Etv6, Meis1, Erg, and Lmo2 was 
observed in all populations. More negative correlations were seen in progenitor populations 
compared to the whole dataset, suggesting that repressive relationships may be particularly 
important in more differentiated populations. 
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The HSC and FSR-HSC populations generally had similar pairwise correlation patterns. A key 
difference between the two cell types was that Tcf7 was involved in many negative relationships 
in HSCs, but mainly had a positive role, if any, in FSR-HSCs. Tcf7 has been implicated in HSC 
quiescence and self-renewal; therefore, it may attribute to the long-term self-renewal potential that 
is specific to the stem cell compartment (J. Q. Wu et al. 2012). Interestingly, Gata2 and Runx1 
were positively correlated in HSCs, but negatively correlated in FSR-HSCs. MPPs had similar 
relationships to FSR-HSCs, but had a positive correlation cluster between Hoxb4, Tcf7, Hoxa5, 
Prdm16, and Gata3. This cluster also included Nkx2.3, Hoxa9, Notch, and Ets1 in the PreMegE 
population only. Compared to the other populations, MEPs, GMPs, and CMPs displayed many 
negative correlations. Hoxa5 was generally involved in negative relationships in MEPs, and 
positive in CMPs and GMPs. Conversely, Notch was negatively correlated with erythroid genes 
such as Gata1 and Gf1b in CMPs and GMPs; Ets1 was also negatively correlated with these 
erythroid genes in CMPs, but not in GMPs. Finally, LMPPs displayed the same relationships that 
were shared among all populations, but lacked correlations with most genes, reflecting the myeloid-
erythroid bias of the gene set. While Ets1 and Notch, genes important in lymphoid lineage, were 
positively correlated with each other, they were negatively correlated with megakaryopoiesis genes 
Etv6 and Nfe2 (Andrews et al. 1993; Hock, Meade, et al. 2004). Ets1 and Ets2 were negatively 
correlated, as previously described (Bhat et al. 1990).  
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Figure 5.7. Pairwise correlations for each HSPC population. Hierarchical clustering of Spearman Rank correlations 
between pairs of transcription factors for individual HSPC populations. Cells are grouped based on cell type. Positive 
correlations are shown in red and negative correlations are shown in blue. Genes are ordered according to the clustering 
in Fig 5.6. 
 
5.8. Reconstructing differentiation trajectories from single-cell gene expression 
profiles 
The diffusion map representation described in Section 5.6. demonstrates that the HSPC dataset 
recapitulates the structure of the haematopoietic hierarchy. To confirm the apex of the hierarchy, 
molecular overlap cells (MolO cells) were projected onto the atlas (Fig. 5.8A). Wilson et al. 
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identified the MolO cells during their investigation for a sorting strategy that enriches for functional 
LT-HSCs with high purity (N. K. Wilson et al. 2015). The MolO cells are HSCs that share a 
transcriptional profile and have increased probability of long-term multilineage repopulation 
potential upon single-cell transplantation. When projected onto the landscape, MolO cells sit at the 
top of the structure with the most primitive cells, as expected. Cells belonging to MEP and LMPP 
populations are at the end of the landscape, and intermediate populations such as MPPs and 
PreMegEs were present between the highlighted cell types.  
In Chapter 3, the diffusion map was used to capture cells on differentiation trajectories towards 
mature cell types. Motivated by the structure of the hierarchy described by the qRT-PCR data, 
pseudotime analysis was performed to better understand the transcriptional changes occurring 
throughout differentiation. Pseudotime orders cells based on their gene expression profiles to infer 
their position in differentiation, which can be used to construct differentiation trajectories through 
single-cell expression data (Ocone et al. 2015). Coordinates on the diffusion map were used to 
identify cells on trajectories from HSCs to MEPs and LMPPs (Fig. 5.8B). Cells were assigned to 
two broad branches and were ordered in pseudotime using the Wanderlust algorithm (Bendall et 
al. 2014).  
The expression of transcription factors was visualised through the pseudotime progression for both 
MEP and LMPP trajectories (Fig. 5.8C). Distinct expression patterns were noted between the two 
trajectories. On the MEP trajectory, Nkx2.3, Meis1 and Pbx1 expression decreased as Gata1, Gfi1b 
and Ikzf1 expression increased, consistent with the negative correlation seen between these genes 
in Fig. 5.6. Along the LMPP trajectory, genes important in lymphoid development, such as Notch 
and Ets1, increased, whereas genes important in HSC characteristics, such as Prdm16 and Hoxb4, 
decreased early in the trajectory and the key erythroid gene Gata1 was not expressed at all. Overall, 
fewer genes showed increased expression compared to the MEP trajectory, once again reflecting 
the myeloid-erythroid bias of the gene set. Pseudotime ordering demonstrates the gene expression 
dynamics occurring in haematopoiesis and suggests that the data could be further used to 
investigate regulatory networks along the trajectories. 
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Figure 5.8. Pseudotime ordering reveals two differentiation trajectories in the single-cell HSPC data. (A) 
Projection of MolO cells onto the qRT-PCR dataset using a diffusion plot visualisation. MEPs and LMPPs are 
highlighted. MolO cells – purple; MEP – red; LMPP – blue. (B) Differentiation trajectories from stem cells to MEPs 
or LMPPs. Cells are coloured by their pseudotime value, moving from blue (early in pseudotime) to red (late in 
pseudotime). Cells not in the trajectory are grey. (C) Heatmaps showing the expression of transcription factor encoding 
genes. Cells are ordered along the pseudotime trajectories towards MEP or LMPP fates. The colour bar at the top of 
each heatmap indicated the cell types along each trajectory. HSC – purple; FSR-HSC – forest green; MPP – light blue; 
CMP – yellow green; LMPP – blue; PreMegE – brown, MEP – red, GMP – yellow. Figure was generated by Fiona 
Hamey and modified by Sonia Shaw. 
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5.9. Conclusions 
In this chapter, single cell gene expression profiles were generated using the Fluidigm BioMarkTM 
platform to explore heterogeneity and regulatory relationships within the haematopoietic hierarchy. 
A qRT-PCR dataset of 2,167 cells was generated, spanning HSCs and early progenitors. The 
dataset was then explored using dimensionality-reduction methods, correlation analysis and 
pseudotime ordering. 
This investigation built on a pre-existing dataset which included HSCs, FSR-HSCs, and four 
additional progenitor populations: CMPs, GMPs, MEPs and LMPPs (N. K. Wilson et al. 2015). 
The gene set was handpicked to include 33 transcription factor encoding genes important in HSPC 
biology, as well as 12 other genes implicated in HSC function. While this was already a large 
dataset with good coverage of early haematopoiesis, it did not include intermediate progenitor 
populations that occur during the differentiation process. Including these intermediate populations 
gave a more complete picture of early haematopoietic differentiation, which proved to be useful 
for inferring differentiation trajectories and regulatory networks. The three additional populations 
isolated were FSR-HSCs, MPPs, and PreMegEs. These populations were chosen because FSR-
HSCs and MPPs should have multi-lineage potential without the capability of reconstituting a 
mouse long-term, and PreMegEs are an early precursor of megakaryocytic, erythroid, or mixed 
colonies (Pronk et al. 2007; Cabezas-Wallscheid et al. 2014).  
The HSPCs were visualised using three dimensionality-reduction methods: PCA, t-SNE, and 
diffusion maps. All three methods recapitulated the haematopoietic hierarchy but gave varying 
levels of resolution in terms of heterogeneity and gene expression relationships. The PCA plots 
showed little separation of the four HSC isolation strategies, whereas HSC4 was more separated 
from the other strategies in both the t-SNE and diffusion map plots. As PCA only recognises linear 
relationships in the data, it will miss any non-linear relationships and therefore may not provide 
the most suitable visualisation for more complex structures, such as single-cell data. t-SNE is useful 
for visualising highly heterogeneous data and positions cells with similar expression profiles close 
together. In this HSPC dataset, the t-SNE plot positioned the MEPs and LMPPs further away from 
each other. However, while t-SNEs are often used to represent heterogeneous datasets, they are 
stochastic and may struggle to display continuous processes such as differentiation. Diffusion maps 
have been adapted to specifically deal with single-cell expression data (Coifman et al. 2005; 
Haghverdi, Buettner, and Theis 2015). When this dataset was visualised using diffusion maps, the 
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LMPPs were clearly separated from PreMegEs and MEPs. Based on the structure of the data, the 
diffusion map was the best method for recapitulating the structure of the haematopoietic hierarchy. 
Unsupervised hierarchical clustering was used to group cells based on their gene expression and 
clearly separated the more mature progenitors and HSC populations into two distinct clusters. 
However, within the HSC cluster, there was a great amount of heterogeneity and overlap with FSR-
HSC, LMPP, CMP and GMP populations. The clustering showed that the four isolation strategies 
used for HSCs do overlap but vary in their functional purity. The four strategies capture different 
“contaminating” cells, i.e. non-HSC cells, and the frequency and nature of these contaminating 
cells depends on the sorting strategy used. Correlation analysis was performed on all 2,167 cells 
together as well as the individual populations to examine regulatory relationships between the 
different populations. Previously published positive interactions were observed between Scl and 
Gata2 and between Gata2 and Gfi1b, corroborating the accuracy of this dataset (Moignard et al. 
2013; J. E. Pimanda et al. 2007). Furthermore, negative correlations were observed between genes 
involved in opposing branches of haematopoietic differentiation, such as Notch and Gata1, which 
are genes involved in the lymphoid and erythroid lineages, respectively (Pui et al. 1999; Hamlett 
et al. 2008).  
The correlation analysis for individual populations showed that many positive correlations were 
stable among the HSPC populations, but key differences were observed in their negative 
correlations. MEPs, GMPs, and CMPs in particular had the most negative correlations between 
genes. A multipotent phenotype may therefore be more associated with positive relationships, 
while repression, or lack of it, becomes more important in increasingly differentiated populations. 
CMPs and GMPs had similar regulatory relationships, in which Notch was negatively correlated 
with many erythroid genes. Current research suggests that CMPs may actually be a heterogeneous 
population primed towards erythroid and myeloid fates (Perié et al. 2015; Jaitin et al. 2014). Indeed, 
this investigation suggests that CMPs and GMPs are very similar, based on the visualisation of 
their transcriptional structures, clustering of the cells, and correlation analyses. 
The cells were ordered along differentiation using pseudotime ordering, which identified two 
trajectories in the data from HSCs towards MEPs and LMPPs. Visualising the expression of 
transcription factor encoding genes along the trajectories showed that the genes had both static and 
dynamic expression patterns. Gata1 was differentially expressed along the two trajectories and was 
associated with the MEP trajectory, while Notch and Ets1 increased along the LMPP trajectory but 
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were only expressed in the HSC component of the MEP trajectory. Conversely, Bptf, Smarcc1 and 
Myb, which were positively correlated in the analysis of all 2,167 cells, were constitutively 
expressed in both trajectories. The complexity of correlations observed, as well as the gene 
expression changes occurring along pseudotime, imply that it may be a useful dataset for inferring 
regulatory network models along the two trajectories, explored in Chapter 6. 
5.9.1. Limitations 
Although pairwise correlations were identified for all populations, fewer relationships could be 
identified for LMPPs as the gene set was biased towards myeloid-erythroid genes and focused on 
HSCs rather than the progenitor populations. A limitation of qRT-PCR is that the number of genes 
profiled is limited and chosen by the investigator, which may hinder discovery of novel regulators, 
and, in the context of this work, may miss key regulators of haematopoietic differentiation. 
Furthermore, the limited gene set fails to capture the full transcriptional heterogeneity of the 
different cell types. Visualisations of this dataset have suggested a significant overlap between 
GMP and LMPP populations; however, the work in Chapter 3 shows these populations can be 
separated based on the full transcriptome, where LMPPs and GMPs occupy separate territories on 
the transcriptional landscape. These populations could potentially be separated better if specific 
lymphoid genes were included in the gene set, such as Dntt, Il7r, or Cd19. 
Another limitation of this work arose due to technical issues in the processing of samples, which 
resulted in key regulators such as Gfi1 and Spi1 being excluded from the analysis. Spi1 would have 
been a valuable addition to the analysis due to its proposed antagonistic relationship with Gata1 in 
megakaryocytic-erythroid versus granulocytic-monocytic lineage decision making (Burda, Laslo, 
and Stopka 2010). Recent research from continuous live cell imaging and reporter mouse lines 
suggest that these two genes do not initiate the megakaryocytic-erythroid versus granulocytic-
monocytic lineage switch, but rather reinforce the lineage choices once made (Hoppe et al. 2016). 
It would have been interesting to see if these recent findings could be seen in this single cell qRT-
PCR dataset. Gfi1 was previously identified to be part of a regulatory triad with Gata2 and Gfi1b, 
and would have been a useful addition to compare the work to previous literature (Moignard et al. 
2013). Missing these key regulators renders the findings from hierarchical clustering and pairwise 
correlation analysis incomplete, although the dataset does accomplish its original goal of 
distinguishing between HSC sorting strategies. 
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5.9.2. Further work 
In this chapter, a qRT-PCR dataset of HSPC expression profiles was generated and interrogated 
for heterogeneity and regulatory relationships. The results indicate that there are complex 
relationships occurring between genes during differentiation, and that HSC regulators are not only 
involved in HSC maintenance but play a role in differentiation decisions as well. Genes that have 
similar expression profiles may also share regulatory mechanisms, whereas genes that don’t have 
similar expression profiles are likely to have unrelated regulatory mechanisms (Ståhlberg and 
Bengtsson 2010). It would be interesting to try to infer regulatory networks of transcription factors 
along the MEP and LMPP trajectories to further explore their unique regulatory mechanisms as 
well as those shared between them. Furthermore, these networks can be validated using functional 
assays. The regulatory networks and their validation will be explored in Chapter 6. 
5.9.3. Summary 
Single-cell expression profiling of HSPC populations using qRT-PCR demonstrated the 
heterogeneity present within populations of the haematopoietic hierarchy. Pairwise correlations of 
the different haematopoietic lineages identified regulatory relationships in individual populations 
and across the HSPC compartment. Pseudotime analysis ordered the cells in two trajectories from 
HSC to MEP or LMPP fates and was used to compare the dynamics of transcription factor 
expression along these trajectories. 
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Chapter 6: Validating regulatory networks models 
 
Parts of this chapter have been modified from Hamey et al. (2017). Fiona Hamey developed the 
network inference method and carried out the in-silico modelling of networks. Nicola Wilson 
profiled HoxB8-FL cells by qRT-PCR and generated the ChIP-seq data. Rebecca Hannah aligned 
the ChIP-seq data. Sonia Shaw analysed the ChIP-seq data and performed luciferase assays. 
 
6.1. Background 
The haematopoietic differentiation system consists of individual cells making cell fate decisions 
that influence the balance of mature cell type output at the population level; any dysregulation in 
fate choices can cause an imbalance that leads to serious blood disorders, such as leukaemia. 
Therefore, it is important to study the regulation of fate decisions during blood development.  
Cell fate decision making is heavily influenced by transcription factors, which work together in a 
transcriptional regulatory network (Peter and Davidson 2015). It is challenging to identify 
functional relationships between genes as experimental validation does not readily scale to a 
system-wide approach; therefore, computational network inference methods are used to predict 
these functional relationships. Attempts at modelling transcriptional regulation in blood have 
included using literature-curated regulatory relationships to construct networks, which limit 
discovery as they rely on prior knowledge of the system (Krumsiek et al. 2011; Narula et al. 2010; 
Chickarmane, Enver, and Peterson 2009; Swiers, Patient, and Loose 2006). Most network 
construction methods have been restricted to bulk expression data. Using single-cell data is 
becoming an increasingly recognised method for uncovering regulatory relationships (Pina et al. 
2015; Moignard et al. 2013).  
In Chapter 5, a single-cell HSPC dataset was established by combining quantitative real-time PCR 
(qRT-PCR) data from Wilson et al. with three intermediate progenitor populations to extend the 
coverage of the murine bone marrow HSPC compartment (N. K. Wilson et al. 2015). The chapter 
showed that haematopoietic stem and progenitor cell (HSPC) populations are highly heterogeneous 
and gene expression is dynamic across differentiation trajectories towards megakaryocytic-
erythroid progenitor (MEP) and lymphoid multipotent progenitor (LMPP) cell fates. Fiona Hamey 
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used this qRT-PCR dataset of 2,167 HSPCs to identify transcriptional regulatory networks as this 
dataset profiles a large number of cells at different stages across haematopoietic differentiation. A 
hybrid network inference method was developed based on information about continuous gene 
expression levels obtained through pseudotime ordering (Ocone et al. 2015). The hybrid method 
took advantage of Boolean abstraction, which has previously been used to model transcriptional 
regulatory networks in HSCs, embryonic stem cells, and embryonic blood development (Bonzanni 
et al. 2013; Dunn et al. 2014; Xu et al. 2014; Moignard et al. 2015). Boolean abstraction converts 
gene expression to binary functions, where gene expression is either “on” or “off”. These functions 
then form part of a Boolean network to describe gene interactions (Fig. 6.1A). The pseudotime 
trajectories were used to identify the most suitable Boolean functions. Cells were ordered based on 
continuous expression data and converted to binary expression profiles. Pairs of cells were treated 
as input-output pairs for Boolean function to identify which functions best fitted the data (Fig. 
6.1B) (Hamey et al. 2017).  
 
 
Figure 6.1. Single-cell molecular profiles allow inference of regulatory network models. (A) Boolean logic 
functions. Four different scenarios may explain a regulatory relationship where A and B activate D, but C does not. (i) 
A and B act together to activate D, described by the AND function; (ii) either A or B can activate D alone, described 
by the OR function; (iii) C does not activate D, described by the NOT function; (iv) A is required to activate D but C 
is not, but this must occur in combination. This is described by the AND NOT function (B) Schematic of the network 
inference method starting from gene expression profiling using single-cell qRT-PCR data. 
 
When this method was applied to the single-cell qRT-PCR dataset, Boolean network models were 
reconstructed to describe the HSC to MEP trajectory and HSC to LMPP trajectory. These models 
were found to have complex structures, with each gene receiving inputs from multiple regulators 
and often as a composite of the Boolean functions described in Fig. 6.1A (e.g. (Notch AND Tcf7) 
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AND NOT Etv6 activates Ets1). A simplified graphical representation of the networks illustrates 
the highly connected nature of the networks (Fig. 6.2). 
 
 
Figure 6.2. Transcriptional regulatory network models for differentiation from HSCs to MEPs or LMPPs. 
Activation is indicated by a red pointed arrow, and repression by a blue flat-headed arrow. Figure generated by Fiona 
Hamey for publication (Hamey et al. 2017). 
 
Experimental validation was required to confirm the accuracy of the hybrid network inference 
method. In this chapter, the work done to validate the regulatory networks from HSCs to MEPs 
(MEP network) and HSCs to LMPPs (LMPP network) will be presented. 
6.1.1. Aims 
The aims of this chapter were to: 
• Correlate the identified network rules to transcription factor binding patterns 
• Experimentally validate regulatory relationships identified from the proposed network 
model 
To address these aims, previously published Chromatin Immunoprecipitation Sequencing (ChIP-
seq) data was interrogated in erythroid and myeloid-lymphoid model cell lines (Schütte et al. 2016; 
Hamey et al. 2017). Comparing the ChIP-seq data with the network rules identified a regulatory 
relationship which could be validated in vitro using luciferase assays. 
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6.2. Boolean network modelling reveals regulatory relationships within MEP 
and LMPP differentiation networks 
Boolean abstraction was used to model transcriptional regulatory networks along the two 
differentiation trajectories identified in the qRT-PCR data described in Chapter 5. Modelling the 
transcriptional networks was performed to gain insight into the regulatory relationships governing 
the differentiation process. Boolean functions were abstracted for each gene based on pairwise 
correlations across the data (Hamey et al. 2017). These functions are simplified to activating or 
repressing relationships in Table 6.1 and Table 6.2, respectively. The genes had rules, or Boolean 
functions, that were specific to one or both networks, or shared between the two. A previously 
described and experimentally validated regulatory relationship was present in both regulatory 
networks, in which Gata2 activated Gfi1b (Moignard et al. 2013). In the LMPP network, several 
genes inhibited the expression of Gata1, which is important in erythroid development (Leonard et 
al. 1993; Martin et al. 1990; Zon et al. 1993). Conversely, Nkx2.3 and Notch were inhibited in the 
MEP network; both these genes are involved in the lymphoid lineage, influencing lymphoid tissue 
development and commitment towards lymphoid fates (Pabst, Zweigerdt, and Arnold 1999; Pabst 
et al. 2000; Pui et al. 1999). 
 
Table 6.1. Simplified rules: activating relationships in MEP and LMPP networks. Activation between 
transcription factors in the MEP and LMPP network models, identified through Boolean abstraction. The activation of 
genes may also be shared between networks. The activating gene is the first column, and its targets are in the MEP 
network, LMPP network, or Shared Rules columns. 
Gene MEP network LMPP network Shared Rules 
Bptf Gata2 Erg 
Smarcc1 
Nfe2 
Lmo2 
Ikzf1 
Cbfa2t3h Gata2 
Gata1 Nfe2 
Fli1 Ikzf1 
Meis1  
Erg Erg 
Lyl1 Meis1 
Fli1 Bptf 
Ets1 Notch 
Hoxa9 
Tcf7 
Ets1 
Ets2 Gfi1b Ets2 Smarcc1 
Etv6 --- 
Fli1 Smarcc1 
Meis1  
Fli1 
Mitf Etv6 Runx1 
Prdm16 Meis1 Cbfa2t3h 
Ets2 Erg Smarcc1 
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Gene MEP network LMPP network Shared Rules 
Fli1  Nfe2 
Gata1 
Myb --- Tcf7 
Tal1   
Gfi1b   
Gata2   
Gata1   
Cbfa2t3h   
Smarcc1   
Gata2 
Cbfa2t3h Pbx1 
Tal1 
Gfi1b 
Nfe2 Gata1 
Bptf Gata2 
Gata3 
  Gata3 
  Tcf7 
Gfi1b 
Tal1 Gata1 
--- Gata2 Gfi1b 
Ets2  
Hhex Nfe2 Hhex --- 
Hoxa5 --- 
Hoxa9 
Tcf7 Gata1 
Prdm16 
Hoxa9 --- 
Meis1 Lyl1 
Nkx2.3 Ikzf1 
Hoxba4 --- --- Tcf7 
Ikzf1 --- --- 
Ldb1 
Hoxa9 
Cbfa2t3h 
Smarcc1 
Bptf 
Ldb1 --- 
Myb Smarcc1 
 Lmo2 
Lmo2 Tal1 
Nkx2.3 
Meis1 
Ldb1 
Lyl1 
Notch 
Nfe2 
Bptf 
Lyl1 --- 
Hoxa9 
Nkx2.3 
Smarcc1 
Nfe2 
Lmo2 
Meis1 
Pbx1 
Gata2 
Meis1 
Nkx2.3 
Etv6 
Hoxa9 
Runx1 
Fli1 
Erg 
Cbfa2t3h 
Nfe2 
Lmo2 
Mitf --- --- Mitf 
Myb 
Runx1 
Cbfa2t3h 
Myb 
Gata1 
Ikzf1 
Ldb1 
Lyl1 
Smarcc1 
Nfe2 
Bptf 
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Gene MEP network LMPP network Shared Rules 
Nfe2 
Hhex Fli1 Lyl1 
Gata2 Meis1 Cbfa2t3h 
  Lmo2 
  Bptf 
Nkx2.3 Nkx2.3 
Hoxa9 
Tcf7 Meis1 
Lmo2 
Notch --- Lmo2 
Tcf7 
Ets1 
Pbx1 Gata2 --- --- 
Prdm16 --- Hoxa5 --- 
Runx1 Myb 
Pbx1 
--- 
Fli1 
Tcf7 
Meis1 
Smarcc1 
Etv6 
Ets2 
Gata1 
Fli1 
Ldb1 
Lyl1 
Ikzf1 
Bptf 
Tal1 Gfi1b 
Gata3 
--- 
Tal1 
Gata1 
Lmo2 
Tcf7 
Notch 
Gata1 
Hoxb4 
Ets1 Hoxa5 
 
Table 6.2. Simplified rules: repressive relationships in MEP and LMPP networks. Repression between 
transcription factors in the MEP and LMPP network models, identified through Boolean abstraction. The repression 
of genes may also be shared between networks. The repressing gene is the first column, and its targets are in the MEP 
network, LMPP network, or Shared Rules columns.  
Gene MEP only LMPP only Shared Rules 
Erg --- Gata1 --- 
Etv6 Ets1 --- --- 
Fli1 --- Gata1 --- 
Gata1 Nkx2.3 --- --- 
Gata2 --- --- Notch 
Gata3 --- --- Myb 
Gfi1b --- --- Notch 
Hoxa9 --- Gata1 --- 
Ikzf1 --- --- Tcf7 
Lyl1 --- Gata1 --- 
Myb Gata3 --- Prdm16 
Nfe2 Notch --- --- 
Nkx2.3 Myb Gata1 --- 
Notch --- Gfi1b --- 
Prdm16 --- Myb --- 
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6.3. Linking ChIP-seq data and regulatory rules to identify relationships to 
validate in vitro  
To understand which rules could be validated in vitro, ChIP-seq data for 416B and HoxB8-FL cell 
lines was analysed for binding patterns at genes of interest. ChIP-seq identifies genome-wide 
binding profiles for transcription factors and other proteins and can be visualised using the UCSC 
genome browser (W. J. Kent et al. 2002). The 416B cell line is a murine cell line with 
megakaryocytic potential, whereas the HoxB8-FL cell line was established to investigate myeloid 
and lymphoid cell differentiation (Dexter et al. 1979; Redecke et al. 2013). Validating regulatory 
relationships using primary cells would be challenging due to the very limited availability of 
material. Moreover, in vitro cell lines ensure a more homogenous cell population; therefore, these 
model cell lines were used instead. The 416B cell line is supposed to be transcriptionally similar 
to MEPs, while the HoxB8-FL cell line should resemble LMPPs and GMPs. Previously, single-
cell qRT-PCR data was collected for 416B and HoxB8-FL cells using the same gene set; the data 
was projected onto the diffusion map described in Chapter 5 (Fig. 6.3A). This confirmed that 416B 
cells occupied a territory that forms part of the MEP trajectory, and the expression state of HoxB8-
FL cells resembled that of primary bone marrow cells from the LMPP trajectory. Therefore, 416B 
could be used to represent the MEP trajectory, and that the LMPP trajectory could be represented 
by HoxB8-FL cells (Fig. 6.3B).  
 
 
 
Figure 6.3. Transcriptional profiles of model haematopoietic cell lines occupy territories on MEP and LMPP 
trajectories on the HSPC qRT-PCR dataset. (A) Diffusion map of qRT-PCR data collected for 2,167 HSPC single 
cells. The MolO cells are highlighted to represent HSCs (purple); LMPPs (blue) and MEPs (red) are highlighted and 
represent the end points for the identified differentiation trajectories. (B) Diffusion map of qRT-PCR data collected 
for 2,167 HSPC single cells with projected cell line data. 416B cells – green; HoxB8-FL cells – blue. The primary 
HSPC cells are shown in grey.  
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In addition to qRT-PCR data, ChIP-seq data was previously collected for these cell lines (Schütte 
et al. 2016; Hamey et al. 2017). However, ChIP-seq data was only available for ERG, FLI1, 
GATA2, GFI1B, LMO2, LYL1, RUNX1, and SCL. The binding patterns for each of these proteins 
were analysed for all transcription factor-encoding genes included in the gene set (an example is 
shown in Fig. 6.4). The presence of peaks indicated that the transcription factor was bound within 
a specific genomic region. The transcription factor may be differentially bound between the two 
cell lines or show similar binding patterns in both. For example, Bptf is bound by LYL1 in HoxB8-
FL cells, but not in 416B cells. Bptf is also bound by FLI1 in both cell lines but at distinct genomic 
regions and is not bound by GATA2 in either cell line. The binding profile may be influenced by 
the behaviour and expression of the transcription factor as well as the expression of the target gene 
in the cell line.  
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Figure 6.4. ChIP-seq data reveals transcription factor binding patterns in 416B and HoxB8-FL cell lines. ChIP-
seq analysis of transcription factor binding in 416B and HoxB8-FL cell lines. Bptf was chosen as an example of how 
the raw data and binding peaks are visualised in the UCSC genome browser. Bars above each track indicate a binding 
event that was called as a peak.  
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The network rules for MEP and LMPP trajectories were integrated with the ChIP-seq data for 416B 
and HoxB8-FL cells to determine which regulatory network rules could be validated in the model 
cell lines (Fig. 6.5). Transcription factor binding to each gene was recorded in a binary matter (i.e. 
“yes” or “no”) and did not take into account the expression level of the gene in the cell line, which 
would potentially impact on the binding intensity. Most genes, except for Prdm16 and Hoxa5, were 
bound by most proteins in either 416B or HoxB8-FL cells lines, or both (Fig.6.5A). However, not 
all network rules correlated with the binding peaks observed (Fig. 6.5B). By linking these analyses, 
it was possible to select potential candidates to validate in vitro. 
 
Figure 6.5. Integrating transcription factor binding with network rules to identify regulatory relationships to 
validate in vitro. (A) Figure showing where transcription factor binding (columns) was observed in transcription 
factor-encoding genes (rows) in 416B and HoxB8-FL cell lines. Squares are coloured by transcription factor binding: 
No binding – white; HoxB8 binding only – light green; 416B binding only – light blue; 416B and HoxB8 binding – 
peach. (B) Figure showing network rules observed in the MEP and LMPP trajectories, and the agreement of the binding 
patterns with network rules. Squares are coloured by the presence of network rules. No rules – white; LMPP network 
rule only (no binding in HoxB8-FL cells) – pale green; MEP network rule only (no binding in 416B cells) – pale blue; 
MEP and LMPP network rule (no binding in either cell line) – pale peach; HoxB8 binding and LMPP rule –green; 
416B binding and MEP rule – dark blue; All (shared rules; binding in both cell lines) – orange. 
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In the MEP network model, GATA2 positively regulated Cbfa2t3h and Nfe2, which was not seen 
in the LMPP network model (Fig. 6.6A). Interrogating the ChIP-Seq data for GATA2 showed that 
GATA2 bound to both Cbfa2t3h and Nfe2 loci in 416B cells. Whilst binding could be seen in the 
Hoxb8 cells, these binding events were minor compared with regions bound elsewhere in the 
genome, and therefore not recognised as peaks by the computational algorithm (Fig. 6.6B and C). 
At the Cbfa2t3h locus, two prominent binding peaks were identified at the promoter region in 416B 
cells. The two peaks represent the previously identified minimal and full promoter; the minimal 
promoter represents the most conserved region. At the Nfe2 locus, a prominent peak was identified 
at the -7kb enhancer region in 416B cells. Single-cell profiling previously performed in our lab 
showed that Gata2 is not highly expressed in HoxB8-FL cells, which is consistent with primary 
bone marrow LMPP cells (Hamey et al. 2017). The ChIP-seq data was in accordance with the 
single-cell profiling data, as GATA2 binding at both Cbfa2t3h and Nfe2 loci was limited in HoxB8-
FL cells. The ChIP-seq data therefore corroborates the Gata2-activates-Cbfa2t3h and Gata2-
activates-Nfe2 rules found only in the MEP network model. 
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Figure 6.6. Regulatory relationships unique to the MEP network model are supported by transcription factor 
binding. (A) Diagram of the MEP network model zoomed into the trio of genes with a regulatory pattern identified as 
unique to the MEP network. The diagram shows the trio within the network model and alone for clarity. (B) ChIP-seq 
analysis of GATA2 binding in 416B and HoxB8-FL cell lines at the Cbfa2t3h locus. The minimal and full promoters 
are highlighted. The bars above the tracks indicate a binding event that was called as a peak. (C) ChIP-seq analysis of 
GATA2 binding in 416B and HoxB8-FL cell lines at the Nfe2 locus. The -7kb enhancer region is highlighted. The bars 
above the tracks indicate a binding event that was called as a peak.  
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6.4. In vitro validation supports differences in network model connectivity  
To validate whether GATA2 binding contributes to the transcriptional activation of Cbfa2t3h and 
Nfe2 in 416B cells, as predicted by the network model, reporter constructs were generated for the 
Cbfa2t3h minimal and full promoter as well as the Nfe2 enhancer. The constructs were generated 
as wild-type versions (WT) or with GATA2 binding site mutations. Luciferase reporter assays were 
performed to determine the activation of Cbfa2t3h and Nfe2 constructs with and without mutated 
GATA2 binding sites (n=3 biological replicates). A construct that lacked the promoter/enhancer 
was included as an empty vector control (pGL2-Basic vector for Cbfa2t3h and pGL2-Promoter 
vector for Nfe2). The level of luciferase activity directly corresponded to the activity of the 
Cbfa2t3h promoter or Nfe2 enhancer (Fig. 6.7). Luciferase assays were performed in 416B cells 
only as the interrogated rules were specific to the MEP network model. 
Luciferase assays showed that the Cbfa2t3h promoter and Nfe2 enhancer regions are active in 416B 
cells, with the Cbfa2t3h promoter being more active than the Nfe2 enhancer (Fig. 6.7A/B). 
Mutation of the GATA2 binding sites decreases their activity, as seen by a decrease in luciferase 
activity normalised against the empty vector control. The GATA2 mutants show a significant fold 
reduction in luciferase activity compared to the WT control (Fig. 6.7C/D). Specifically, GATA2 
mutations caused a 0.48±0.05-fold change in activity at the Cbfa2t3h promoter (p<0.001), a 
0.58±0.05-fold change in activity at the Cbfa2t3h minimal promoter ( p<0.001), and a 0.46±0.03-
fold change in activity at the Nfe2 enhancer (p<0.05). These results are consistent with GATA2 
activating Cbfa2t3h and Nfe2 during MEP differentiation, as suggested by the network model. 
Therefore, the luciferase assays validated the regulatory relationships proposed in silico between 
GATA2 and Cbfa2t3h, and between GATA2 and Nfe2, which was also supported by transcription 
factor binding. 
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Figure 6.7. In vitro validation of MEP regulatory network rules. Normalised luciferase activity at the (A) Cbfa2t3h 
promoter and (B) Nfe2 enhancer, comparing the wild-type and GATA2 mutant regulatory regions. Results are 
normalised to the empty vector (A: pGL2-Basic vector; B: pGL2-Promoter vector). Fold change in luciferase activity 
at the (C) Cbfa2t3h promoter and (D) Nfe2 enhancer, comparing the wild-type and GATA2 mutant regulatory regions. 
WT: wild-type; *P <0.05, **P<0.01, ***P<0.001; two-tailed unpaired t-Test, n=3 ± SD 
 
6.5. Conclusions 
This chapter focused on validating the hybrid inference method used to identify transcriptional 
regulatory networks describing HSC differentiation to MEP and LMPP cell fates. The regulatory 
network inference methods were constructed using qRT-PCR data which profiled 2,167 single cells 
and included HSCs and early progenitors. Both ChIP-seq and luciferase assays served to validate 
regulatory relationships predicted by the network model. 
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Boolean modelling has been used to infer regulatory networks in many studies, including the stem 
cell field (Dunn et al. 2014; Moignard et al. 2015). However, these studies were either limited by 
the use of bulk expression data, which obscures heterogeneity in cell fate decisions, or only 
considered binary gene expression. In doing so, the continuous data is not considered and therefore 
the accuracy of a model describing how cells transition across differentiation may be affected. To 
overcome this problem, a hybrid Boolean network inference model, which considers pseudotime 
ordering of single cells, was developed. Although the model is restricted to binary expression 
states, it does not exclude cyclical relationships and does not computationally limit the number of 
genes in the network model, unlike other existing methods (Ocone et al. 2015; Schütte et al. 2016).  
Examining the regulatory relationships identified by the network model revealed previously 
identified relationships, such as the activation of Gfi1b by Gata2, as well as expected expression 
patterns in which erythroid genes were inhibited along the lymphoid trajectory, and vice versa 
(Moignard et al. 2013). The identified MEP network-specific relationships, in which Gata2 
positively regulates Nfe2 and Cbfa2t3h, are consistent with known biological functions of these 
genes. Gata2 is a regulator of HSPC function and involved in HSC maintenance and expansion, as 
well as early haematopoietic cell formation (Rodrigues et al. 2005; K.-C. Lim et al. 2012; Tsai and 
Orkin 1997). Gata2 mouse models demonstrate that a homozygous mutation in Gata2 is embryonic 
lethal, and knockout models show defects in primary haematopoiesis (Tsai et al. 1994). Cbfa2t3h 
is a component of a transcription factor complex that regulates erythroid and megakaryocytic 
programs (Goardon et al. 2006; Fujiwara et al. 2010; Hamlett et al. 2008). The gene encodes for 
ETO2, a corepressor in complex with SCL (encoded by Tal1) (Schuh et al. 2005). During 
differentiation, GATA2 binds and activates Cbfa2t3h, causing ETO2 to repress its own promoter, 
leading to erythroid maturation and a GATA1-driven transcriptional program (Fujiwara et al. 
2009). Nfe2 was originally discovered as an upstream regulator of globin gene expression (Ney et 
al. 1993). It is expressed in HSCs and erythroid and megakaryocytic lineages, and is required for 
megakaryocyte maturation and platelet production (Andrews et al. 1993; Shivdasani et al. 1995). 
To validate the MEP network specific rule, transcription factor binding patterns were investigated 
in 416B and HoxB8-FL cell lines, which represent erythroid and myeloid-lymphoid lineages, 
respectively (Dexter et al. 1979; Redecke et al. 2013). Gene expression profiles for these cell lines 
were previously obtained by interrogating the same gene set using qRT-PCR. ChIP-seq data 
showed prominent binding peaks at the Cbfa2t3h minimal and full promoter, and the -7kb Nfe2 
enhancer region, in 416B cells; while binding was also observed in HoxB9-FL cells, it was very 
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limited. Luciferase reporter constructs were generated to experimentally validate GATA2 
transcriptional activation and showed that the wild-type constructs had significantly higher activity 
than constructs without the promoter/enhancer region or with mutated GATA2 binding sites. 
Therefore, transcription factor binding and luciferase assays validated regulatory relationships 
proposed in silico by the inferred network model. Furthermore, linking regulatory relationships to 
the MEP regulatory network but not the LMPP network model illustrates how network topology 
guides interactions between HSPC regulators such as Gata2 and lineage-restricted genes like 
Cbfa2t3h and Nfe2. Identifying and validating simple rules in the network models demonstrates 
how in-silico investigations can drive in vitro and in vivo studies. 
6.5.1. Limitations and future work 
Single-cell qRT-PCR is a sensitive method of measuring gene expression but limits the focus of 
any study to the genes selected by the investigator. In this study, the gene set was myeloid-biased 
and focused on regulators of stem cell maintenance, limiting discovery of regulatory relationships 
along the LMPP trajectory. However, a handpicked gene set also results in incomplete network 
models, as it is not possible to discovery relationships involving novel genes. Our model suggests 
that Cbfa2t3h activates several genes in the network; however, it has been traditionally identified 
as a corepressor with SCL (Schuh et al. 2005). The described relationships could therefore be 
explained by the direct function of Cbfa2t3h or a double repressive link, but it is not possible to 
verify this activity without expanding the gene set used. It would be interesting to identify and 
validate regulatory relationships with a larger, unbiased gene set to uncover more of the complex 
interactions involved in HSPC differentiation. Furthermore, identifying mechanisms that direct 
stem cells into specific differentiation trajectories would be a valuable investigation for improving 
our understanding of the haematopoietic system, as well as our understanding of the genes involved 
in cell fate and the perturbations that occur in disease. 
6.5.2. Summary 
In summary, a computational network inference method was applied to single-cell gene expression 
profiles and identified differences in transcriptional regulatory programs between cells 
differentiating towards erythroid and lymphoid lineages. Regulatory network rules were validated 
using transcription factor binding patterns and in vitro assays, demonstrating the value of in silico 
network inference for driving further investigation into processes governing differentiation. 
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Chapter 7: Discussion 
7.1. Thesis Overview 
The purpose of this thesis was to interrogate the transcriptional landscape of haematopoietic stem 
and progenitor cell (HSPC) differentiation using single-cell techniques and genome editing 
technologies. Specifically, single-cell RNA-sequencing (scRNA-seq) and quantitative real-time 
PCR (qRT-PCR) were used to investigate the structure of the haematopoietic hierarchy. The 
scRNA-seq dataset formed the basis of an investigation into genes implicated in HSC biology using 
CRISPR genome editing. The qRT-PCR dataset was used to infer regulatory networks for cell fates 
and identify regulatory relationships that could be experimentally validated. An overview of this 
work, as well as its implications for HSPC biology, will be discussed here. 
7.1.1. Characterising the haematopoietic transcriptional landscape using single-cell 
technologies 
Two single-cell profiling techniques were used in this thesis to measure gene expression in 
individual HSPCs: scRNA-seq (Chapter 3) and qRT-PCR (Chapter 5). Interrogation of both 
datasets revealed they were able to generate structures of the transcriptional landscape that 
recapitulated known aspects the haematopoietic hierarchy. 
A previously published dataset was the basis of the qRT-PCR investigation (N. K. Wilson et al. 
2015). This dataset isolated discrete populations of LT-HSCs using four commonly used sorting 
strategies, as well as discrete progenitor populations: FSR-HSCs, LMPPs, MEPs, CMPs and 
GMPs. The focus of the study was to resolve heterogeneity within the LT-HSC compartment and 
therefore the gene set consisted of genes important in HSC biology, skewed towards the myeloid-
erythroid lineages. In the work presented in Chapter 5, this dataset was supplemented with 
intermediate progenitor populations to more comprehensively interrogate the HSPC compartment. 
The three additional populations were FSR-HSCs, MPPs, and PreMegEs, and were chosen as they 
are defined populations within the HSPC compartment that should have multi-lineage potential 
whilst lacking the long-term potential of reconstituting the haematopoietic system in an irradiated 
mouse (Pronk et al. 2007; Cabezas-Wallscheid et al. 2014). 
The four HSC sorting strategies were generally similar in their gene expression, but also 
demonstrated key differences which may reflect properties of the HSCs themselves or that of 
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‘contaminating’ cells present in the impure HSC fractions. HSC4 in particular was the most 
transcriptionally unique of the four LT-HSC populations, as seen in the dimensionality-reduction 
visualisations and clustering analysis. It was characterised by less Cbfa2t3h-expressing cells and 
higher Gata3 expression relative to the other LT-HSC populations, together suggesting that HSC4 
cells have less erythroid potential and are instead biased towards the lymphoid lineage (Pandolfi et 
al. 1995; Goardon et al. 2006). Studies show that Gata3, which is essential to T-lymphocyte 
differentiation, is present in LT-HSCs and involved in regulating their self-renewal and entry into 
the cell cycle (Ku et al. 2012; Frelin et al. 2013; D. G. Kent et al. 2009). Together with the reduced 
Cbfa2t3h expression, this suggests that the expression pattern seen in HSC4 cells can in fact be 
attributed to the functional HSCs and that this sorting strategy may enrich for lymphoid-primed 
HSCs. 
Clustering and correlation analysis demonstrated that the transcriptional profiles of these HSPC 
populations were in line with known biology. Correlation analysis measures the strength of 
relationships between sets of genes; if two genes are positively correlated, their expression 
increases simultaneously, whereas a negative correlation describes a situation where the expression 
of one gene decreases while the expression of another increases. While correlation analysis does 
not describe cause-and-effect relationships, it can give insights into functional relationships 
between genes. In the qRT-PCR data described in Chapter 5, a cluster of positive correlations was 
observed between Gata2, Gfi1b, and Tal1, which is consistent with literature that describes positive 
Gata2-Tal1 and Gata2-Gfi1b relationships (Moignard et al. 2013; Bloor et al. 2002; J. E. Pimanda 
et al. 2007). Furthermore, negative correlations were apparent between erythroid and lymphoid 
genes, such as Gata1-Nkx2.3 and Gata1-Notch (Pabst et al. 2000; Pabst, Zweigerdt, and Arnold 
1999). Overall, this demonstrates that the qRT-PCR dataset accurately depicted relationships in 
haematopoiesis and could be used to further study transcriptional regulation in these populations.  
Interestingly, the functional and fate-output properties of CMPs have been increasingly challenged, 
with studies suggesting that CMPs are not a bipotent population, but rather a heterogeneous 
population of committed myeloid or erythroid/megakaryocyte progenitors (Paul et al. 2015). The 
CMP phenotype was further challenged in this study, which showed that CMPs generally clustered 
with GMPs and had similar correlations between pairs of genes. Clustering of GMPs and CMPs 
was also described by Wilson et al. (2015). In particular, genes such as Hoxa9 and Notch were 
involved in similar, predominantly negative relationships in CMPs and GMPs, whereas these genes 
have positive correlations with other transcription factors in MEPs. This suggests that CMPs are in 
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fact already committed towards a cell fate lineage, and the sorting strategy used in this experiment 
isolated cells moving towards a myeloid fate. Importantly, bulk analysis may not have captured the 
similarities between these populations, demonstrating the value of single-cell expression analysis. 
Pseudotime analysis identified two differentiation trajectories in the dataset, which described the 
differentiation of HSCs towards MEPs and LMPPs. The high number of transcription factor genes 
measured made it possible to construct a regulatory network model for differentiation along these 
two trajectories. The regulatory rules Gata2-activates-Cbfa2t3h and Gata2-activates-Nfe2 were 
specific to the MEP trajectory and confirmed in vitro, validating the in-silico model. Interestingly, 
while the progenitor populations were associated with more negative correlations, the trajectories 
involved mainly activating relationships, and very few inhibiting relationships. A possible 
explanation is that while repression may be important in defining progenitor cell phenotypes, 
activating relationships are key in driving differentiation towards these cell fates. 
The qRT-PCR dataset was useful for identifying regulatory networks within haematopoiesis but 
was limited in its gene set and cell sampling method. In the MEP trajectory, there is a large gap 
between the HSCs and MEPs, suggesting cells that have transcriptional profiles representing an 
intermediate state between these two phenotypes are still missing, despite the additional sampling 
of MPPs, PreMegEs, and MEPs. Alternatively, the gene set used may not have been sufficient to 
differentiate these intermediate populations and order them on the pseudotime trajectory. 
Furthermore, considerable overlap was seen between GMPs and LMPPs, which separate in the 
scRNA-seq data based on their transcriptional profiles, highlighting the disadvantages of a limited 
gene set for discriminating between cell-fates. The scRNA-seq experiment in Chapter 3 describes 
a transcriptome-wide approach to gene expression profiling, and samples cells using broad, 
inclusive gates. 
Broad gates were used to capture cells outside of conventional, strict sorting gates, which are 
normally considered ‘contaminating’ cells. This approach was used to see whether the 
contaminating cells represented intermediates between cell states and could contribute towards a 
continuous picture of the haematopoietic hierarchy. Index sorting made it possible to 
retrospectively assign cells to HSPC populations. Dimensionality reduction methods confirmed 
that the scRNA-seq data recapitulated the haematopoietic hierarchy. The diffusion map method 
was particularly successful for visualising continuous data and clearly separated three trajectories: 
erythroid, myeloid, and lymphoid. This separation was also seen using STREAM analysis. 
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However, SPRING analysis revealed that the scRNA-seq atlas was capturing early differentiation 
into specific trajectories, for example towards megakaryocytes or B-cells. When the top 
differentially expressed genes for each branch were plotted on the diffusion map, it showed that 
the diffusion map method was unable to separate out these early, specific branches. This 
demonstrates that SPRING was the superior method for capturing the full scope of the 
differentiation events in the scRNA-seq dataset. Furthermore, the results highlight early lineage 
choices occurring in HSPCs that were not observed at the population level, in line with other studies 
that suggest cell-fate restricted cells arise from HSPCs without major transitions through 
intermediate stages (Laurenti and Göttgens 2018; Notta et al. 2015; Paul et al. 2015; Grün et al. 
2016; Velten et al. 2017). 
Gene expression analysis using scRNA-seq has more scope for discovering novel population 
markers and gene regulation trends; however, it is limited by a high dropout rate. Dropout events 
occur when the expression of a gene is moderate in one cell and undetected in another, usually due 
to low mRNA in individual cells. The low starting amounts of mRNA in single-cells compared to 
bulk populations make it more likely that a transcript may not be transcribed and/or amplified 
during cell processing and therefore goes undetected during sequencing, resulting in a dropout 
event (Kharchenko, Silberstein, and Scadden 2014; W. V. Li and Li 2018). Furthermore, scRNA-
seq analysis only considers highly variable genes, meaning that genes that did not demonstrate 
changes in expression between different samples or conditions were excluded from further 
analysis. Overall, scRNA-seq suffers from high technical and biological noise, which make it 
difficult to accurately infer transcriptional regulatory networks using these gene measurements.  
Ultimately, the method of choice for gene expression analysis depends on the question being 
asked—while scRNA-seq gives a transcriptome-wide overview of the transcriptional landscape, is 
beneficial for novel marker discovery and offers better discrimination between cell-fates and their 
differentiation trajectories, it is costly and suffers from dropouts. On the other hand, qRT-PCR is 
limited to a curated gene set but allows for a deeper analysis of specific sets of genes and confers 
fewer challenges for studying regulatory networks with currently available computational methods.  
7.1.2. Genome editing to interrogate HSC biology 
Genome editing using the CRISPR/Cas9 system was used in Chapter 4 to investigate genes 
implicated in HSC biology. This technology has been applied to investigations of the 
haematopoietic system to create leukaemic mouse models and CRISPR screening platforms to 
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identify potential therapeutic targets (overview in Section 1.4.1.1) (Heckl et al. 2014; Tzelepis et 
al. 2016). In this thesis, a CRISPR screen was designed to determine the effect of perturbing the 
previously identified MolO (molecularly overlapping) and SuMO (surface marker overlap) genes, 
using changes in EPCR expression as the primary outcome, and changes in apoptosis and colony 
output as secondary experiments (N. K. Wilson et al. 2015). The MolO and SuMO genes are 
associated with a molecularly similar subpopulation of HSCs and repopulating HSCs, respectively; 
the curated candidate gene list included 16 genes that were most highly expressed in LT-HSCs. 
Genotyping analysis performed in this investigation suggests that CRISPR gRNAs were 
successfully targeting the candidate genes, but the results indicate that the gene perturbations had 
no significant effect on EPCR expression, apoptosis, nor lineage output. Significant changes in 
EPCR expression based on the percentage of EPCR+ cells or median EPCR expression after seven 
days in culture were generally caused by one gRNA out of three for the candidate gene. 
CRISPR/Cas9 technology has been associated with off-target mutations that may cause genomic 
instability and disrupt the normal function of genes other than the intended target; therefore, 
drawing conclusions about the effect of perturbing candidate genes based on one gRNA may 
incorrectly represent their function (Pattanayak et al. 2013; Cho et al. 2014; Y. Fu et al. 2013; X.-
H. Zhang et al. 2015). Pooling the results from individual gRNAs for each perturbation together 
showed that only Procr significantly decreased median EPCR expression in cultured E-SLAM 
cells. 
The loss of function of a single gene may not influence the overall function of cells due to genetic 
compensation, where related genes are upregulated as a consequence of gene knockout in order to 
maintain normal function (El-Brolosy and Stainier 2017). Furthermore, possible gene redundancies 
may mean that perturbing a single gene would have no effect on the biological phenotype as another 
gene would perform the same function (Nowak et al. 1997). Another possible approach for this 
CRISPR screen would be to transduce cells with CRISPR gRNAs for multiple genes and include 
a unique barcode for each gRNA. The transduced cells could then be sequenced to reveal which 
gRNAs contributed to the phenotype (Dixit et al. 2016). This type of analysis may produce more 
significant results, as multiple genes would be simultaneously perturbed. 
However, the overall lack of significant results in this investigation suggest that there are several 
weaknesses in the study design. These weaknesses concern the medium conditions used and the 
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parameters investigated. A further explanation and possible solution for each is offered in the list 
below: 
• Medium conditions. The conditions in which the HSCs are cultured are optimal for their 
expansion. It was hypothesized that the gene perturbations would decrease properties such 
as HSC maintenance and may therefore increase differentiation and mature cell output. 
However, any effects of the candidate gene perturbations could be masked by the culture 
conditions used, because factors such as cell proliferation and differentiation are already 
being encouraged. It would be interesting to see how the results would be affected if the 
HSCs were cultured in medium that instead discouraged cell expansion, and whether the 
gene perturbations could result in increased differentiation in HSC maintenance conditions. 
• Investigating changes in EPCR expression. EPCR is a well-established marker of HSCs but 
is also a rarely expressed protein. The hypothesis in this investigation was that perturbing 
the candidate genes would decrease cells that remain in the primitive HSC state, and would 
therefore decrease EPCR expression. However, assaying the loss of an already lowly 
expressed protein is difficult and unreliable to quantify. The study could be strengthened 
by focusing on surface marker expression that is gained after treatment with the various 
CRISPR gRNAs. As cells are dividing and differentiating, the more mature cells will 
express different lineage markers. A lineage cocktail was used in this investigation and 
therefore obscured any interpretation of the more mature cells. Analysing the individual 
mature lineages separately may reveal more apparent changes in differentiation towards the 
diverse lineages. Mature cells will also occur more frequently in culture as they have a 
higher proliferation rate than HSCs, and therefore could be assayed more reliably. 
• Repopulation potential. The SuMO genes defined in the Wilson et al. study were associated 
with functional HSCs and it was predicted that their perturbation may cause a change in 
HSC characteristics (N. K. Wilson et al. 2015). The true measure of a real stem cell is to 
test its ability to repopulate a mouse. Therefore, transplanting the treated cells into 
irradiated mice could show whether the gene perturbations prevent reconstitution of the 
haematopoietic system, as well as their impact on lineage output. 
A couple other issues, however, call into question whether the study should be improved, or 
completely redesigned. HSCs are a rare population in the adult bone marrow, estimated at 1 in 
10,000 cells (Szilvassy et al. 1990). As 250 E-SLAM cells were sorted into each well in triplicate 
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for each gene, the number of genes that could be assayed in each individual screen was severely 
restricted. Furthermore, the Cas9-transgenic mice also had to be specifically bred for this study, 
limiting the number of individual screens and repetitions possible based on age and litter size. 
Instead of using Cas9-transgenic mice, more readily available mice could be used, such as 
C57BL/6, and transduced with Cas9 vector together with the CRISPR gRNA vector. This would 
make it much more feasible to obtain repeats for all experiments.  
A possible redesign for this study would also assay a more abundant cell type. As the MolO and 
SuMO genes are associated with HSC maintenance and repopulation capacity, it would be 
interesting to see whether overexpressing these genes in other populations would restore self-
renewal and an HSC state. Specifically, the candidate genes could be overexpressed in multipotent 
populations with finite or no self-renewal, such as MPPs and FSR-HSCs. These cell types are more 
abundant in the bone marrow and therefore individual screens could include more candidate genes 
and could be done more frequently. As this experiment design would be investigating a gain of 
HSC characteristics, assaying HSC markers such as SLAM (CD48- CD150+) and EPCR would be 
appropriate, as their expression should increase and therefore any changes would be easier to 
detect. This proposed design could address the original aim of the CRISPR screen, which was to 
identify genes important in HSC biology; furthermore, identifying genes that are able to restore 
self-renewal and an HSC state could have major implications for stem cell therapies. 
7.1.3. Implications of this thesis for HSPC biology 
The single-cell gene expression analyses performed in this thesis confirm the known structure of 
the haematopoietic hierarchy, in which HSCs differentiate into mature cell-fates, a process which 
is regulated by diverse interactions in complex transcriptional networks. The use of single-cell 
technologies made several observations possible: 
• SPRING analysis of the scRNA-seq dataset revealed early lineage branching that was 
previously undetected in smaller datasets and bulk expression experiments 
• Heterogeneity in HSC populations was demonstrated in the qRT-PCR dataset, revealing 
possible lymphoid-priming in the HSC4 population 
• Clustering and correlation analysis showed that the isolated CMP population was most 
similar to GMPs and most likely represents cells primed towards a myeloid lineage, rather 
than a bipotent population 
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• Single-cell analysis can be used to construct transcriptional networks of differentiation 
processes based on pseudotime ordering, which were validated in vivo. 
The scRNA-seq dataset is the first of its kind to describe the whole haematopoietic hierarchy and 
provides a powerful reference dataset for biologists. The interactive website allows researchers to 
interrogate gene expression on the HSPC landscape. Several groups have used the dataset to 
demonstrate the computational algorithms they developed to analyse single-cell gene expression 
data (Griffiths et al. 2018; H. Chen et al. 2018). Furthermore, researchers can project their single-
cell datasets onto our dataset to interrogate changes in gene expression caused by their particular 
phenotype of interest. In our paper describing the scRNA-seq dataset, we projected young and old 
HSCs from C57BL/6, DBA/2, and Vwf-EGFP mice to show both types of HSCs cluster with the 
LT-HSCs from our dataset, but old HSCs form a tighter, more molecularly homogenous population 
(Kowalczyk et al. 2015; Grover et al. 2016; Nestorowa et al. 2016). This type of analysis could 
also be performed with disease models, leading to potential discoveries about differences in gene 
regulation in normal versus leukaemic cells that could inform future therapies. 
 
7.2. Future directions for single-cell biology 
This thesis described the use of single cell RNA-sequencing and qRT-PCR to further our 
knowledge of the transcriptional landscape of HSPC differentiation. Numerous techniques have 
since been developed that offer a different approach to gene expression analysis or enable it to be 
paired with perturbation or epigenetic research. This section describes these technologies and their 
implications for cell-fate research. 
7.2.1. Advances in single cell gene expression analysis 
Single-cell RNA-sequencing is a powerful approach to collect gene expression measurements for 
the whole transcriptome of individual cells. However, it is associated with a high cost per cell, 
especially in plate-based methods that require high volumes of reagents (Picelli et al. 2014).  
Microwell technologies such as CytoSeq and Microwell-Seq are plate-based methods designed to 
decrease costs by reducing the reagents required (Fan, Fu, and Fodor 2015; Han et al. 2018). Single 
cells are deposited into individual wells together with a library of barcoded beads; after cell lysis, 
the mRNA is able to hybridize to the beads, making it possible to pool the cells before reverse 
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transcription, amplification and sequencing (Fan, Fu, and Fodor 2015). Microwell-Seq has recently 
been used to analyse more than 400,000 single cells from major mouse tissues to construct a mouse 
cell atlas (Han et al. 2018). The Genesis system (Celsee) and SMARTer ICELL8 Single-Cell 
System (Takara) are commercially available platforms that use microwell technology for single-
cell analysis. 
Another recent high-throughput scRNA-seq method is SPLiT-seq (Split Pool Ligation-based 
Transcriptome sequencing), which can be used to transcriptionally profile thousands of 
formaldehyde fixed cells (Rosenberg et al. 2018). Individual transcriptomes go through multiple 
rounds of combinatorial barcoding, which append well-specific barcodes, unique molecular 
identifiers, and sequencing barcodes. Prior to sequencing, this method does not require any 
complex instruments or expensive reagents. SPLiT-seq was used to analyse more than 150,000 
transcriptomes from mouse brains and spinal cords, identifying over 100 different cell types 
(Rosenberg et al. 2018). 
Droplet-based microfluidic methods have been used widely as they successfully reduce the cost 
per cell while also increasing throughput (Hamey et al. 2016). These technologies encapsulate 
single cells in nanolitre droplets with barcoded beads. Within each droplet, the single cell is lysed 
and the bead dissolves to release barcoded reverse transcription oligonucleotides into solution. 
Reverse transcription of the polyadenylated mRNA can then occur, barcoding all the cDNA from 
a single cell with the same barcode. The cells are then pooled and sequenced together. Gene 
expression profiles can be simultaneously generated for thousands of cells, drastically reducing the 
cost per cell. The first high-throughput droplet-based methods to be published were Drop-Seq and 
InDrop (Macosko et al. 2015; Allon M. Klein et al. 2015). The 10x Chromium™ system is a 
commercially available platform from 10x Genomics that allows researchers to perform droplet-
based scRNA-seq without having to generate their own microfluidic devices and reagents (Zheng 
et al. 2017).  
Dahlin et al. recently used the 10x Chromium™ system to resolve eight lineage trajectories in 
mouse bone marrow HSPCs: lymphoid, megakaryocyte, erythroid, neutrophil, monocyte, 
eosinophil, mast cell, and basophil lineages (Dahlin et al. 2018). Furthermore, they observed 
reduced Myc expression and proliferative defects in a c-Kit mutant mouse model (W41/W41), in 
which transcriptional profiling revealed the lack of a mast cell lineage entry point. This study 
profiled 44,802 wild-type HSPCs and 13,815 W41/W41 HSPCs, demonstrating how droplet-based 
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methods can be used to perform informative, large-scale transcriptomic studies at a fraction of the 
cost of plate-based scRNA-seq (Dahlin et al. 2018). 
7.2.2. Combining single-cell gene and protein expression measurements 
In this thesis, scRNA-seq was combined with index sorting to record surface marker expression 
data for all the individual cells sorted. This made it possible to use surface marker protein 
expression to differentiate between cells and retrospectively assign them to HSPC cell types. 
Wilson et al. also used index sorting to link molecular characterisation of single cells by qRT-PCR 
with functional studies (N. K. Wilson et al. 2015).  
Analysing the proteome can elucidate which proteins are involved in defining cell phenotype and 
function. However, it is not possible to collect index sorting data using droplet-based approaches 
as they are incompatible with cytometry. Researchers have therefore developed methods to 
combine transcriptome profiling with protein expression measurements. CITE-seq (Cellular 
Indexing of Transcriptomes and Epitopes by Sequencing) and REAP-seq (RNA expression and 
protein sequencing) use antibodies conjugated to DNA barcodes instead of fluorophores to label 
cells (Peterson et al. 2017; Stoeckius et al. 2017). In CITE-seq, the antibodies are conjugated to 
streptavidin, which is bound to the biotinylated DNA barcodes, whereas in REAP-seq, the antibody 
and DNA barcode are covalently bound (Todorovic 2017). Droplet-based scRNA-seq approaches 
can then be applied to these DNA-barcode labelled cells to generate both mRNA and protein 
expression data.  
The application of CITE-seq was demonstrated on 8,000 individual cord blood cells, which 
produced cell profiles consistent with established flow cytometry profiles and improved 
characterisation of natural killer cells based on protein expression (Stoeckius et al. 2017). REAP-
seq was first used to study human naïve CD8+ T-cells using a panel of 80 barcoded antibodies. 
Peterson et al. investigated the activation of these T-cells after treatment with a CD27 agonist and 
characterised differentially expressed genes and proteins in untreated versus treated cells, 
demonstrating how this technology can be used to enhance preclinical studies (Peterson et al. 
2017). Both these methods are compatible with the 10x Chromium™ platform and therefore can 
be widely used to simultaneously study gene and protein expression in a high-throughput manner. 
Both methods are currently limited to measuring surface marker protein expression, but may be 
extended in the future to measure intracellular proteins as well (Todorovic 2017). 
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7.2.3. Genome and transcriptome sequencing 
New single-cell technologies have been developed to sequence the genomic DNA and mRNA from 
the same cell. These methods pair established scRNA-seq technologies with whole genome 
amplification methods. DR-seq (gDNA-mRNA sequencing) first amplifies the nucleic acids prior 
to physical separation to minimise sample loss (Dey et al. 2015). However, it uses CEL-seq to 
sequence the transcriptome, which only targets the 3’ end of mRNAs (Hashimshony et al. 2012). 
The cells are also manually selected, preventing high throughput application. An alternative 
method is G&T-seq (genome and transcriptome sequencing), which captures RNA using 
biotinylated primers and separates it from DNA using streptavidin-coated magnetic beads; the 
RNA is processed using the Smart-seq2 protocol and multiple displacement amplification is used 
to amplify DNA (Macaulay et al. 2015, 2016). Sequencing both the genome and transcriptome 
from a single cell makes it possible to link genomic and transcriptomic heterogeneity. These 
technologies have not been applied to the haematopoietic system yet, but could be particularly 
useful in studying blood disorders where acquired mutations are linked to aberrant function 
(Hamey et al. 2016). 
7.2.4. Combining single-cell transcriptomic and epigenomic measurements 
While this thesis focused on transcriptional heterogeneity and regulation of HSPC differentiation, 
the transcriptome is not the only factor that impacts cell fate decision making. Epigenetic regulation 
plays an important role during HSC maintenance and differentiation. Chromatin modifications are 
involved in programming gene expression changes in undifferentiated HSCs as well as 
differentiating cells (Cui et al. 2009). Several single-cell methods have been designed to interrogate 
the epigenome (Table 7.1). 
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Table 7.1. Single-cell methods interrogating the epigenome. Methods are grouped by the target of interest. 
Target Methods 
DNA 
methylation 
• Single-cell Reduced Representation Bisulfite Sequencing (scRRBS) (H. Guo et al. 
2013) 
• Single-cell Bisulfite Sequencing (scBS) (Smallwood et al. 2014) 
Histone 
modifications 
• Drop-ChIP: combines microfluidics, DNA barcoding and next-generation 
sequencing to assess the chromatin state of single cells (Rotem et al. 2015)  
Chromatin 
accessibility 
• Single-cell Assay for Transposase-Accessible Chromatin (scATAC-seq)  
• Cusanovich et al.: based on cellular indexing (Cusanovich et al. 2015) 
• Buenrostro et al.: based on microfluidics (Buenrostro et al. 2015) 
Chromatin 
arrangement 
• Single-cell Hi-C (Nagano et al. 2013) 
Combined 
approaches 
• Single-cell genome-wide methylome and transcriptome profiling 
• scM&T-seq (Angermueller et al. 2016) 
• scMT-seq (Hu et al. 2016) 
• Single-cell Nucleosome, Methylation and Transcription Sequencing (scNMT-seq) 
(Clark et al. 2018) 
• Single-cell Trio-seq (Y. Hou et al. 2016) 
• Single-cell analysis of genotype, expression and methylation (sc-GEM) (Cheow et 
al. 2016) 
 
Buenrostro et al. used scATAC-seq to interrogate the chromatin accessibility of 10 HSPC 
populations and recapitulated the haematopoietic hierarchy (Buenrostro et al. 2018). They also 
performed scRNA-seq separately and associated the transcriptomic and epigenomic data using 
computational methods. Recently, new methods have been developed that simultaneously profile 
the transcriptome and features of the epigenome. Angermueller et al. and Hu et al. both published 
methods that combined single-cell genome-wide methylome and transcriptome profiling, called 
scM&T-seq and scMT-seq, respectively (Angermueller et al. 2016; Hu et al. 2016). Single-cell 
NMT-seq is a recent method that simultaneously profiles chromatin accessibility, DNA 
methylation, and the transcriptome (Clark et al. 2018). New technologies are also combining 
measurements of genomic, transcriptomic, and epigenomic data. Hou et al. combined scRNA-seq 
with scRRBS to create scTrio-seq, which is a single-cell triple-omics approach that simultaneously 
captures information of genomic copy-number variations, the DNA methylome, and the 
transcriptome (Y. Hou et al. 2016). An alternative method is sc-GEM, which combines a 
methylation assay with single-cell qRT-PCR and single-cell genotyping (Cheow et al. 2016).  
These methods provide a new single-cell approach for studying heterogeneity during 
differentiation processes whilst combining the analysis of multiple factors that influence cell fate 
decision making. Many of these methods require the separation of cellular components of the 
individual analyses, reducing sensitivity, and may be restricted by the cost of performing the multi-
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omics approach. The continued growth of the single-cell field is likely to yield solutions to the 
current issues facing multi-omics approaches, leading to new insights into HSPC biology. 
7.2.5. High-throughput CRISPR screening with gene expression analysis 
Genome editing is a powerful approach for studying the roles of particular genes and how 
perturbing their function affects the system in which they act. This approach can provide insights 
into gene functions in a normal state but is also important for understanding the effect of gene 
perturbations in disease states. 
In the work described in Chapter 4, a low-throughput approach was used to perturb genes 
implicated in HSC biology to study their effect on cell phenotype and differentiation. Specifically, 
genes were targeted using CRISPR gRNAs, which guided the Cas9 nuclease to the gene of interest 
to cut the double stranded DNA, leading to loss of function mutations. This CRISPR screen was 
performed in bulk populations and measured changes in surface marker expression and colony 
output. Researchers have also used CRISPR/Cas9 technology to perform genome-wide knockout 
screens in individual cells, but these screens required follow-up investigations to dissect gene 
functions and their effect on the transcriptional network (Shalem et al. 2014; T. Wang et al. 2014).  
Advances in single-cell and CRISPR/Cas9 technologies have made it possible to perform high-
throughput, genome-wide knockout screens that show how the perturbations influence a cell’s 
molecular profile. CRISP-Seq and Perturb-Seq use a library of barcoded gRNAs to target different 
genes; these barcodes can then identify the gRNAs present within a cell (Adamson et al. 2016; 
Dixit et al. 2016; Jaitin et al. 2016). While both approaches pair scRNA-seq with the CRISPR-
based perturbations, CRISP-seq was developed on the massively parallel RNA-seq (MARS-seq) 
platform, whereas Perturb-seq uses a droplet-based approach. Jaitin et al. used CRISP-seq to 
interrogate gene regulation and heterogeneity in the immune system using a pool of gRNAs 
targeting 22 genes. The responses to the various perturbations were heterogeneous across different 
cell types, highlighting the need for single-cell analysis (Jaitin et al. 2016). Dixit et al. used Perturb-
seq to interrogate the consequences of perturbing 24 different transcription factors in the immune 
system, either alone or in combination (Dixit et al. 2016). In their coordinating study, Adamson et 
al. performed CRISPR interference screens using the Perturb-seq platform to investigate the effect 
of repressing target genes on the mammalian unfolded protein response (Adamson et al. 2016). 
Typical gRNAs lack a polyadenylated tail and thus are not detectable by scRNAseq; an alternative 
approach, CROP-seq, redesigned a CRISPR vector to include the gRNA in a polyadenylated 
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mRNA transcript (Datlinger et al. 2017). This design makes it possible for the gRNA to be detected 
by scRNA-seq, circumventing the need for a barcoded gRNA library. Importantly, all these 
approaches were developed with accompanying computational methods capable of handling the 
complexity of the resultant data sets. These combined CRISPR perturbation and scRNA-seq 
methods are powerful tools for gaining functional and molecular insights into biological systems, 
including haematopoiesis. 
7.2.6. Lineage tracing and “real time” cell dynamics 
In this thesis, lineage trajectories were inferred from single-cell gene expression data using 
pseudotime ordering. Single-cell gene expression data represents a snapshot of each cell in a 
particular gene expression state, and pseudotime trajectory inference methods order these snapshots 
to reconstruct possible differentiation pathways, describing the gene expression changes occurring 
along the trajectory (Trapnell et al. 2014; Setty et al. 2016; Haghverdi et al. 2016). However, as 
these methods rely on snapshots, they lack temporal resolution, missing information such as the 
length of time a cell resides in a particular molecular state and how many cell divisions occur before 
developmental processes are observed. Furthermore, snapshot data may miss some of the gene 
expression dynamics that occur between the captured cell states, potentially leading to 
misrepresentation of the fate decision making processes (Etzrodt and Schroeder 2017). 
Quantitative time-lapse imaging technologies offer an alternative approach to studying 
transcriptional regulation in single cells. Continuous single-cell imaging that is uninterrupted over 
several cell divisions provides temporal information about molecular dynamics (Skylaki, 
Hilsenbeck, and Schroeder 2016). This method was applied to investigate the relationship between 
GATA1 and PU.1 during differentiation towards megakaryocytic-erythroid and granulocytic-
monocytic lineages (Hoppe et al. 2016). Traditionally, it was thought that these transcription factors 
inhibit each other’s expression and can reprogram cells towards their respective lineages. However, 
this was not detected in live cell imaging; instead, the transcription factors were independently 
regulated at the start of megakaryocytic-erythroid or granulocytic-monocytic differentiation, and 
they were reinforcing lineage choices rather than initiating them (Hoppe et al. 2016). These 
findings show how live-cell imaging can reveal biological relationships that are contrary to 
snapshot gene expression data. Relating live-cell imaging to pseudotime ordering could add a new 
dimension to transcriptional regulation research, leading to an improved understanding of how a 
single HSC can differentiate into multiple distinct mature blood cell types. 
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Continuous live-cell imaging is a non-invasive technique that preserves information about the past 
and future of a single-cell. The observed molecular dynamics can therefore be used to identify past 
cell states and predict future fate decisions (Skylaki, Hilsenbeck, and Schroeder 2016). However, 
it is a very low-throughput method due to the intensive imaging and computational power required 
to track a single cell through differentiation. Recently, new methods have been developed that 
interrogate past and future cell states, which could offer meaningful insights into the structure of 
the haematopoietic tree.  
Single-cell gene expression has been combined with genetic labelling of single cells to reconstruct 
lineage hierarchies in three related technologies: LINNAEUS (lineage tracing by nuclease-
activated editing of ubiquitous sequences), scGESTALT (single cell genome editing of synthetic 
target arrays for lineage tracing) and ScarTrace (Spanjaard et al. 2017; Raj et al. 2018; Alemany et 
al. 2018). These technologies use CRISPR/Cas9 technology to randomly cause indels in target 
genes, called genomic scars, which produce somatic mutations that are heritable through cell 
divisions (Shapiro 2018). Paired with single-cell transcriptome sequencing, cell type and lineage 
information are recorded and used to reconstruct lineage trees. LINNAEUS and scGESTALT only 
use scRNA-seq to quantify the genomic scars, whereas ScarTrace also detects the scars from 
genomic DNA. These methods have been used in zebrafish to study fate decisions governing 
embryogenesis, brain development, haematopoiesis, and fin regeneration (Spanjaard et al. 2017; 
Alemany et al. 2018; Raj et al. 2018). It is challenging to implement these methods in more 
complex organisms; only very recently has a new technology been suggested for a ‘molecular 
recorder’ that characterises mammalian fate maps (Chan et al. 2018). Undoubtedly, these lineage 
tracing methods will continue to be optimised and further developed, as they confer a unique 
opportunity to characterise the molecular identities and lineage histories of cells. In contrast, a 
recent publication describes a computational method used to predict a cell’s future from scRNA-
seq data. RNA velocity uses information about the ratios of unspliced and spliced mRNA to model 
the direction in which a cell is moving in the transcriptional space (La Manno et al. 2018). This 
method can be applied to datasets generated with commonly used single-cell plate- and droplet-
based RNA-seq platforms, meaning it could be used to study cell dynamics in already existing 
datasets. Together, these technologies that look to the past and future of cell fate decisions could 
be particularly useful in HSPC biology, where many questions are raised about the structure of the 
haematopoietic hierarchy.  
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7.3. Concluding remarks 
This thesis focused on improving our understanding of the transcriptional regulation underpinning 
haematopoietic stem and progenitor cell differentiation. Advances in single-cell technologies made 
in-depth study of transcriptional regulation and heterogeneity in HSPC populations possible, using 
single-cell gene expression techniques to reconstruct lineage trajectories and regulatory networks. 
The transcriptional landscape generated in this thesis using scRNA-seq has been made publicly 
available, providing a powerful resource for the haematopoietic community. The methods 
described in this thesis should be widely applicable to study haematopoiesis in normal and 
perturbed cells, furthering our knowledge of haematological diseases with implications for future 
therapies. 
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